<SEC-DOCUMENT>0001213900-16-013671.txt : 20160520
<SEC-HEADER>0001213900-16-013671.hdr.sgml : 20160520
<ACCEPTANCE-DATETIME>20160520160546
ACCESSION NUMBER:		0001213900-16-013671
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		35
CONFORMED PERIOD OF REPORT:	20160331
FILED AS OF DATE:		20160520
DATE AS OF CHANGE:		20160520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Harmony Merger Corp.
		CENTRAL INDEX KEY:			0001612720
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				465723951
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36842
		FILM NUMBER:		161666227

	BUSINESS ADDRESS:	
		STREET 1:		777 THIRD AVENUE, 37TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		212-319-7676

	MAIL ADDRESS:	
		STREET 1:		777 THIRD AVENUE, 37TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>f10q0316_harmonymerger.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<B>UNITED STATES</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>(MARK ONE)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Calibri,sans-serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: MS Mincho"><B>&#9746;</B></FONT><B><FONT STYLE="font-family: Times New Roman,serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>For the period ended March&nbsp;31, 2016</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Calibri,sans-serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: MS Mincho"><B>&#9744;</B></FONT><B><FONT STYLE="font-family: Times New Roman,serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Commission file number: <U>001-36842</U></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<tr style="vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt/115% Calibri,sans-serif; text-align: center; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 18pt"><b>HARMONY MERGER CORP.</b></font></td></tr>
<tr style="vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt/115% Calibri,sans-serif; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">(Exact Name of Registrant as Specified in Its Charter)</font></td></tr>
<tr style="vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt/115% Calibri,sans-serif; text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1.5pt solid; font: 10pt/115% Calibri,sans-serif; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt"><b>Delaware</b></font></td>
    <TD STYLE="width: 1%; font: 10pt/115% Calibri,sans-serif; text-align: center">&nbsp;</td>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; font: 10pt/115% Calibri,sans-serif; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt"><b>46-5723951</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-align: center">
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">(State or other jurisdiction of</P>
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">incorporation or organization)</P></td>
    <TD STYLE="font: 10pt/115% Calibri,sans-serif; text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">(I.R.S. Employer</P>
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">Identification No.)</P></td></tr>
</table>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>777 Third Avenue, 37th Floor</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>New York, New York 10017</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>212-319-7676</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">(Issuer&rsquo;s telephone number)</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Calibri,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman,serif">Check
whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to file such reports), and&nbsp;&nbsp;(2) has been subject to such
filing requirements for the past 90 days.&nbsp;&nbsp;Yes&nbsp;</FONT><FONT STYLE="font-family: MS Mincho">&#9746;</FONT><FONT STYLE="font-family: Times New Roman,serif">&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT><FONT STYLE="font-family: MS Mincho">&#9744;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Calibri,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman,serif">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (</FONT><FONT STYLE="font-family: Symbol">'</FONT><FONT STYLE="font-family: Times New Roman,serif">232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post
such files).&nbsp;&nbsp;Yes&nbsp;&nbsp;</FONT><FONT STYLE="font-family: MS Mincho">&#9746;</FONT><FONT STYLE="font-family: Wingdings">
</FONT><FONT STYLE="font-family: Times New Roman,serif">No </FONT><FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Indicate by check mark whether the Registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&nbsp;&nbsp;See the
definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo;
in Rule 12b-2 of the Exchange Act (Check one).</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="background-color: white">
    <td style="width: 25%; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">Large accelerated filer</font></td>
    <td style="width: 15%; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: MS Mincho; font-size: 10pt">&#9744;</font></td>
    <td style="width: 25%; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">Accelerated filer</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: MS Mincho; font-size: 10pt">&#9744;</font></td></tr>
<tr style="background-color: white">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td></tr>
<tr style="background-color: white">
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">Non-accelerated filer&nbsp;&nbsp;</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: MS Mincho; font-size: 10pt">&#9746;</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">Smaller reporting company</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: MS Mincho; font-size: 10pt">&#9744;</font></td></tr>
<tr style="background-color: white">
    <td nowrap colspan="2" style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">(Do not check if smaller reporting company)</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Calibri,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman,serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;Yes </FONT><FONT STYLE="font-family: MS Mincho">&#9746;</FONT><FONT STYLE="font-family: Times New Roman,serif">
&nbsp;No&nbsp;</FONT><FONT STYLE="font-family: MS Mincho">&#9744;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">As of May 20, 2016, 15,084,750 shares of common
stock, par value $0.0001 per share were issued and outstanding.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><BR CLEAR="ALL">
</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>HARMONY MERGER CORP.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>FORM 10-Q FOR THE QUARTER ENDED March&nbsp;31,
2016</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%; line-height: 107%">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Part I. Financial Information</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-left: 27pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Item 1. Financial Statements</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-left: 45pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Condensed Balance Sheets </FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-left: 63pt; text-indent: -0.25in; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Condensed Statements of Operations </FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-left: 63pt; text-indent: -0.25in; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Condensed Statements of Cash Flows</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-left: 63pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Notes to Unaudited Condensed Financial Statements</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">4-10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-left: 27pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Item 2. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">11-12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-left: 27pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-left: 27pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Item 4. Controls and Procedures</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">12</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Part II. Other Information</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-left: 27pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">13-14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-left: 27pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Item 6. Exhibits</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">14</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Signatures</FONT></TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">15</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>PART I &ndash; FINANCIAL INFORMATION</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Item 1. Financial Statements.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Condensed Balance Sheets</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="color: #323232; font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31, 2016</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31, 2015</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="color: #323232; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="color: #323232; font-weight: bold">ASSETS</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="color: #323232; font-weight: bold">Current Assets:</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; color: #323232; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; color: #323232">&nbsp;</TD>
    <TD STYLE="width: 1%; color: #323232; text-align: left">$</TD><TD STYLE="width: 9%; color: #323232; text-align: right">157,422</TD><TD STYLE="width: 1%; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; color: #323232">&nbsp;</TD>
    <TD STYLE="width: 1%; color: #323232; text-align: left">$</TD><TD STYLE="width: 9%; color: #323232; text-align: right">324,991</TD><TD STYLE="width: 1%; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; text-align: left; padding-bottom: 1.5pt">Prepaid expenses</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">48,555</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">46,687</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 9px">Total current assets:</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">205,977</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">371,678</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; text-align: left">Cash, cash equivalents and securities held in Trust</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">117,420,942</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">117,374,895</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; text-align: left; padding-bottom: 1.5pt">Prepaid expenses - long term</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">65,756</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">66,373</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 9px">Total assets:</TD><TD STYLE="color: #323232; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: right">117,692,675</TD><TD STYLE="padding-bottom: 4pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: right">117,812,946</TD><TD STYLE="padding-bottom: 4pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">LIABILITIES &amp; STOCKHOLDERS' EQUITY</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">Current Liabilities</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; text-align: left; padding-bottom: 1.5pt">Accounts Payable</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">53,193</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">17,259</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 9px">Total current liabilities:</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">53,193</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">17,259</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; text-align: left; padding-bottom: 1.5pt">Deferred Underwriters Fee</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">4,325,000</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">4,325,000</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 9px">Total liabilities</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">4,378,193</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">4,342,259</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold">Commitments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">Common Stock, subject to possible conversion (10,585,784 shares at conversion value)</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">108,086,324</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">108,043,938</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">Stockholders' equity</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; text-align: left">Preferred stock, $.0001 par value, 1,000,000 authorized, 0 outstanding</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">-</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">-</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; text-align: left">Common stock, $.0001 par value; Authorized 27,500,000 shares, 4,498,966 issued and outstanding at March&nbsp;31, 2016 (excluding 10,585,784 shares subject to possible conversion) and 4,498,966 issued and outstanding at December&nbsp;31, 2015.</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">450</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">450</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; text-align: left; padding-left: 20pt">Additional paid-in capital</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">5,648,423</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">5,690,809</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Accumulated deficit</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">(420,715</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">)</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">(264,510</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding: 0; text-indent: 0">Total stockholders' equity</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">5,228,158</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">5,426,749</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding: 0; text-indent: 0">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="color: #323232; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: right">117,692,675</TD><TD STYLE="padding-bottom: 4pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; color: #323232; text-align: right">117,812,946</TD><TD STYLE="padding-bottom: 4pt; color: #323232; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">The accompanying notes are
an integral part of these unaudited condensed financial statements.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0 0 10pt; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>Condensed Statements of Operations</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Three months ended<BR>
March&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>2016</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>2015</B></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold; text-align: left">General and administrative costs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">164,801</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,217</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">General and administrative costs - related party</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">37,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 9px">Operating loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(202,301</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,217</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Interest Income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">46,096</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">24</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Net loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(156,205</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(8,193</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt">Weighted average shares outstanding</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,498,966</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,726,204</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Basic and diluted net loss per share</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(0.00</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt/normal Calibri,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">The accompanying notes are an integral part of
these unaudited condensed financial statements.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Condensed Statements of Cash Flows</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-family: Calibri, sans-serif">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2015</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-family: Calibri, sans-serif">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; color: #323232; font-weight: bold; text-align: left; padding-left: 27px">Net Loss</TD><TD STYLE="width: 1%; color: #323232">&nbsp;</TD>
    <TD STYLE="width: 1%; color: #323232; text-align: left">$</TD><TD STYLE="width: 9%; color: #323232; text-align: right">(156,205</TD><TD STYLE="width: 1%; color: #323232; text-align: left">)</TD><TD STYLE="width: 1%; color: #323232">&nbsp;</TD>
    <TD STYLE="width: 1%; color: #323232; text-align: left">$</TD><TD STYLE="width: 9%; color: #323232; text-align: right">(8,193</TD><TD STYLE="width: 1%; color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 27px">Adjustments to reconcile Net Loss to net cash provided by operations:</TD><TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD>
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 36px">Interest earned on cash and securities in trust</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">(46,047</TD><TD STYLE="color: #323232; text-align: left">)</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 36px">Changes in operating assets and liabilities:</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">-</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 20pt">&nbsp;&nbsp;&nbsp;Prepaid expenses</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">(1,251</TD><TD STYLE="color: #323232; text-align: left">)</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">(119,345</TD><TD STYLE="color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">&nbsp;&nbsp;&nbsp;Accounts payable</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">35,934</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">81,977</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by Operating Activities</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">(167,569</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">)</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">(45,561</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 27px">Investment in cash, cash equivalents and securities in Trust Account</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">(117,300,000</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in Investing Activities</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">(117,300,000</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 9px">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 27px">Payment of offering costs</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">-</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">(43,208</TD><TD STYLE="color: #323232; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 27px">Proceeds from sale of shares of common stock to initial stockholders</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">-</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">75,674</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 27px">Proceeds from Public Offering, net of offering costs</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">-</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">112,605,665</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 27px">Proceeds from Insider Units</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">5,585,000</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by Financing Activities</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: right">118,223,131</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-left: 9px">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left">Net increase in cash and cash equivalents</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">(167,569</TD><TD STYLE="color: #323232; text-align: left">)</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">877,570</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232">&nbsp;</TD>
    <TD STYLE="color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; text-align: right">&nbsp;</TD><TD STYLE="color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 27px">Cash and cash equivalents at beginning of period</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">324,991</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">1,115</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents at end of period</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: right">157,422</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: right">878,685</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Supplemental disclosure of non-cash investing and financing activities</TD><TD STYLE="color: #323232; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; text-align: left">&nbsp;</TD><TD STYLE="font-family: Calibri, sans-serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Calibri, sans-serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Calibri, sans-serif; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-family: Calibri, sans-serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="color: #323232; font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 27px">Accrual of deferred underwriting fee</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="color: #323232; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; color: #323232; font-weight: bold; text-align: right">(4,325,000</TD><TD STYLE="padding-bottom: 1.5pt; color: #323232; font-weight: bold; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">The accompanying notes are an integral part of
these unaudited condensed financial statements.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Note 1 &mdash; Organization and Plan of Business Operations</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Harmony Merger Corp. (the &ldquo;Company&rdquo;)
was incorporated in Delaware on May 21, 2014 as a blank check company whose objective is to acquire, through a merger, share exchange,
asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, one or more businesses
or entities (a &ldquo;Business Combination&rdquo;).</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The accompanying financial statements are presented
in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America
(&ldquo;US GAAP&rdquo;) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange
Commission (the &ldquo;SEC&rdquo;).</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">All activity through March&nbsp;31, 2016 relates
to the Company&rsquo;s formation, initial public offering and identifying suitable candidates for a Business Combination.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The registration statement for the Company&rsquo;s
initial public offering was declared effective on March 23, 2015. The Company consummated a public offering of 11,500,000 units
(&ldquo;Units&rdquo;) on March 27, 2015 (the &ldquo;Offering&rdquo;), including the exercise of the over-allotment option (&ldquo;Overallotment&rdquo;)
of 1,500,000 Units, generating gross proceeds of $115,000,000 and net proceeds of $112,605,665 after deducting $2,394,335 of transaction
costs (up to an additional $4,325,000 of deferred underwriting expenses may be paid upon the completion of a business combination),
which is discussed in Note 3. In addition, the Company generated gross and net proceeds of $5,585,000 from a private placement
(the &ldquo;Private Placement&rdquo;) of units (&ldquo;Private Units&rdquo;) to certain of the Initial Stockholders (defined below)
and Cantor Fitzgerald &amp; Co., the representative of the underwriters in the Offering (&ldquo;Cantor&rdquo;), which is described
in Note 4.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company&rsquo;s management has broad discretion
with respect to the specific application of the net proceeds of the Offering and Private Placement, although substantially all
of the net proceeds are intended to be generally applied toward consummating a Business Combination. The Company&rsquo;s securities
are listed on the Nasdaq Capital Market (&ldquo;NASDAQ&rdquo;). Pursuant to the NASDAQ listing rules, the Company&rsquo;s initial
Business Combination must be with a target business or businesses whose collective fair market value is at least equal to 80% of
the balance in the trust account at the time of the execution of a definitive agreement for such Business Combination, although
this may entail simultaneous acquisitions of several target businesses. There is no assurance that the Company will be able to
effect a Business Combination successfully.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Following the closing of the Offering and the
Private Placement on March 27, 2015, an amount of $117,300,000 (or $10.20 per share sold to the public in the Offering included
in the Units (&ldquo;Public Shares&rdquo;)) from the sale of the Units and Private Units is being held in a trust account (&ldquo;Trust
Account&rdquo;) and may be invested in money market funds meeting the applicable conditions of Rule 2a-7 promulgated under the
Investment Company Act of 1940, as amended, and that invest solely in U.S. treasuries or United States bonds, treasuries or notes
having a maturity of 180 days or less. The $117,300,000 placed into the Trust Account may not be released until the earlier of
(i) the consummation of the Company&rsquo;s initial Business Combination and (ii) the Company&rsquo;s failure to consummate a Business
Combination within the prescribed time. The remaining net proceeds (not held in the Trust Account) may be used to pay for business,
legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally,
the interest earned on the Trust Account balance may be released to the Company to pay the Company&rsquo;s tax obligations. Placing
funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek
to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the
Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will
execute such agreements.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company, after signing a Business
Combination, is required to provide stockholders who acquired Public Shares in the Offering (&ldquo;Public
Stockholders&rdquo;) with the opportunity to convert their Public Shares for a pro rata share of the Trust Account. In the
event that stockholders owning approximately 92.05% or more of the Public Shares exercise their conversion rights described
below, the Business Combination will not be consummated. The actual percentages, however, will only be able to be determined
once a target business is located and the Company can assess all of the assets and liabilities of the combined company upon
consummation of the proposed Business Combination, subject to the requirement that the Company must have at least $5,000,001
of net tangible assets upon close of such Business Combination. As a result, the actual percentage of shares that can be
converted may be significantly lower than the above estimates. The stockholders of the Company prior to the Offering (the
&ldquo;Initial Stockholders&rdquo;) have agreed to vote any shares they then hold in favor of any proposed Business
Combination and will waive any conversion rights with respect to these shares and the shares included in the Private Units
pursuant to letter agreements executed in connection with the Offering.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements (continued)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">In connection with any proposed Business Combination,
the Company will seek stockholder approval of an initial Business Combination at a meeting called for such purpose at which Public
Stockholders may seek to convert their Public Shares, regardless of whether they vote for or against the proposed Business Combination.
If the Company seeks stockholder approval of an initial Business Combination, any Public Stockholder voting either for or against
such proposed Business Combination will be entitled to demand that his Public Shares be converted into a full pro rata portion
of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the
Trust Account and not released to the Company to pay its taxes). Holders of warrants sold as part of the Units will not be entitled
to vote on the proposed Business Combination and will have no conversion or liquidation rights with respect to their shares of
common stock underlying such warrants.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company will consummate a Business Combination
only if holders of less than approximately 92.05% of the Public Shares, subject to adjustment as described above, elect to convert
their shares to a pro-rata portion of the amount held in the Trust Account and a majority of the outstanding shares of common stock
voted, are voted in favor of the Business Combination. Notwithstanding the foregoing, the Amended and Restated Certificate of Incorporation
of the Company provides that a Public Stockholder, together with any affiliate or other person with whom such Public Stockholder
is acting in concert or as a &ldquo;group&rdquo; (within the meaning of Section 13 of the Securities Act of 1934, as amended),
will be restricted from seeking conversion rights with respect to an aggregate of more than 20% of the Public Shares (but only
with respect to the amount over 20% of the Public Shares). A &ldquo;group&rdquo; will be deemed to exist if Public Stockholders
(i) file a Schedule 13D or 13G indicating the presence of a group or (ii) acknowledge to the Company that they are acting, or intend
to act, as a group.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Pursuant to the Company&rsquo;s Amended and
Restated Certificate of Incorporation, if the Company is unable to complete its initial Business Combination by March 27, 2017,
the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not
more than ten business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of the remaining holders of common stock and the Company&rsquo;s board of directors,
dissolve and liquidate. If the Company is unable to consummate an initial Business Combination and is forced to redeem 100% of
the outstanding public shares for a pro rata portion of the funds held in the Trust Account, each holder will receive a full pro
rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account
and not released to the Company to pay any of its taxes. Holders of warrants will receive no proceeds in connection with the liquidation.
The Initial Stockholders and the holders of Private Units will not participate in any redemption distribution with respect to their
initial shares and Private Units, including the common stock included in the Private Units.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">If the Company is unable to complete its initial
Business Combination and expends all of the net proceeds of the Offering not deposited in the Trust Account, without taking into
account any interest earned on the Trust Account, the Company expects that the initial per-share redemption price for common stock
will be $10.20. The proceeds deposited in the Trust Account could, however, become subject to claims of the Company&rsquo;s creditors
that are in preference to the claims of the Company&rsquo;s stockholders. In addition, if the Company is forced to file a bankruptcy
case or an involuntary bankruptcy case is filed against it that is not dismissed, the proceeds held in the Trust Account could
be subject to applicable bankruptcy law, and may be included in its bankruptcy estate and subject to the claims of third parties
with priority over the claims of the Company&rsquo;s common stockholders. Therefore, the actual per-share redemption price may
be less than $10.20.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements (continued)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Eric S. Rosenfeld, the Company&rsquo;s Chief
Executive Officer, has agreed that he will be liable to the Company if and to the extent any claims by a vendor for services rendered
or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement, reduces the amount of funds in the Trust Account to below $10.20 per public share, except as to any claims by a third
party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the indemnity
of the underwriters of the Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the
event that an executed waiver is deemed to be unenforceable against a third party, Mr. Rosenfeld will not be responsible to the
extent of any liability for such third party claims. Furthermore, he will not be personally liable to Public Stockholders and instead
will only have liability to the Company. The Company has not independently verified whether Mr. Rosenfeld has sufficient funds
to satisfy his indemnity obligations and, therefore, Mr. Rosenfeld may not be able to satisfy those obligations. The Company has
not asked Mr. Rosenfeld to reserve for such eventuality. Accordingly, if the Company liquidates, the per-share distribution from
the trust account could be less than $10.20 due to claims or potential claims of creditors.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Mr. Rosenfeld has also agreed to enter into
an agreement in accordance with the guidelines of Rule 10b5-1of the Exchange Act, pursuant to which he will place limit orders
for an aggregate of up to $500,000 of common stock of the Company commencing on the later of (1) two business days after a Form
8-K disclosing all material information relating to an initial Business Combination, and (2) 60 days after the termination of the
&ldquo;restricted period&rdquo; in connection with Offering under Regulation M of the Exchange Act, and ending on the record date
for the shareholder meeting at which such initial Business Combination is to be approved, or earlier in certain circumstances as
described in the limit order agreement, which is referred to as the buyback period. These limit orders will require Mr. Rosenfeld
to purchase any shares of common stock of the Company offered for sale (and not purchased by another investor) at or below a price
equal to the per-share amount held in the Trust Account as reported in such Form 8-K, until the earlier of (1) the expiration of
the buyback period or (2) the date such purchases reach $500,000 in total. The Company will provide at least 20 business days between
the beginning of the buyback period and the record date for the shareholder meeting for such initial Business Combination. It is
intended that the purchases will satisfy the conditions of Rule 10b-18(b) under the Exchange Act to the extent possible and the
concernbroker&rsquo;s purchase obligation will otherwise be subject to applicable law, including Regulation M under the Exchange
Act, which may prohibit or limit purchases pursuant to the limit order agreement in certain circumstances. Any shares purchased
by Mr. Rosenfeld pursuant to this arrangement will be voted in favor of the proposed Business Combination. Additionally, Mr. Rosenfeld
has agreed not to convert any buyback shares into the right to receive a pro rata portion of the funds held in the Trust Account
or to transfer, assign or sell any buyback shares (except to the same permitted transferees as the insider shares and provided
the transferees agree to the same transfer restrictions) until (A) the earlier of one year after the completion of an Initial Business
combination and the date on which the closing price of common stock of the Company exceeds $12.50 for any 20 trading days within
a 30-trading day period following the completion of an Initial Business combination with respect to 50% of the buyback shares and
(B) one year after the completion of an Initial Business combination with respect to the remaining 50% of the buyback shares.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company anticipates that in order to fund
its working capital requirements, the Company will need to use all of the remaining funds not held in trust, the interest earned
on the funds held in the trust account, as well as enter into contingent fee arrangements with its vendors. The Company may need
to enter into contingent fee arrangements with vendors or raise additional capital through loans or additional investments from
initial shareholders, officers, directors, or third parties. None of the initial shareholders, officers or directors is under any
obligation to advance funds to, or invest in, the Company. Accordingly, the Company may not be able to obtain additional financing.
If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which
could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and controlling
overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable
terms, if at all. The Company has no present revenue, and the Company&rsquo;s cash and working capital as of March&nbsp;31, 2016 are
not sufficient to complete its planned activities for the upcoming year. These conditions raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements (continued)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Note 2 &mdash; Significant Accounting Policies</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B><I>Basis of Presentation</I></B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The accompanying unaudited condensed financial
statements have been prepared for interim financial information and the instructions to Form 10-Q.&nbsp;&nbsp;Accordingly, they
do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting
of normal accruals) considered for a fair presentation have been included.&nbsp;&nbsp;The Company has evaluated subsequent events
through the issuance of this Form 10-Q.&nbsp;&nbsp;Operating results for the quarter ended March&nbsp;31, 2016&nbsp;are not necessarily
indicative of the results that may be expected for the year ending December&nbsp;31, 2016 or any other period. The accompanying condensed
financial statements should be read in conjunction with the Company&rsquo;s financial statements and notes thereto included in
the Company&rsquo;s prospectus filed with the Securities and Exchange Commission on March 24, 2015.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Cash and Cash Equivalents</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company considers all short-term investments
with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times
may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash
deposits with major financial institutions.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Cash, cash equivalents and securities held
in Trust Account</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">At March&nbsp;31, 2016, substantially all of the
assets in the Trust Account were held in United States Treasury Bills with a maturity of April 21, 2016. $117,340,445 in US Treasury
Bills were purchased on October 27, 2015. At March&nbsp;31, 2016 the trust account had earned $46,047 and accrued $78,926 in interest
and held $1,571 in cash. This account is classified as restricted.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Fair value of financial instruments</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The fair value of the Company&rsquo;s assets
and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (&ldquo;FASB&rdquo;) Accounting
Standards Codification (&ldquo;ASC&rdquo;) 820, &ldquo;Fair Value Measurements and Disclosures,&rdquo; approximates the carrying
amounts represented in the balance sheet, primarily due to their short-term nature.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Net loss per common share </B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company complies with accounting and disclosure
requirements of ASC 260, &ldquo;Earnings Per Share.&rdquo; Net loss per common share is computed by dividing net loss applicable
to common stockholders by the weighted average number of common shares outstanding for the period. The Company has not considered
the effect of (i) warrants sold in the Initial Public Offering to purchase 11,500,000 shares of the Company and (ii) warrants sold
in the Private Units to purchase 558,500 shares of the Company, in the calculation of diluted loss per share, since the exercise
of the warrants is contingent on the occurrence of future events. 10,585,784<B> </B>shares of common stock subject to possible
conversion at March&nbsp;31, 2016, were also excluded from the calculation of basic loss per share since such shares, if redeemed, only
participate in their pro rata share of the trust earnings. At March&nbsp;31, 2016, the Company did not have any other dilutive securities
or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company.
As a result, diluted loss per common share is the same as basic loss per common share for the period.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Common stock subject to possible conversion</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company accounts for its common stock subject
to possible conversion in accordance with the guidance enumerated in ASC 480 &ldquo;Distinguishing Liabilities from Equity&rdquo;.&nbsp;&nbsp;&nbsp;Common
stock subject to mandatory conversion is classified as a liability instrument and is measured at fair value. Conditionally convertible
common stock (including common stock that features conversion rights that are either within the control of the holder or subject
to conversion upon the occurrence of uncertain events not solely within the Company&rsquo;s control) is classified as temporary
equity. At all other times, common stock is classified as stockholders&rsquo; equity. The Company&rsquo;s common stock features
certain conversion rights that are considered by the Company to be outside of the Company&rsquo;s control and subject to the occurrence
of uncertain future events. Accordingly at March&nbsp;31, 2016, the common stock subject to possible conversion is presented as temporary
equity, outside of the stockholders&rsquo; equity section of the Company&rsquo;s balance sheet.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements (continued)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Income Taxes</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company accounts for income taxes under
ASC 740 Income Taxes (&ldquo;ASC 740&rdquo;). ASC 740 requires the recognition of deferred tax assets and liabilities for both
the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected
future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance
to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">ASC 740 also clarifies the accounting for uncertainty
in income taxes recognized in an enterprise&rsquo;s financial statements and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For
those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure
and transition. The Company is required to file income tax returns in the United States (federal) and in various state and local
jurisdictions. Based on the Company&rsquo;s evaluation, it has been concluded that there are no significant uncertain tax positions
requiring recognition in the Company&rsquo;s financial statements. Since the Company was incorporated on May 21, 2014, the evaluation
was performed for the 2014 and 2015 tax years, which would be the only period subject to examination. The Company believes that
its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in
a material change to its financial position.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company&rsquo;s policy for recording interest
and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued
for penalties or interest as of or during the three months ended March&nbsp;31, 2016. Management is currently unaware of any issues
under review that could result in significant payments, accruals or material deviations from its position.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Use of Estimates</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The preparation of financial statements in conformity
with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those
estimates.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Recent Accounting Pronouncements</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Management does not believe that any recently
issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial
statements.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Subsequent Events</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Management has evaluated subsequent events to
determine if events or transactions occurring through the date these financial statements were issued, require potential adjustment
to or disclosure in the financial statements and has concluded that no subsequent events have occurred that would require recognition
in the financial statements or disclosure in the notes to the financial statements.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements (continued)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Note 3 &mdash; Initial Public Offering</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">On March 27, 2015, the Company sold 11,500,000
Units at a price of $10.00 per unit in the Offering. Each Unit consists of one share of common stock and one warrant (&ldquo;Warrant&rdquo;)
to purchase one share of common stock at a price of $11.50 per share. The Warrants are exercisable commencing on the later of 30
days after the Company&rsquo;s completion of a Business Combination or March 23, 2016 and expire five years from the completion
of a Business Combination. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days&rsquo; notice, only
in the event that the last sale price of the shares of common stock is at least $17.50 per share for any 20 trading days within
a 30-trading day period ending on the third day prior to the date on which notice of redemption is given. If the Company redeems
the Warrants as described above, it will have the option to require any holder that wishes to exercise his Warrant to do so on
a &ldquo;cashless basis.&rdquo; In accordance with the warrant agreement relating to the Warrants sold in the Offering, the Company
is only required to use its best efforts to file the registration statement covering the shares underlying the Warrants within
15 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement. If a registration
statement is not effective within 90 days following the consummation of a Business Combination, Warrant holders may, until such
time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective
registration statement, exercise Warrants on a cashless basis. If the Company is unable to consummate a Business Combination, the
Company will redeem 100% of the Public Shares using the funds in the Trust Account as described in Note 1. In such event, the Warrants
will be worthless. In no event will the Company be required to net cash settle the Warrants.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Note 4 &mdash; Private Units</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">Simultaneously with the Offering, certain of
the Initial Stockholders of the Company and Cantor purchased an aggregate of 558,500 Private Units at $10.00 per Private Unit (for
an aggregate purchase price of $5,585,000) from the Company.&nbsp;All of the proceeds received from these purchases were placed
in the Trust Account.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Private Units are identical to the Units
sold in the Offering, except the Warrants included in the Private Units are non-redeemable and may be exercised on a cashless basis,
in each case so long as they continue to be held by the initial purchasers or their permitted transferees. In addition, for as
long as any of the warrants underlying the Private Units are held by Cantor or its designees or affiliates, they may not be exercised
after five years from the effective date of the registration statement relating to the Offering. Additionally the initial stockholders
have agreed to vote the shares of common stock included therein in favor of any proposed Business Combination. All of the purchasers
of the Private Units have agreed (i) not to convert any shares of common stock included therein into the right to receive cash
from the Trust Account in connection with a stockholder vote to approve the proposed initial Business Combination and (ii) that
the shares of common stock included therein shall not participate in any liquidating distribution upon winding up if a Business
Combination is not consummated. Additionally, the holders have agreed not to transfer, assign or sell any of the Private Units
or underlying securities (except to certain permitted transferees) until the completion of the initial Business Combination.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Note 5 &mdash; Notes Payable and Advance
From Stockholders</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company issued a $50,000 principal amount
unsecured promissory note to Eric S. Rosenfeld, the Company&rsquo;s Chief Executive Officer and an Initial Stockholder, on May
30, 2014. The note was non-interest bearing and payable on the earlier of (i) May 31, 2015, (ii) the consummation of the Offering
or (iii) the date on which the Company determined not to proceed with the Offering. This loan became payable upon the consummation
of the Offering and was paid to Mr. Rosenfeld in April 2015.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Note 6 &mdash; Commitments</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company has entered into an agreement with
the underwriters of the Offering (&ldquo;Underwriting Agreement&rdquo;) that required the Company to pay an underwriting discount
of 2.0% of the gross proceeds of the Offering as an underwriting discount (excluding proceeds received from the exercise of the
over-allotment option, on which the Company will not pay any upfront underwriting discount) and a deferred underwriting discount
of up to 3.5% (or up to 5.5% on any proceeds received from the exercise of the over-allotment option) for an aggregate underwriting
discount of up to 5.5% of the gross proceeds of the Offering. The Underwriting Agreement provides that up to $926,786 of the deferred
underwriting discount may be payable to certain parties who are instrumental in advising the Company in connection with the closing
of the Business Combination on either a contingent or non-contingent basis; provided, however that any portion of the deferred
underwriting commission relating to an allocation made on a contingent basis where the contingency is not met shall not be paid
to any party. The Underwriting Agreement provides that the deferred underwriting discount will only be payable if the Company successfully
completes its initial Business Combination.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Harmony Merger Corp.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Notes to Condensed Financial Statements (continued)</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company has entered into an agreement with
Canaccord Genuity Inc. (&ldquo;Canaccord Genuity&rdquo;) pursuant to which Canaccord Genuity will provide the Company with certain
financial advisory services in connection with a preliminary review of potential merger and acquisition opportunities, or other
services as reasonably requested by the Company and mutually agreeable by Canaccord Genuity, for a period of 18 months from the
consummation of the Offering. In consideration of such services, the Company paid Canaccord Genuity a fee of $135,000 in cash upon
consummation of the Offering. Such amount was paid in April 2015. The son of the Company&rsquo;s Chief Executive Officer is an
employee of Canaccord Genuity.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company presently occupies office space
provided by an entity controlled by the Company&rsquo;s Chairman and Chief Executive Officer. Such entity has agreed that until
the earlier of Company&rsquo;s consummation of a Business Combination or the liquidation of the Trust Account, it will make such
office space, as well as general and administrative services including utilities and administrative support, available to the Company
as may be required by the Company from time to time. The Company pays an aggregate of $12,500 per month for such services.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Initial Stockholders and the holders of
the Private Units (or underlying securities) will be entitled to registration rights with respect to the founding shares and the
Private Units (or underlying securities) pursuant to a registration rights agreement signed in connection with the Offering. The
holders of the majority of the Initial Shares (defined below) are entitled to demand that the Company register these shares at
any time commencing three months prior to the first anniversary of the consummation of a Business Combination. The holders of the
Private Units (or underlying securities) and Cantor are entitled to demand that the Company register these securities at any time
after the Company consummates a Business Combination. In addition, the Initial Stockholders and holders of the Private Units (or
underlying securities) have certain &ldquo;piggy-back&rdquo; registration rights on registration statements filed after the Company&rsquo;s
consummation of a Business Combination.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Note 7 &mdash; Stockholders&rsquo; Equity</B>&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><I>Preferred Stock</I>&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company is authorized to issue 1,000,000
shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined
from time to time by the Company&rsquo;s board of directors.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">As of March&nbsp;31, 2016, there are no shares of
preferred stock issued or outstanding.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><I>Common Stock</I>&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">The Company is authorized to issue 27,500,000
shares of common stock with a par value of $0.0001 per share.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">In connection with the organization of the Company,
a total of 2,875,000 shares of the Company&rsquo;s shares of common stock were sold to the Initial Stockholders at a price of approximately
$0.01 per share for an aggregate of $25,000. Effective November 7, 2014, the Company&rsquo;s Board of Directors authorized a stock
dividend of approximately 0.05 shares of common stock for each outstanding share of common stock.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: justify">The Initial Stockholders&rsquo; 3,026,250 shares
(&ldquo;Initial Shares&rdquo;) were placed into an escrow account on the closing of the Offering. Subject to certain limited exceptions,
these shares will not be released from escrow until with respect to 50% of the shares, the earlier of one year after the date of
the consummation of an initial Business Combination and the date on which the closing price of the common stock exceeds $12.50
per share for any 20 trading days within a 30-trading day period following the consummation of an initial Business Combination
and, with respect to the remaining 50% of the shares, one year after the date of the consummation of an initial Business Combination,
or earlier if, subsequent to the Company&rsquo;s initial Business Combination, the Company consummates a subsequent liquidation,
merger, share exchange or other similar transaction which results in all of the Company&rsquo;s stockholders having the right to
exchange their shares of common stock for cash, securities or other property. Pursuant to letter agreements executed with the Company
and the underwriter, the Initial Stockholders have waived their right to receive distributions with respect to their Initial Shares
upon the Company&rsquo;s redemption of 100% of the outstanding public shares held by the Public Stockholders. As of March&nbsp;31, 2016,
4,498,966 shares of common stock were issued and outstanding which excludes 10,585,784 shares subject to possible conversion.</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><B>Item 2. Management&rsquo;s Discussion and
Analysis.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">This Quarterly Report on
Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). We have based these forward-looking
statements on our current expectations and projections about future events. These forward-looking statements are subject to known
and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or
achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied
by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &ldquo;may,&rdquo;
&ldquo;should,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; or the negative of such terms or other similar expressions.
Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities
and Exchange Commission (&ldquo;SEC&rdquo;) filings.&nbsp;&nbsp;References to &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo;
or the &ldquo;Company&rdquo; are to Harmony Merger Corp., except where the context requires otherwise.&nbsp;&nbsp;The following
discussion should be read in conjunction with our condensed financial statements and related notes thereto included elsewhere in
this report.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Overview</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We are a blank check company
formed on May 21, 2014 to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization
or other similar business combination, one or more businesses or entities.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We presently have no revenue,
have had losses since inception from incurring general and administration costs and have no other operations other than searching
for a business combination.&nbsp;&nbsp;We have relied upon the sale of our securities and loans from our officers and directors
to fund our operations.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company consummated
the Offering of 11,500,000 units on March 27, 2015 generating gross proceeds of $115,000,000 and net proceeds of $112,605,665 after
deducting $2,394,335 of transaction costs (up to an additional $4,325,000 of deferred underwriting expenses may be paid upon the
completion of a business combination) and $5,585,000 from the private placement to the initial stockholders of the Company (&ldquo;Initial
Stockholders&rdquo;) and Cantor Fitzgerald &amp; Co., the representative of the underwriters in the Offering (&ldquo;Cantor&rdquo;).</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our management has broad
discretion with respect to the specific application of the net proceeds of the offering and the Private Placement, although substantially
all of the net proceeds are intended to be applied generally towards consummating a business combination successfully.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Results of Operations</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Our
entire activity since inception up to the closing of our Initial Public Offering on March 23, 2015 was in preparation for that
event.&nbsp;&nbsp;Since the offering, our activity has been limited to the evaluation of business combination candidates, and we
will not be generating any operating revenues until the closing and completion of our Initial Business Combination.&nbsp;&nbsp;We
expect to generate small amounts of non-operating income in the form of interest income on cash, cash equivalents and securities.&nbsp;&nbsp;Interest
income is not expected to be significant in view of current low interest rates on risk-free investments (treasury securities).&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">For the three months ended
March&nbsp;31, 2016, we had net losses of $156,205, which consisted primarily of $60,900 in Delaware franchise taxes, $41,600 in professional
fees, $37,500 in administrative fees to Crescendo Advisors II, LLC, an affiliate of our Chairman and CEO, Eric Rosenfeld, investment
banking fees of approximately $21,800, public company costs of approximately $13,700, trust fund administration costs of approximately
$11,100, insurance costs of approximately $7,200, and research costs of approximately $6,800 which were offset by interest income
of approximately $46,100.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">For the three months ended
March&nbsp;31, 2015, we had net losses of $8,193, which consisted primarily of general and administration costs. Activity during this
period was mostly attributable to the Initial Public Offering on March 27, 2015, therefore there was minimal operating activity
and costs.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">As of March&nbsp;31, 2016, we
had $157,422 in our operating bank account. Interest earned in the trust account may be released to the Company to pay the Company&rsquo;s
tax obligations. As of March&nbsp;31, 2016, U.S Treasury Bills with one month, three month, and six month maturities were yielding approximately
0.18%, 0.21%, and 0.39%, respectively. While we may invest in other securities, we believe such rates are representative of those
we may receive on the balance of the trust account.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Over the next 12 months
we will be using these funds for identifying and evaluating prospective acquisition candidates, performing business due diligence
on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses,
reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire
and structuring, negotiating and consummating the business combination. Our estimates are based upon the belief that in-depth due
diligence will be undertaken only after we have negotiated and signed a letter of intent or other preliminary agreement that addresses
the terms of a business combination. Our actual costs may be higher or lower than these estimates.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in; text-align: justify">We anticipate that in order to fund our working
capital requirements, we will need to use all of the remaining funds not held in trust and the interest earned on the funds held
in the trust account. We may need to enter into contingent fee arrangements with our vendors or raise additional capital through
loans or additional investments from our initial shareholders, officers, directors, or third parties. None of the initial shareholders,
officers or directors is under any obligation to advance funds to, or invest in, us. Accordingly, we may not be able to obtain
additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve
liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of our business
plan, and controlling overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially
acceptable terms, if at all. The Company has no present revenue, and the Company&rsquo;s cash and working capital as of March&nbsp;31,
2016 are not sufficient to complete its planned activities for the upcoming year. These conditions raise substantial doubt about
the Company&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We did not have any off-balance
sheet arrangements as of March&nbsp;31, 2016.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Item 3. Quantitative and Qualitative Disclosures About Market
Risk</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The net proceeds of our
initial public offering and sale of Private Units held in the Trust Account, may be invested in U.S. government treasury bills,
notes or bonds with a maturity of 180 days or less or in certain money market funds that invest solely in US treasuries. Due to
the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Item 4. Controls and Procedures</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><I>Evaluation of Disclosure Controls and Procedures</I></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;Disclosure controls
and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded,
processed, summarized, and reported within the time periods specified in the SEC&rsquo;s rules and forms, and that such information
is accumulated and communicated to our management, including our principal executive officer and principal financial officer or
persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the supervision and
with the participation of our management, including our principal executive officer and principal financial and accounting officer,
we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended
March&nbsp;31, 2016, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our
principal executive officer and principal financial and accounting officer have concluded that during the period covered by this
report, our disclosure controls and procedures were effective.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify"><I>Changes in Internal Control over Financial
Reporting</I></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">There was no change in our
internal control over financial reporting that occurred during the fiscal quarter of 2016 covered by this Quarterly Report on Form
10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>PART II &ndash; OTHER INFORMATION</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>Item 1 &amp; Item 1a</B>&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
from Registered Securities</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">In May 2014, we issued an aggregate of 2,875,000
shares of common stock for a total of $25,000 in cash, at a purchase price of approximately $0.01 share, to Eric S. Rosenfeld.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2014, Mr. Rosenfeld
transferred an aggregate of 693,000 shares of common stock to the following entities and in the following amounts:</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt"><b>Name</b></font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt"><b>Number of Shares</b></font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt"><b>Relationship to Us</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">NPIC Limited</font></td>
    <td style="width: 1%; font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="width: 1%; font-family: Calibri,sans-serif; line-height: 115%; text-align: center">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">231,000</font></td>
    <td style="width: 1%; font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="width: 1%; font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="width: 40%; font-family: Calibri,sans-serif; line-height: 115%; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">Initial Stockholder</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">DKU 2013 LLC</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">231,000</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">Initial Stockholder</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">The K2 Principal Fund L.P.</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">231,000</font></td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: center"><font style="font-family: Times New Roman,serif; font-size: 10pt">Initial Stockholder</font></td></tr>
</table>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 7, 2014, we
effected a stock dividend of approximately 0.05 shares of common stock for each outstanding share of common stock, resulting in
our initial stockholders owning an aggregate of 3,026,250 insider shares.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">In November and December
2014 and January and March 2015, our initial shareholders transferred shares amongst themselves, all for the same effective purchase
price that the transferees paid for such shares, to effectuate economic arrangements between the parties.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company consummated
the Offering of 11,500,000 units on March 27, 2015 generating gross proceeds of $115,000,000 and net proceeds of $112,605,665 after
deducting $2,394,335 of transaction costs (up to an additional $4,325,000 of deferred underwriting expenses may be paid upon the
completion of a business combination) and $5,585,000 from the private placement to the initial stockholders of the Company (&ldquo;Initial
Stockholders&rdquo;) and Cantor Fitzgerald &amp; Co., the representative of the underwriters in the Offering (&ldquo;Cantor&rdquo;).
Each unit consisted of one share of common stock and one warrant, each to purchase one share of common stock. Cantor acted as the
lead managing underwriter of the initial public offering.&nbsp;&nbsp; The securities sold in the offering were registered under
the Securities Act of 1933 on a registration statement on Form S-1 (No. 333-197330). The Securities and Exchange Commission declared
the registration statement effective on March 23, 2015.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 20.15pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">Simultaneously with the
consummation of the initial public offering, we consummated the private placement (&ldquo;Private Placement&rdquo;) of 558,500
Units (&ldquo;Private Placement Units&rdquo;) purchased by the Company&rsquo;s initial stockholders and Cantor at a price of $10.00
per Private Placement Unit, generating total proceeds of $5,585,000. The Private Placement Units are identical to the Units sold
in the initial public offering except the warrants included in the Private Placement Units will be non-redeemable and may be exercised
on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their permitted transferees.
In addition, for as long as any of the warrants underlying the Private Placement Units are held by Cantor or its designees or affiliates,
they may not be exercised after March 23, 2020. Additionally, because the warrants underlying the Private Placement Units were
issued in a private transaction, the holders and their transferees will be allowed to exercise such warrants for cash even if a
registration statement covering the shares of common stock issuable upon exercise of such warrants is not effective and receive
unregistered shares. Furthermore, the initial stockholders have agreed to vote the shares of common stock underlying the Private
Placement Units (&ldquo;Private Shares&rdquo;) in favor of any proposed business combination. All the purchasers of the Private
Placement Units have also agreed (A) not to convert any Private Shares for cash from the trust account in connection with a stockholder
vote to approve a proposed initial business combination or a vote to amend the provisions of the Company&rsquo;s amended and restated
certificate of incorporation relating to stockholders&rsquo; rights or pre-business combination activity and (B) that the Private
Shares shall not participate in any liquidating distribution upon winding up if a business combination is not consummated. The
purchasers have also agreed not to transfer, assign or sell any of the Private Placement Units or underlying securities (except
to certain permitted transferees in limited situations) until the completion of an initial business combination.&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 20.15pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 20.15pt"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 20.15pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">We paid a total of $2,000,000
in underwriting discounts and commissions and $549,803 for other costs and expenses related to the offering (plus up to an additional
$4,325,000 of deferred underwriting expenses may be paid upon the completion of a business combination).</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">For a description of the
use of the proceeds generated in our initial public offering, see Part I, Item 2 of this Form 10-Q.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0"><B>Item 6.&nbsp;&nbsp;Exhibits.</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 8%; border-bottom: black 1.5pt solid; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt">Exhibit No.</font></td>
    <td style="width: 1%; font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="width: 91%; border-bottom: black 1.5pt solid; font-family: Calibri,sans-serif; line-height: 115%; text-align: justify"><font style="font-family: Times New Roman,serif; font-size: 10pt">Description</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 10pt">31.1</font></td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: justify; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 10pt">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: justify; vertical-align: top">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 10pt">31.2</font></td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: justify; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 10pt">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: justify; vertical-align: top">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 10pt">32</font></td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: left; vertical-align: top">&nbsp;</td>
    <TD STYLE="font-family: Calibri,sans-serif; line-height: 115%; text-align: justify; vertical-align: top"><font style="font-family: Times New Roman,serif; font-size: 10pt">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></td></tr>
</table>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2" style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">HARMONY MERGER CORP.</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2" style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 62%; font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td nowrap style="width: 3%; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">By:</font></td>
    <td style="width: 35%; border-bottom: black 1.5pt solid; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">/s/ Eric S. Rosenfeld &nbsp;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2" style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Eric S. Rosenfeld</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2">
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Chief Executive Officer</P>
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">(Principal executive officer)</P></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2" style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td nowrap style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">By:</font></td>
    <td style="border-bottom: black 1.5pt solid; font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">/s/ Tom Kobylarz &nbsp;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2" style="font-family: Calibri,sans-serif; line-height: 115%"><font style="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Tom Kobylarz</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-family: Calibri,sans-serif; line-height: 115%">&nbsp;</td>
    <td colspan="2">
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Chief Financial Officer</P>
        <P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">(Principal financial and accounting officer)</P></td></tr>
</table>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0">Date:&nbsp;&nbsp;May 20, 2016</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center">15</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>f10q0316ex31i_harmony.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>FORM OF CERTIFICATION</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>PURSUANT TO RULE 13a-14 AND 15d-14</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF
1934, AS AMENDED</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>CERTIFICATIONS</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">I, Eric S. Rosenfeld, certify that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font: 10pt/115% Calibri,sans-serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">1.</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt/115% Calibri,sans-serif; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">I have reviewed this quarterly report on Form 10-Q of Harmony Merger Corp.;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font: 10pt/115% Calibri,sans-serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">2.</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt/115% Calibri,sans-serif; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font: 10pt/115% Calibri,sans-serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">3.</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt/115% Calibri,sans-serif; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font: 10pt/115% Calibri,sans-serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">4.</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt/115% Calibri,sans-serif; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font: 10pt/115% Calibri,sans-serif; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font: 10pt/115% Calibri,sans-serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">a)</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt/115% Calibri,sans-serif; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">b)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">c)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">d)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 0 0.3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">5.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">a)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">b)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">Date: May 20, 2016</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.5in; line-height: 115%; font-family: Calibri,sans-serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt/115% Times New Roman,serif">/s/ Eric S. Rosenfeld &nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; width: 5%"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 35%"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt; line-height: 115%">Eric S. Rosenfeld</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0"></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>f10q0316ex31ii_harmony.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>FORM OF CERTIFICATION</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>PURSUANT TO RULE 13a-14 AND 15d-14</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF
1934, AS AMENDED</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>CERTIFICATIONS</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">I, Thomas Kobylarz, certify that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">1.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">I have reviewed this quarterly report on Form 10-Q of Harmony Merger Corp.;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">2.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">3.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">4.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">a)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">b)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">c)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">d)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 0 0.3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">5.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">a)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">b)</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">Date: May 20, 2016</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt/115% Times New Roman,serif">/s/ Thomas Kobylarz &nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; width: 5%"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 35%"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Thomas Kobylarz</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Financial Officer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">(Principal Financial and Accounting Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>f10q0316ex32_harmony.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"><B>Exhibit 32</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>18 U.S.C. SECTION 1350</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify">In connection with the Quarterly Report of Harmony
Merger Corp. (the &ldquo;Company&rdquo;) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange
Commission (the &ldquo;Report&rdquo;), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">1.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">2.</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; font-family: Calibri,sans-serif; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt/115% Times New Roman,serif">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">Date: May 20, 2016</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.5in; line-height: 115%; font-family: Calibri,sans-serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt/115% Times New Roman,serif">/s/ Eric S. Rosenfeld &nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; width: 5%"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 35%"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Eric S. Rosenfeld</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Executive Officer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">(Principal Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman,serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt/115% Times New Roman,serif">/s/ Thomas Kobylarz &nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif; width: 5%"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif; width: 35%"><FONT STYLE="font: 10pt/115% Times New Roman,serif">Thomas Kobylarz</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">Chief Financial Officer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-family: Calibri,sans-serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; line-height: 115%; font-family: Calibri,sans-serif"><FONT STYLE="font: 10pt Times New Roman,serif">(Principal Financial and Accounting Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.5in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>hrmn-20160331.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated using Ez-XBRL version 8.0.0.0 [05/20/2016 09:20:19 PM] -->
<!-- Based on XBRL 2.1 -->

<xbrli:xbrl xmlns:hrmn="http://www.harmonymergercorp.com/20160331"
 xmlns:link="http://www.xbrl.org/2003/linkbase"
 xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
 xmlns:xlink="http://www.w3.org/1999/xlink"
 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
 xmlns:xbrli="http://www.xbrl.org/2003/instance"
 xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
 xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
 xmlns:num="http://www.xbrl.org/dtr/type/numeric"
 xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
 xmlns:country="http://xbrl.sec.gov/country/2016-01-31"
 xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31"
 xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31"
 xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31"
 xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31"
 xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31"
 xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
 xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31"
 xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31"
 xmlns:us-types="http://fasb.org/us-types/2016-01-31"
 xmlns:xl="http://www.xbrl.org/2003/XLink"
 xmlns:utr="http://www.xbrl.org/2009/utr"
>
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="hrmn-20160331.xsd" />
<!-- Context Section  -->
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_22_May_2014T00_00_00_TO_31_Dec_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-05-22
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-03-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-03-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-22
</xbrli:startDate>
<xbrli:endDate>
2015-03-27
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-22
</xbrli:startDate>
<xbrli:endDate>
2015-03-27
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2015T00_00_00_TO_31_Dec_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_DefinedBenefitPlanByPlanAssetCategoriesAxis_PrivateEquityFundsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_StatementEquityComponentsAxis_CommonStockMember_DefinedBenefitPlanByPlanAssetCategoriesAxis_PrivateEquityFundsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2016-01-01
</xbrli:startDate>
<xbrli:endDate>
2016-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_20_May_2016T00_00_00_TO_20_May_2016T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001612720</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2016-05-20
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<!--
I~1\FVPHexeD5678YReqi>IhkevEkirxw:8c444c555cT{h><IFIFGI416=G8189GF1E6J81F4EH:=J5EG4F -->
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">Harmony Merger Corp.</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">0001612720</dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">false</dei:AmendmentFlag>
<dei:CurrentFiscalYearEndDate contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">--12-31</dei:CurrentFiscalYearEndDate>
<dei:DocumentType contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">10-Q</dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">2016-03-31</dei:DocumentPeriodEndDate>
<dei:DocumentFiscalYearFocus contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">2016</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">Q1</dei:DocumentFiscalPeriodFocus>
<dei:EntityFilerCategory contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">Non-accelerated Filer</dei:EntityFilerCategory>
<dei:EntityCommonStockSharesOutstanding contextRef="Context_As_Of_20_May_2016T00_00_00_TO_20_May_2016T00_00_00" unitRef="shares" decimals="INF">15084750</dei:EntityCommonStockSharesOutstanding>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">1115</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">878685</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">324991</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">157422</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">46687</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">48555</us-gaap:PrepaidExpenseCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">371678</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">205977</us-gaap:AssetsCurrent>
<hrmn:CashCashEquivalentsAndSecuritiesHeldInTrust contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">117374895</hrmn:CashCashEquivalentsAndSecuritiesHeldInTrust>
<hrmn:CashCashEquivalentsAndSecuritiesHeldInTrust contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">117420942</hrmn:CashCashEquivalentsAndSecuritiesHeldInTrust>
<us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">66373</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
<us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">65756</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
<us-gaap:Assets contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">117812946</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">117692675</us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">17259</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">53193</us-gaap:AccountsPayableCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">17259</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">53193</us-gaap:LiabilitiesCurrent>
<hrmn:DeferredUnderwritersFee contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">4325000</hrmn:DeferredUnderwritersFee>
<hrmn:DeferredUnderwritersFee contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">4325000</hrmn:DeferredUnderwritersFee>
<us-gaap:Liabilities contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">4342259</us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">4378193</us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">108043938</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">108086324</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">450</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">450</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">500000</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">5690809</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">5648423</us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">-264510</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">-420715</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">5426749</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">5228158</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">117812946</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">117692675</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD_per_Share" decimals="4">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD_per_Share" decimals="4">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<hrmn:CommonStockSharesSubjectToPossibleConversion contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">10585784</hrmn:CommonStockSharesSubjectToPossibleConversion>
<hrmn:CommonStockSharesSubjectToPossibleConversion contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">10585784</hrmn:CommonStockSharesSubjectToPossibleConversion>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">11.50</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD_per_Share" decimals="4">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD_per_Share" decimals="4">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="shares" decimals="INF">27500000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">27500000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="shares" decimals="INF">4498966</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">4498966</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">4498966</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="shares" decimals="INF">4498966</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">4498966</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">4498966</us-gaap:CommonStockSharesOutstanding>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">8217</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">164801</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OtherGeneralAndAdministrativeExpense contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:OtherGeneralAndAdministrativeExpense contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">37500</us-gaap:OtherGeneralAndAdministrativeExpense>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">-8217</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">-202301</us-gaap:OperatingIncomeLoss>
<us-gaap:InterestIncomeExpenseNet contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">24</us-gaap:InterestIncomeExpenseNet>
<us-gaap:InterestIncomeExpenseNet contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">46096</us-gaap:InterestIncomeExpenseNet>
<us-gaap:NetIncomeLoss contextRef="Context_Custom_22_May_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-1323</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">-8193</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" decimals="0">-263187</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">-156205</us-gaap:NetIncomeLoss>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="shares" decimals="0">2726204</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="0">4498966</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD_per_Share" decimals="2">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD_per_Share" decimals="2">-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
<hrmn:InterestEarnedOnCashAndSecuritiesInTrust contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<hrmn:InterestEarnedOnCashAndSecuritiesInTrust contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">-46047</hrmn:InterestEarnedOnCashAndSecuritiesInTrust>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">119345</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">1251</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">81977</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">35934</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">-45561</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">-167569</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:PaymentsForProceedsFromInvestments contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">117300000</us-gaap:PaymentsForProceedsFromInvestments>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">-117300000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<hrmn:PaymentOfOfferingCosts contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">43208</hrmn:PaymentOfOfferingCosts>
<hrmn:PaymentOfOfferingCosts contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">75674</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">112605665</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
<us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">112605665</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
<us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfPreferredLimitedPartnersUnits contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">5585000</us-gaap:ProceedsFromIssuanceOfPreferredLimitedPartnersUnits>
<us-gaap:ProceedsFromIssuanceOfPreferredLimitedPartnersUnits contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">118223131</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">877570</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">-167569</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<hrmn:AccrualOfDeferredUnderwritingFee contextRef="Context_3ME_01_Jan_2015T00_00_00_TO_31_Mar_2015T00_00_00" unitRef="USD" decimals="0">-4325000</hrmn:AccrualOfDeferredUnderwritingFee>
<hrmn:AccrualOfDeferredUnderwritingFee contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:NatureOfOperations contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 1 &amp;#8212; Organization and Plan of Business Operations&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Harmony Merger Corp. (the &amp;#8220;Company&amp;#8221;) was incorporated in Delaware on May 21, 2014 as a blank check company whose objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, one or more businesses or entities (a &amp;#8220;Business Combination&amp;#8221;).&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#8220;US GAAP&amp;#8221;) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;).&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;All activity through March&amp;#160;31, 2016 relates to the Company&amp;#8217;s formation, initial public offering and identifying suitable candidates for a Business Combination.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The registration statement for the Company&amp;#8217;s initial public offering was declared effective on March 23, 2015. The Company consummated a public offering of 11,500,000 units (&amp;#8220;Units&amp;#8221;) on March 27, 2015 (the &amp;#8220;Offering&amp;#8221;), including the exercise of the over-allotment option (&amp;#8220;Overallotment&amp;#8221;) of 1,500,000 Units, generating gross proceeds of $115,000,000 and net proceeds of $112,605,665 after deducting $2,394,335 of transaction costs (up to an additional $4,325,000 of deferred underwriting expenses may be paid upon the completion of a business combination), which is discussed in Note 3. In addition, the Company generated gross and net proceeds of $5,585,000 from a private placement (the &amp;#8220;Private Placement&amp;#8221;) of units (&amp;#8220;Private Units&amp;#8221;) to certain of the Initial Stockholders (defined below) and Cantor Fitzgerald &amp;amp; Co., the representative of the underwriters in the Offering (&amp;#8220;Cantor&amp;#8221;), which is described in Note 4.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company&amp;#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Offering and Private Placement, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination. The Company&amp;#8217;s securities are listed on the Nasdaq Capital Market (&amp;#8220;NASDAQ&amp;#8221;). Pursuant to the NASDAQ listing rules, the Company&amp;#8217;s initial Business Combination must be with a target business or businesses whose collective fair market value is at least equal to 80% of the balance in the trust account at the time of the execution of a definitive agreement for such Business Combination, although this may entail simultaneous acquisitions of several target businesses. There is no assurance that the Company will be able to effect a Business Combination successfully.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Following the closing of the Offering and the Private Placement on March 27, 2015, an amount of $117,300,000 (or $10.20 per share sold to the public in the Offering included in the Units (&amp;#8220;Public Shares&amp;#8221;)) from the sale of the Units and Private Units is being held in a trust account (&amp;#8220;Trust Account&amp;#8221;) and may be invested in money market funds meeting the applicable conditions of Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, and that invest solely in U.S. treasuries or United States bonds, treasuries or notes
 having a maturity of 180 days or less. The $117,300,000 placed into the Trust Account may not be released until the earlier of (i) the consummation of the Company&amp;#8217;s initial Business Combination and (ii) the Company&amp;#8217;s failure to consummate a Business Combination within the prescribed time. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to pay the Company&amp;#8217;s tax obligations. Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company, after signing a Business Combination, is required to provide stockholders who acquired Public Shares in the Offering (&amp;#8220;Public Stockholders&amp;#8221;) with the opportunity to convert their Public Shares for a pro rata share of the Trust Account. In the event that stockholders owning approximately 92.05% or more of the Public Shares exercise their conversion rights described below, the Business Combination will not be consummated. The actual percentages, however, will only be able to be determined once a target business is located and the Company can assess all of the assets and liabilities of the combined company upon consummation of the proposed Business Combination, subject to the requirement that the Company must have at least $5,000,001 of net tangible assets upon close of such Business Combination. As a result, the actual percentage of shares that can be converted may be significantly lower than the above estimates. The stockholders of the Company prior to the Offering (the &amp;#8220;Initial Stockholders&amp;#8221;) have agreed to vote any shares they then hold in favor of any proposed Business Combination and will waive any conversion rights with respect to these shares and the shares included in the Private Units pursuant to letter agreements executed in connection with the Offering.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In connection with any proposed Business Combination, the Company will seek stockholder approval of an initial Business Combination at a meeting called for such purpose at which Public Stockholders may seek to convert their Public Shares, regardless of whether they vote for or against the proposed Business Combination. If the Company seeks stockholder approval of an initial Business Combination, any Public Stockholder voting either for or against such proposed Business Combination will be entitled to demand that his Public Shares be converted into a full pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay its taxes). Holders of warrants sold as part of the Units will not be entitled to vote on the proposed Business Combination and will have no conversion or liquidation rights with respect to their shares of common stock underlying such warrants.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company will consummate a Business Combination only if holders of less than approximately 92.05% of the Public Shares, subject to adjustment as described above, elect to convert their shares to a pro-rata portion of the amount held in the Trust Account and a majority of the outstanding shares of common stock voted, are voted in favor of the Business Combination. Notwithstanding the foregoing, the Amended and Restated Certificate of Incorporation of the Company provides that a Public Stockholder, together with any affiliate or other person with whom such Public Stockholder is acting in concert or as a &amp;#8220;group&amp;#8221; (within the meaning of Section 13 of the Securities Act of 1934, as amended), will be restricted from seeking conversion rights with respect to an aggregate of more than 20% of the Public Shares (but only with respect to the amount over 20% of the Public Shares). A &amp;#8220;group&amp;#8221; will be deemed to exist if Public Stockholders (i) file a Schedule 13D or 13G indicating the presence of a group or (ii) acknowledge to the Company that they are acting, or intend to act, as a group.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Pursuant to the Company&amp;#8217;s Amended and Restated Certificate of Incorporation, if the Company is unable to complete its initial Business Combination by March 27, 2017, the Company will (i) cease all operations except for the purpose
 of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of common stock and the Company&amp;#8217;s board of directors, dissolve and liquidate. If the Company is unable to consummate an initial Business Combination and is forced to redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay any of its taxes. Holders of warrants will receive no proceeds in connection with the liquidation. The Initial Stockholders and the holders of Private Units will not participate in any redemption distribution with respect to their initial shares and Private Units, including the common stock included in the Private Units.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;If the Company is unable to complete its initial Business Combination and expends all of the net proceeds of the Offering not deposited in the Trust Account, without taking into account any interest earned on the Trust Account, the Company expects that the initial per-share redemption price for common stock will be $10.20. The proceeds deposited in the Trust Account could, however, become subject to claims of the Company&amp;#8217;s creditors that are in preference to the claims of the Company&amp;#8217;s stockholders. In addition, if the Company is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against it that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be included in its bankruptcy estate and subject to the claims of third parties with priority over the claims of the Company&amp;#8217;s common stockholders. Therefore, the actual per-share redemption price may be less than $10.20.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Eric S. Rosenfeld, the Company&amp;#8217;s Chief Executive Officer, has agreed that he will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduces the amount of funds in the Trust Account to below $10.20 per public share, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the indemnity of the underwriters of the Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, Mr. Rosenfeld will not be responsible to the extent of any liability for such third party claims. Furthermore, he will not be personally liable to Public Stockholders and instead will only have liability to the Company. The Company has not independently verified whether Mr. Rosenfeld has sufficient funds to satisfy his indemnity obligations and, therefore, Mr. Rosenfeld may not be able to satisfy those obligations. The Company has not asked Mr. Rosenfeld to reserve for such eventuality. Accordingly, if the Company liquidates, the per-share distribution from the trust account could be less than $10.20 due to claims or potential claims of creditors.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Mr. Rosenfeld has also agreed to enter into an agreement in accordance with the guidelines of Rule 10b5-1of the Exchange Act, pursuant to which he will place limit orders for an aggregate of up to $500,000 of common stock of the Company commencing on the later of (1) two business days after a Form 8-K disclosing all material information relating to an initial Business Combination, and (2) 60 days after the termination of the &amp;#8220;restricted period&amp;#8221; in connection with Offering under Regulation M of the Exchange Act, and ending on the record date for the shareholder meeting at which such initial Business Combination is to be approved, or earlier in certain circumstances as described in the limit order agreement, which is referred to as the buyback period. These limit orders will require Mr. Rosenfeld to purchase any shares of common stock of the Company offered for sale (and not purchased by another investor) at or below a price equal to the per-share amount held in the Trust Account as reported in such Form 8-K, until the earlier of (1) the expiration of the buyback period or (2) the date such purchases reach $500,000 in total. The Company will provide at least 20 business days between the beginning of the buyback period and the record date for the shareholder meeting for such initial Business Combination. It is intended that the purchases will satisfy the conditions of Rule 10b-18(b) under the Exchange Act to the extent possible and the concernbroker&amp;#8217;s purchase obligation will otherwise be subject to applicable law, including Regulation M under the Exchange Act, which may prohibit or limit purchases pursuant to the limit order agreement in certain circumstances. Any shares purchased by Mr. Rosenfeld pursuant to this arrangement will be voted in favor of the proposed
 Business Combination. Additionally, Mr. Rosenfeld has agreed not to convert any buyback shares into the right to receive a pro rata portion of the funds held in the Trust Account or to transfer, assign or sell any buyback shares (except to the same permitted transferees as the insider shares and provided the transferees agree to the same transfer restrictions) until (A) the earlier of one year after the completion of an Initial Business combination and the date on which the closing price of common stock of the Company exceeds $12.50 for any 20 trading days within a 30-trading day period following the completion of an Initial Business combination with respect to 50% of the buyback shares and (B) one year after the completion of an Initial Business combination with respect to the remaining 50% of the buyback shares.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company anticipates that in order to fund its working capital requirements, the Company will need to use all of the remaining funds not held in trust, the interest earned on the funds held in the trust account, as well as enter into contingent fee arrangements with its vendors. The Company may need to enter into contingent fee arrangements with vendors or raise additional capital through loans or additional investments from initial shareholders, officers, directors, or third parties. None of the initial shareholders, officers or directors is under any obligation to advance funds to, or invest in, the Company. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and controlling overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company has no present revenue, and the Company&amp;#8217;s cash and working capital as of March&amp;#160;31, 2016 are not sufficient to complete its planned activities for the upcoming year. These conditions raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&lt;/p&gt;</us-gaap:NatureOfOperations>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 2 &amp;#8212; Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The accompanying unaudited condensed financial statements have been prepared for interim financial information and the instructions to Form 10-Q.&amp;#160;&amp;#160;Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included.&amp;#160;&amp;#160;The Company has evaluated subsequent events through the issuance of this Form 10-Q.&amp;#160;&amp;#160;Operating results for the quarter ended March&amp;#160;31, 2016&amp;#160;are not necessarily indicative of the results that may be expected for the year ending December&amp;#160;31, 2016 or any other period. The accompanying condensed financial statements should be read in conjunction with the Company&amp;#8217;s financial statements and notes thereto included in the Company&amp;#8217;s prospectus filed with the Securities and Exchange Commission on March 24, 2015.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Cash, cash equivalents and securities held in Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;At March&amp;#160;31, 2016, substantially all of the assets in the Trust Account were held in United States Treasury Bills with a maturity of April 21, 2016. $117,340,445 in US Treasury Bills were purchased on October 27, 2015. At March&amp;#160;31, 2016 the trust account had earned $46,047 and accrued $78,926 in interest and held $1,571 in cash. This account is classified as restricted.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The fair value of the Company&amp;#8217;s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 820, &amp;#8220;Fair Value Measurements and Disclosures,&amp;#8221; approximates the carrying amounts represented in the balance sheet, primarily
 due to their short-term nature.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Net loss per common share&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company complies with accounting and disclosure requirements of ASC 260, &amp;#8220;Earnings Per Share.&amp;#8221; Net loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of (i) warrants sold in the Initial Public Offering to purchase 11,500,000 shares of the Company and (ii) warrants sold in the Private Units to purchase 558,500 shares of the Company, in the calculation of diluted loss per share, since the exercise of the warrants is contingent on the occurrence of future events. 10,585,784&lt;b&gt;&amp;#160;&lt;/b&gt;shares of common stock subject to possible conversion at March&amp;#160;31, 2016, were also excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the trust earnings. At March&amp;#160;31, 2016, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Common stock subject to possible conversion&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company accounts for its common stock subject to possible conversion in accordance with the guidance enumerated in ASC 480 &amp;#8220;Distinguishing Liabilities from Equity&amp;#8221;.&amp;#160;&amp;#160;&amp;#160;Common stock subject to mandatory conversion is classified as a liability instrument and is measured at fair value. Conditionally convertible common stock (including common stock that features conversion rights that are either within the control of the holder or subject to conversion upon the occurrence of uncertain events not solely within the Company&amp;#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&amp;#8217; equity. The Company&amp;#8217;s common stock features certain conversion rights that are considered by the Company to be outside of the Company&amp;#8217;s control and subject to the occurrence of uncertain future events. Accordingly at March&amp;#160;31, 2016, the common stock subject to possible conversion is presented as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s balance sheet.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company accounts for income taxes under ASC 740 Income Taxes (&amp;#8220;ASC 740&amp;#8221;). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an
 enterprise&amp;#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company is required to file income tax returns in the United States (federal) and in various state and local jurisdictions. Based on the Company&amp;#8217;s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company&amp;#8217;s financial statements. Since the Company was incorporated on May 21, 2014, the evaluation was performed for the 2014 and 2015 tax years, which would be the only period subject to examination. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company&amp;#8217;s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest as of or during the three months ended March&amp;#160;31, 2016. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Subsequent Events&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Management has evaluated subsequent events to determine if events or transactions occurring through the date these financial statements were issued, require potential adjustment to or disclosure in the financial statements and has concluded that no subsequent events have occurred that would require recognition in the financial statements or disclosure in the notes to the financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
<hrmn:InitialPublicOfferingTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 3 &amp;#8212; Initial Public Offering&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;On March 27, 2015, the Company sold 11,500,000 Units at a price of $10.00 per unit in the Offering. Each Unit consists of one share of common stock and one warrant (&amp;#8220;Warrant&amp;#8221;) to purchase one share of common stock at a price of $11.50 per share. The Warrants are exercisable commencing on the later of 30 days after the Company&amp;#8217;s completion of a Business Combination or March 23, 2016 and expire five years from the completion of a Business Combination. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days&amp;#8217; notice, only in the event that the last sale price of the shares of common stock is at least $17.50 per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given. If the Company redeems the Warrants as described above, it will have the option to require any holder that wishes to exercise his Warrant to do so on a &amp;#8220;cashless basis.&amp;#8221; In accordance with the warrant agreement relating to the Warrants sold in the Offering, the Company is only required to use its best efforts to file the registration statement covering the shares underlying the Warrants within 15 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement. If a registration statement is not effective within 90 days following the consummation of a Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise Warrants on a cashless basis. If the Company is unable to consummate a Business Combination, the Company will redeem 100% of the Public Shares using the funds in the Trust Account as described in Note 1. In such event, the Warrants will be worthless. In no event will the Company be required to net cash settle the Warrants.&lt;/p&gt;</hrmn:InitialPublicOfferingTextBlock>
<hrmn:PrivateUnitsTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 4 &amp;#8212; Private Units&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Simultaneously with the Offering, certain of the Initial Stockholders of the Company and Cantor purchased an aggregate of 558,500 Private Units at $10.00 per Private Unit (for an aggregate purchase price of $5,585,000) from the Company.&amp;#160;All of the proceeds received from these purchases were placed in the Trust Account.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Private Units are identical to the Units sold in the Offering, except the Warrants included in the Private Units are non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their permitted transferees. In addition, for as long as any of the warrants underlying the Private Units are held by Cantor or its designees or affiliates, they may not be exercised after five years from the effective date of the registration statement relating to the Offering. Additionally the initial stockholders have agreed to vote the shares of common stock included therein in favor of any proposed Business Combination. All of the purchasers of the Private Units have agreed (i) not to convert any shares of common stock included therein into the right to receive cash from the Trust Account in connection with a stockholder vote to approve the proposed initial Business Combination and (ii) that the shares of common stock included therein shall not participate in any liquidating distribution upon winding up if a Business Combination is not consummated. Additionally, the holders have agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to certain permitted transferees) until the completion of the initial Business Combination.&lt;/p&gt;</hrmn:PrivateUnitsTextBlock>
<hrmn:NotesPayableAndAdvancesFromShareholdersTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 5 &amp;#8212; Notes Payable and Advance From Stockholders&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company issued a $50,000 principal amount unsecured promissory note to Eric S. Rosenfeld, the Company&amp;#8217;s Chief Executive Officer and an Initial Stockholder, on May 30, 2014. The note was non-interest bearing and payable on the earlier of (i) May 31, 2015, (ii) the consummation of the Offering or (iii) the date on which the Company determined not to proceed with the Offering. This loan became payable upon the consummation of the Offering and was paid to Mr. Rosenfeld in April 2015.&lt;/p&gt;</hrmn:NotesPayableAndAdvancesFromShareholdersTextBlock>
<us-gaap:CommitmentsDisclosureTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 6 &amp;#8212; Commitments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company has entered into an agreement with the underwriters of the Offering (&amp;#8220;Underwriting Agreement&amp;#8221;) that required the Company to pay an underwriting discount of 2.0% of the gross proceeds of the Offering as an underwriting discount (excluding proceeds received from the exercise of the over-allotment option, on which the Company will not pay any upfront underwriting discount) and a deferred underwriting discount of up to 3.5% (or up to 5.5% on any proceeds received from the exercise of the over-allotment option) for an aggregate underwriting discount of up to 5.5% of the gross proceeds of the Offering. The Underwriting Agreement provides that up to $926,786 of the deferred underwriting discount may be payable to certain parties who are instrumental in advising the Company in connection with the closing of the Business Combination on either a contingent or non-contingent basis; provided, however that any portion of the deferred underwriting commission relating to an allocation made on a contingent basis where the contingency is not met shall not be paid to any party. The Underwriting Agreement provides that the deferred underwriting discount will only be payable if the Company successfully completes its initial Business Combination.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company has entered into an agreement with Canaccord Genuity Inc. (&amp;#8220;Canaccord Genuity&amp;#8221;) pursuant to which Canaccord Genuity will provide the Company with certain financial advisory services in connection with a preliminary review of potential merger and acquisition opportunities, or other services as reasonably requested by the Company and mutually agreeable by Canaccord Genuity, for a period of 18 months from the consummation of the Offering. In consideration of such services, the Company paid Canaccord Genuity a fee of $135,000 in cash upon consummation of the Offering. Such amount was paid in April 2015. The son of the Company&amp;#8217;s Chief Executive Officer is an employee of Canaccord Genuity.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company presently occupies office space provided by an entity controlled by the Company&amp;#8217;s Chairman and Chief Executive Officer. Such entity has agreed that until the earlier of Company&amp;#8217;s consummation of a Business Combination or the liquidation of the Trust Account, it will make such office space, as well as general and administrative services including utilities and administrative support, available to the Company as may be required by the Company from time to time. The Company pays an aggregate of $12,500 per month for such services.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Initial Stockholders and the holders of the Private Units (or underlying securities) will be entitled to registration rights with respect to the founding shares and the Private Units (or underlying securities) pursuant to a registration rights agreement signed in connection with the Offering. The holders of the majority of the Initial Shares (defined below) are entitled to demand that the Company register these shares at any time commencing three months prior to the first anniversary of the consummation of a Business Combination. The holders of the Private Units (or underlying securities) and Cantor are entitled to demand that the Company register these securities at any time after the Company consummates a Business Combination. In addition, the Initial Stockholders and holders of the Private Units (or underlying securities) have certain &amp;#8220;piggy-back&amp;#8221; registration rights on registration statements filed after the Company&amp;#8217;s consummation of a Business Combination.&lt;/p&gt;</us-gaap:CommitmentsDisclosureTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Note 7 &amp;#8212; Stockholders&amp;#8217; Equity&lt;/b&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company&amp;#8217;s board of directors.&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;As of March&amp;#160;31, 2016, there are no shares of preferred stock issued or outstanding.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company is authorized to issue 27,500,000 shares of common stock with a par value of $0.0001 per share.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In connection with the organization of the Company, a total of 2,875,000 shares of the Company&amp;#8217;s shares of common stock were sold to the Initial Stockholders at a price of approximately $0.01 per share for an aggregate of $25,000. Effective November 7, 2014, the Company&amp;#8217;s Board of Directors authorized a stock dividend of approximately 0.05 shares of common stock for each outstanding share of common stock.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/15.33px 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Initial Stockholders&amp;#8217; 3,026,250 shares (&amp;#8220;Initial Shares&amp;#8221;) were placed into an escrow account on the closing of the Offering. Subject to certain limited exceptions, these shares will not be released from escrow until with respect to 50% of the shares, the earlier of one year after the date of the consummation of an initial Business Combination and the date on which the closing price of the common stock exceeds $12.50 per share for any 20 trading days within a 30-trading day period following the consummation of an initial Business Combination and, with respect to the remaining 50% of the shares, one year after the date of the consummation of an initial Business Combination, or earlier if, subsequent to the Company&amp;#8217;s initial Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company&amp;#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Pursuant to letter agreements executed with the Company and the underwriter, the Initial Stockholders have waived their right to receive distributions with respect to their Initial Shares upon the Company&amp;#8217;s redemption of 100% of the outstanding public shares held by the Public Stockholders. As of March&amp;#160;31, 2016, 4,498,966 shares of common stock were issued and outstanding which excludes 10,585,784 shares subject to possible conversion.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The accompanying unaudited condensed financial statements have been prepared for interim financial information and the instructions to Form 10-Q.&amp;#160;&amp;#160;Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included.&amp;#160;&amp;#160;The Company has evaluated subsequent events through the issuance of this Form 10-Q.&amp;#160;&amp;#160;Operating results for the quarter ended March&amp;#160;31, 2016&amp;#160;are not necessarily indicative of the results that may be expected for the year ending December&amp;#160;31, 2016 or any other period. The accompanying condensed financial statements should be read in conjunction with the Company&amp;#8217;s financial statements and notes thereto included in the Company&amp;#8217;s prospectus filed with the Securities and Exchange Commission on March 24, 2015.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<hrmn:CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Cash, cash equivalents and securities held in Trust Account&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;At March&amp;#160;31, 2016, substantially all of the assets in the Trust Account were held in United States Treasury Bills with a maturity of April 21, 2016. $117,340,445 in US Treasury Bills were purchased on October 27, 2015. At March&amp;#160;31, 2016 the trust account had earned $46,047 and accrued $78,926 in interest and held $1,571 in cash. This account is classified as restricted.&lt;/p&gt;</hrmn:CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Fair value of financial instruments&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The fair value of the Company&amp;#8217;s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 820, &amp;#8220;Fair Value Measurements and Disclosures,&amp;#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Net loss per common share&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company complies with accounting and disclosure requirements of ASC 260, &amp;#8220;Earnings Per Share.&amp;#8221; Net loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of (i) warrants sold in the Initial Public Offering to purchase 11,500,000 shares of the Company and (ii) warrants sold in the Private Units to purchase 558,500 shares of the Company, in the calculation of diluted loss per share, since the exercise of the warrants is contingent on the occurrence of future events. 10,585,784&lt;b&gt;&amp;#160;&lt;/b&gt;shares of common stock subject to possible conversion at March&amp;#160;31, 2016, were also excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the trust earnings. At March&amp;#160;31, 2016, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<hrmn:CommonStockSubjectToPossibleConversionPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Common stock subject to possible conversion&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company accounts for its common stock subject to possible conversion in accordance with the guidance enumerated in ASC 480 &amp;#8220;Distinguishing Liabilities from Equity&amp;#8221;.&amp;#160;&amp;#160;&amp;#160;Common stock subject to mandatory conversion is classified as a liability instrument and is measured at fair value. Conditionally convertible common stock (including common stock that features conversion rights that are either within the control of the holder or subject to conversion upon the occurrence of uncertain events not solely within the Company&amp;#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&amp;#8217; equity. The Company&amp;#8217;s common stock features certain conversion rights that are considered by the Company to be outside of the Company&amp;#8217;s control and subject to the occurrence of uncertain future events. Accordingly at March&amp;#160;31, 2016, the common stock subject to possible conversion is presented as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s balance sheet.&lt;/p&gt;</hrmn:CommonStockSubjectToPossibleConversionPolicyTextBlock>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;The Company accounts for income taxes under ASC 740 Income Taxes (&amp;#8220;ASC 740&amp;#8221;). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&amp;#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company is required to file income tax returns in the United States (federal) and in various state and local jurisdictions. Based on the Company&amp;#8217;s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company&amp;#8217;s financial statements. Since the Company was incorporated on May 21, 2014, the evaluation was performed for the 2014 and 2015 tax years, which would be the only period subject to examination. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;The Company&amp;#8217;s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest as of or during the three months ended March&amp;#160;31, 2016. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;Subsequent Events&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Management has evaluated subsequent events to determine if events or transactions occurring through the date these financial statements were issued, require potential adjustment to or disclosure in the financial statements and has concluded that no subsequent events have occurred that would require recognition in the financial statements or disclosure in the notes to the financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
<hrmn:OfferingShareValueClosed contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">117300000</hrmn:OfferingShareValueClosed>
<hrmn:OfferingSharesClosed contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">11500000</hrmn:OfferingSharesClosed>
<us-gaap:OptionIndexedToIssuersEquityShares contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">1500000</us-gaap:OptionIndexedToIssuersEquityShares>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">115000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">115000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<hrmn:SaleOfPublicOfferingPricePerShare contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD_per_Share" decimals="2">10.20</hrmn:SaleOfPublicOfferingPricePerShare>
<hrmn:SaleOfPublicOfferingPricePerShare contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD_per_Share" decimals="2">10.20</hrmn:SaleOfPublicOfferingPricePerShare>
<hrmn:SaleOfPublicOfferingPricePerShare contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="USD_per_Share" decimals="2">10.20</hrmn:SaleOfPublicOfferingPricePerShare>
<us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">5585000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
<us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts contextRef="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">2394335</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
<us-gaap:PaymentsForUnderwritingExpense contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD" decimals="0">4325000</us-gaap:PaymentsForUnderwritingExpense>
<us-gaap:PaymentsForUnderwritingExpense contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">926786</us-gaap:PaymentsForUnderwritingExpense>
<us-gaap:DebtInstrumentMaturityDateDescription contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">180 days or less.</us-gaap:DebtInstrumentMaturityDateDescription>
<us-gaap:DebtInstrumentMaturityDateDescription contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember">The note was non-interest bearing and payable on the earlier of (i) May 31, 2015, (ii) the consummation of the Offering or (iii) the date on which the Company determined not to proceed with the Offering. This loan became payable upon the consummation of the Offering and was paid to Mr. Rosenfeld in April 2015.</us-gaap:DebtInstrumentMaturityDateDescription>
<us-gaap:FairValueInputsControlPremium contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="pure" decimals="2">0.80</us-gaap:FairValueInputsControlPremium>
<us-gaap:FairValueInputsControlPremium contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="pure" decimals="4">0.9205</us-gaap:FairValueInputsControlPremium>
<us-gaap:BusinessCombinationAcquiredReceivablesDescription contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">The Company's Amended and Restated Certificate of Incorporation, if the Company is unable to complete its initial Business Combination by March 27, 2017, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of common stock and the Company's board of directors, dissolve and liquidate. If the Company is unable to consummate an initial Business Combination and is forced to redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay any of its taxes</us-gaap:BusinessCombinationAcquiredReceivablesDescription>
<us-gaap:BusinessCombinationAcquiredReceivablesDescription contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_DefinedBenefitPlanByPlanAssetCategoriesAxis_PrivateEquityFundsMember">(i) not to convert any shares of common stock included therein into the right to receive cash from the Trust Account in connection with a stockholder vote to approve the proposed initial Business Combination and (ii) that the shares of common stock included therein shall not participate in any liquidating distribution upon winding up if a Business Combination is not consummated. Additionally, the holders have agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to certain permitted transferees) until the completion of the initial Business Combination.</us-gaap:BusinessCombinationAcquiredReceivablesDescription>
<us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00">The Company has entered into an agreement with Canaccord Genuity Inc. ("Canaccord Genuity") pursuant to which Canaccord Genuity will provide the Company with certain financial advisory services in connection with a preliminary review of potential merger and acquisition opportunities, or other services as reasonably requested by the Company and mutually agreeable by Canaccord Genuity, for a period of 18 months from the consummation of the Offering.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
<us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">(A) the earlier of one year after the completion of an Initial Business combination and the date on which the closing price of common stock of the Company exceeds $12.50 for any 20 trading days within a 30-trading day period following the completion of an Initial Business combination with respect to 50% of the buyback shares and (B) one year after the completion of an Initial Business combination with respect to the remaining 50% of the buyback shares.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
<hrmn:BusinessCombinationPublicSharesConversionPercentage contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="pure" decimals="2">0.20</hrmn:BusinessCombinationPublicSharesConversionPercentage>
<us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="pure" decimals="4">0.9205</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
<hrmn:BusinessAcquisitionPurchasePriceNetTangibleAssets contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">5000001</hrmn:BusinessAcquisitionPurchasePriceNetTangibleAssets>
<us-gaap:USGovernmentSecuritiesAtCarryingValue contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember" unitRef="USD" decimals="0">117340445</us-gaap:USGovernmentSecuritiesAtCarryingValue>
<us-gaap:DebtInstrumentMaturityDate contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember">2016-04-21</us-gaap:DebtInstrumentMaturityDate>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember" unitRef="USD" decimals="0">78926</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
<us-gaap:AccountsReceivableNetNoncurrent contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember" unitRef="USD" decimals="0">46047</us-gaap:AccountsReceivableNetNoncurrent>
<us-gaap:Cash contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_CashAndCashEquivalentsAxis_USTreasurySecuritiesMember" unitRef="USD" decimals="0">1571</us-gaap:Cash>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">11500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_StatementEquityComponentsAxis_CommonStockMember_DefinedBenefitPlanByPlanAssetCategoriesAxis_PrivateEquityFundsMember" unitRef="shares" decimals="INF">558500</us-gaap:StockIssuedDuringPeriodSharesOther>
<hrmn:StockIssuedDuringThePeriodSaleOfUnitsShares contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">11500000</hrmn:StockIssuedDuringThePeriodSaleOfUnitsShares>
<us-gaap:SharePrice contextRef="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD_per_Share" decimals="2">10.00</us-gaap:SharePrice>
<us-gaap:SharePrice contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:SharePrice>
<us-gaap:SharesIssuedPricePerShare contextRef="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:SharesIssuedPricePerShare>
<us-gaap:SaleOfStockPricePerShare contextRef="Context_As_Of_27_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">17.50</us-gaap:SaleOfStockPricePerShare>
<us-gaap:SaleOfStockPricePerShare contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD_per_Share" decimals="0">10</us-gaap:SaleOfStockPricePerShare>
<us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1 contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember_StatementEquityComponentsAxis_WarrantMember">2016-03-23</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
<us-gaap:BusinessCombinationReasonForBusinessCombination contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember_StatementEquityComponentsAxis_WarrantMember">Warrant upon 30 days' notice, only in the event that the last sale price of the shares of common stock is at least $17.50 per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given. If the Company redeems the Warrants as described above, it will have the option to require any holder that wishes to exercise his Warrant to do so on a "cashless basis." In accordance with the warrant agreement relating to the Warrants sold in the Offering, the Company is only required to use its best efforts to file the registration statement covering the shares underlying the Warrants within 15 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement.</us-gaap:BusinessCombinationReasonForBusinessCombination>
<hrmn:TermOfWarrant contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember_StatementEquityComponentsAxis_WarrantMember">P5Y</hrmn:TermOfWarrant>
<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="Context_Custom_22_Mar_2015T00_00_00_TO_27_Mar_2015T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="pure" decimals="2">1.00</us-gaap:DebtInstrumentRedemptionPricePercentage>
<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" decimals="INF">558500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
<us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">5585000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
<us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">50000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
<us-gaap:DebtInstrumentIssuanceDate1 contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember">2014-05-30</us-gaap:DebtInstrumentIssuanceDate1>
<hrmn:DiscountOnUnderwritersPublicOffer contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="pure" decimals="3">0.020</hrmn:DiscountOnUnderwritersPublicOffer>
<hrmn:DiscountOnUnderwritersPublicOffer contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_RangeAxis_MaximumMember" unitRef="pure" decimals="3">0.055</hrmn:DiscountOnUnderwritersPublicOffer>
<hrmn:DiscountOnUnderwritersPublicOffer contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00_RangeAxis_MinimumMember" unitRef="pure" decimals="3">0.035</hrmn:DiscountOnUnderwritersPublicOffer>
<us-gaap:OtherUnderwritingExpense contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">12500</us-gaap:OtherUnderwritingExpense>
<us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="USD" decimals="0">135000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_31_Dec_2015T00_00_00_TO_31_Dec_2015T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_31_Mar_2016T00_00_00_TO_31_Mar_2016T00_00_00" unitRef="shares" xsi:nil="true"/>
<hrmn:EscrowSharePercentage contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="pure" decimals="2">0.50</hrmn:EscrowSharePercentage>
<hrmn:CommonStockOutstandingDescription contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">Effective November 7, 2014, the Company's Board of Directors authorized a stock dividend of approximately 0.05 shares of common stock for each outstanding share of common stock.</hrmn:CommonStockOutstandingDescription>
<hrmn:InitialBusinessCombinationDescription contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember">The earlier of one year after the date of the consummation of an initial Business Combination and the date on which the closing price of the common stock exceeds $12.50 per share for any 20 trading days within a 30-trading day period following the consummation of an initial Business Combination and, with respect to the remaining 50% of the shares, one year after the date of the consummation of an initial Business Combination, or earlier if, subsequent to the Company's initial Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company's stockholders having the right to exchange their shares of common stock for cash, securities or other property.</hrmn:InitialBusinessCombinationDescription>
<hrmn:SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering contextRef="Context_3ME_01_Jan_2016T00_00_00_TO_31_Mar_2016T00_00_00_SubsidiarySaleOfStockAxis_IPOMember" unitRef="shares" decimals="INF">3026250</hrmn:SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering>

<!-- Footnote Section -->
<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hrmn-20160331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<schema targetNamespace="http://www.harmonymergercorp.com/20160331" elementFormDefault="qualified"
xmlns:hrmn="http://www.harmonymergercorp.com/20160331"
 xmlns="http://www.w3.org/2001/XMLSchema"
 xmlns:link="http://www.xbrl.org/2003/linkbase"
 xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
 xmlns:xl="http://www.xbrl.org/2003/XLink"
 xmlns:xbrli="http://www.xbrl.org/2003/instance"
 xmlns:xlink="http://www.w3.org/1999/xlink"
 xmlns:negated="http://www.xbrl.org/2009/role/negated"
 xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31"
 xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes"
 xmlns:country="http://xbrl.sec.gov/country/2016-01-31"
 xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31"
 xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31"
 xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31"
 xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31"
 xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31"
 xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
 xmlns:us-types="http://fasb.org/us-types/2016-01-31"
 xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31"
 xmlns:ref="http://www.xbrl.org/2006/ref"
 xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact"
 xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
 xmlns:num="http://www.xbrl.org/dtr/type/numeric"
>
<annotation><appinfo>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition>001 - Document - Document and Entity Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/CondensedBalanceSheets" id="CondensedBalanceSheets">
<link:definition>002 - Statement - Condensed Balance Sheets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/CondensedBalanceSheetsParenthetical" id="CondensedBalanceSheetsParenthetical">
<link:definition>003 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited" id="CondensedStatementsOfOperationsUnaudited">
<link:definition>004 - Statement - Condensed Statements of Operations (unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited" id="CondensedStatementsOfCashFlowsUnaudited">
<link:definition>005 - Statement - Condensed Statements of Cash Flows (unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperations" id="OrganizationAndPlanOfBusinessOperations">
<link:definition>006 - Disclosure - Organization and Plan of Business Operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
<link:definition>007 - Disclosure - Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/InitialPublicOffering" id="InitialPublicOffering">
<link:definition>008 - Disclosure - Initial Public Offering</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/PrivateUnits" id="PrivateUnits">
<link:definition>009 - Disclosure - Private Units</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/NotesPayableAndAdvanceFromStockholders" id="NotesPayableAndAdvanceFromStockholders">
<link:definition>010 - Disclosure - Notes Payable and Advance From Stockholders</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/Commitments" id="Commitments">
<link:definition>011 - Disclosure - Commitments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/StockholdersEquity" id="StockholdersEquity">
<link:definition>012 - Disclosure - Stockholders' Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
<link:definition>013 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperationsDetails" id="OrganizationAndPlanOfBusinessOperationsDetails">
<link:definition>014 - Disclosure - Organization and Plan of Business Operations (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesDetails" id="SignificantAccountingPoliciesDetails">
<link:definition>015 - Disclosure - Significant Accounting Policies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/InitialPublicOfferingDetails" id="InitialPublicOfferingDetails">
<link:definition>016 - Disclosure - Initial Public Offering (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/PrivateUnitsDetails" id="PrivateUnitsDetails">
<link:definition>017 - Disclosure - Private Units (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/NotesPayableandAdvanceFromStockholdersDetails" id="NotesPayableandAdvanceFromStockholdersDetails">
<link:definition>018 - Disclosure - Notes Payable and Advance From Stockholders (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/CommitmentsDetails" id="CommitmentsDetails">
<link:definition>019 - Disclosure - Commitments (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.harmonymergercorp.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
<link:definition>020 - Disclosure - Stockholders' Equity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="hrmn-20160331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="hrmn-20160331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="hrmn-20160331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="hrmn-20160331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo></annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" id="hrmn_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="CashCashEquivalentsAndSecuritiesHeldInTrust" id="hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" />
<element name="DeferredUnderwritersFee" id="hrmn_DeferredUnderwritersFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesSubjectToPossibleConversion" id="hrmn_CommonStockSharesSubjectToPossibleConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" />
<element name="InterestEarnedOnCashAndSecuritiesInTrust" id="hrmn_InterestEarnedOnCashAndSecuritiesInTrust" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" />
<element name="PaymentOfOfferingCosts" id="hrmn_PaymentOfOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" />
<element name="AccrualOfDeferredUnderwritingFee" id="hrmn_AccrualOfDeferredUnderwritingFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" />
<element name="InitialPublicOfferingAbstract" id="hrmn_InitialPublicOfferingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="InitialPublicOfferingTextBlock" id="hrmn_InitialPublicOfferingTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="PrivateUnitsAbstract" id="hrmn_PrivateUnitsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="PrivateUnitsTextBlock" id="hrmn_PrivateUnitsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="NotesPayableAndAdvancesFromShareholdersAbstract" id="hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="NotesPayableAndAdvancesFromShareholdersTextBlock" id="hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" id="hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="CommonStockSubjectToPossibleConversionPolicyTextBlock" id="hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="OrganizationAndPlanOfBusinessOperationsTextualAbstract" id="hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="OfferingShareValueClosed" id="hrmn_OfferingShareValueClosed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" />
<element name="OfferingSharesClosed" id="hrmn_OfferingSharesClosed" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="SaleOfPublicOfferingPricePerShare" id="hrmn_SaleOfPublicOfferingPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="BusinessCombinationPublicSharesConversionPercentage" id="hrmn_BusinessCombinationPublicSharesConversionPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="BusinessAcquisitionPurchasePriceNetTangibleAssets" id="hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" />
<element name="SignificantAccountingPoliciesTextualAbstract" id="hrmn_SignificantAccountingPoliciesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="InitialPublicOfferingTextualAbstract" id="hrmn_InitialPublicOfferingTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringThePeriodSaleOfUnitsShares" id="hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="TermOfWarrant" id="hrmn_TermOfWarrant" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="PrivateUtilitiesInventoryTable" id="hrmn_PrivateUtilitiesInventoryTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" />
<element name="PrivateUtilitiesInventoryLineItems" id="hrmn_PrivateUtilitiesInventoryLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="PrivateUnitsTextualAbstract" id="hrmn_PrivateUnitsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="NotesPayableAndAdvancesFromShareholdersTextualAbstract" id="hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="CommitmentsTextualAbstract" id="hrmn_CommitmentsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="DiscountOnUnderwritersPublicOffer" id="hrmn_DiscountOnUnderwritersPublicOffer" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" />
<element name="StockholdersEquityTextualAbstract" id="hrmn_StockholdersEquityTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="EscrowSharePercentage" id="hrmn_EscrowSharePercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="CommonStockOutstandingDescription" id="hrmn_CommonStockOutstandingDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="InitialBusinessCombinationDescription" id="hrmn_InitialBusinessCombinationDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
<element name="SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" id="hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hrmn-20160331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedBalanceSheets" roleURI="http://www.harmonymergercorp.com/role/CondensedBalanceSheets"/>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseCurrent" order="20" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xlink:label="loc_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent" order="30" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" order="10" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DeferredUnderwritersFee" xlink:label="loc_hrmn_DeferredUnderwritersFee" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_hrmn_DeferredUnderwritersFee" order="20" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" order="40" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_CommitmentsAndContingencies" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" order="40" use="optional" weight="1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedStatementsOfOperationsUnaudited" roleURI="http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" order="10" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense" order="20" use="optional" weight="-1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_OperatingIncomeLoss" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_InterestIncomeExpenseNet" order="20" use="optional" weight="1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedStatementsOfCashFlowsUnaudited" roleURI="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_NetIncomeLoss" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xlink:label="loc_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" order="30" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" order="40" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsForProceedsFromInvestments" order="10" use="optional" weight="-1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PaymentOfOfferingCosts" xlink:label="loc_hrmn_PaymentOfOfferingCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_hrmn_PaymentOfOfferingCosts" order="10" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" order="40" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" order="30" use="optional" weight="1"/>
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hrmn-20160331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" >
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#OrganizationAndPlanOfBusinessOperationsDetails" roleURI="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperationsDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#SignificantAccountingPoliciesDetails" roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#InitialPublicOfferingDetails" roleURI="http://www.harmonymergercorp.com/role/InitialPublicOfferingDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#PrivateUnitsDetails" roleURI="http://www.harmonymergercorp.com/role/PrivateUnitsDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#NotesPayableandAdvanceFromStockholdersDetails" roleURI="http://www.harmonymergercorp.com/role/NotesPayableandAdvanceFromStockholdersDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CommitmentsDetails" roleURI="http://www.harmonymergercorp.com/role/CommitmentsDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#StockholdersEquityDetails" roleURI="http://www.harmonymergercorp.com/role/StockholdersEquityDetails"/>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperationsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" xlink:to="loc_us-gaap_IPOMember_7" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" xlink:label="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OfferingShareValueClosed" xlink:label="loc_hrmn_OfferingShareValueClosed_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_hrmn_OfferingShareValueClosed_9" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OfferingSharesClosed" xlink:label="loc_hrmn_OfferingSharesClosed_10" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_hrmn_OfferingSharesClosed_10" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityShares_11" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityShares_11" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12" order="30" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_13" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_13" order="40" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SaleOfPublicOfferingPricePerShare" xlink:label="loc_hrmn_SaleOfPublicOfferingPricePerShare_14" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_hrmn_SaleOfPublicOfferingPricePerShare_14" order="50" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_15" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_15" order="60" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_16" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_16" order="70" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense_17" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_PaymentsForUnderwritingExpense_17" order="80" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_18" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_18" order="90" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsControlPremium" xlink:label="loc_us-gaap_FairValueInputsControlPremium_19" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_FairValueInputsControlPremium_19" order="100" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_20" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_20" order="110" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_21" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_CommonStockValue_21" order="120" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesDescription" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_22" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_22" order="130" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_23" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_23" order="140" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_BusinessCombinationPublicSharesConversionPercentage" xlink:label="loc_hrmn_BusinessCombinationPublicSharesConversionPercentage_24" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_hrmn_BusinessCombinationPublicSharesConversionPercentage_24" order="150" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_25" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_25" order="160" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xlink:label="loc_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets_26" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_8" xlink:to="loc_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets_26" order="170" use="optional"  />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" xlink:to="loc_us-gaap_IPOMember_7" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" xlink:to="loc_us-gaap_PrivatePlacementMember_8" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9" xlink:to="loc_us-gaap_EquityComponentDomain_10" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9" xlink:to="loc_us-gaap_EquityComponentDomain_10_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_11" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10" xlink:to="loc_us-gaap_CommonStockMember_11" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" order="30" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_13" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_13" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_13_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_13_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="loc_us-gaap_PrivateEquityFundsMember_14" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_13" xlink:to="loc_us-gaap_PrivateEquityFundsMember_14" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:label="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_16" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_16" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="loc_us-gaap_USGovernmentSecuritiesAtCarryingValue_17" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_USGovernmentSecuritiesAtCarryingValue_17" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_18" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_18" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_19" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_19" order="30" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_20" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_20" order="40" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_21" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_Cash_21" order="50" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_22" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_22" order="60" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_23" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_23" order="70" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaap_CashFDICInsuredAmount_24" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_15" xlink:to="loc_us-gaap_CashFDICInsuredAmount_24" order="80" use="optional"  />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/InitialPublicOfferingDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_us-gaap_IPOMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5" xlink:to="loc_us-gaap_EquityComponentDomain_6" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_6_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5" xlink:to="loc_us-gaap_EquityComponentDomain_6_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6" xlink:to="loc_us-gaap_WarrantMember_7" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingTextualAbstract" xlink:label="loc_hrmn_InitialPublicOfferingTextualAbstract_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0" xlink:to="loc_hrmn_InitialPublicOfferingTextualAbstract_8" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xlink:label="loc_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares_9" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_10" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_SharePrice_10" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_11" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_11" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_12" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_12" order="30" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_13" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_13" order="40" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_14" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_14" order="50" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:label="loc_us-gaap_BusinessCombinationReasonForBusinessCombination_15" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_BusinessCombinationReasonForBusinessCombination_15" order="60" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_TermOfWarrant" xlink:label="loc_hrmn_TermOfWarrant_16" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_hrmn_TermOfWarrant_16" order="70" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_17" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_17" order="80" use="optional"  />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/PrivateUnitsDetails">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUtilitiesInventoryLineItems" xlink:label="loc_hrmn_PrivateUtilitiesInventoryLineItems_0" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUtilitiesInventoryTable" xlink:label="loc_hrmn_PrivateUtilitiesInventoryTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hrmn_PrivateUtilitiesInventoryLineItems_0" xlink:to="loc_hrmn_PrivateUtilitiesInventoryTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hrmn_PrivateUtilitiesInventoryTable_1" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="loc_us-gaap_PrivateEquityFundsMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3" xlink:to="loc_us-gaap_PrivateEquityFundsMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsTextualAbstract" xlink:label="loc_hrmn_PrivateUnitsTextualAbstract_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_PrivateUtilitiesInventoryLineItems_0" xlink:to="loc_hrmn_PrivateUnitsTextualAbstract_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_7" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_5" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_8" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesDescription" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_5" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_9" order="30" use="optional"  />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/NotesPayableandAdvanceFromStockholdersDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefOperatingOfficerMember" xlink:label="loc_us-gaap_ChiefOperatingOfficerMember_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefOperatingOfficerMember_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" xlink:label="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_6" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_7" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_8" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_9" order="20" use="optional"  />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CommitmentsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RangeAxis_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_5" xlink:to="loc_us-gaap_RangeMember_6" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_6_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_5" xlink:to="loc_us-gaap_RangeMember_6_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_6" xlink:to="loc_us-gaap_MaximumMember_7" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_6" xlink:to="loc_us-gaap_MinimumMember_8" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommitmentsTextualAbstract" xlink:label="loc_hrmn_CommitmentsTextualAbstract_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_hrmn_CommitmentsTextualAbstract_9" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DiscountOnUnderwritersPublicOffer" xlink:label="loc_hrmn_DiscountOnUnderwritersPublicOffer_10" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_CommitmentsTextualAbstract_9" xlink:to="loc_hrmn_DiscountOnUnderwritersPublicOffer_10" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense_11" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_CommitmentsTextualAbstract_9" xlink:to="loc_us-gaap_PaymentsForUnderwritingExpense_11" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_12" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_CommitmentsTextualAbstract_9" xlink:to="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_12" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_us-gaap_OtherUnderwritingExpense_13" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_CommitmentsTextualAbstract_9" xlink:to="loc_us-gaap_OtherUnderwritingExpense_13" order="30" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_14" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_CommitmentsTextualAbstract_9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_14" order="40" use="optional"  />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/StockholdersEquityDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" order="0" use="optional"  xbrldt:contextElement="segment" xbrldt:closed="true" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3_Default" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_4" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_us-gaap_IPOMember_4" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_StockholdersEquityTextualAbstract" xlink:label="loc_hrmn_StockholdersEquityTextualAbstract_5" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_0" xlink:to="loc_hrmn_StockholdersEquityTextualAbstract_5" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6" order="0" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7" order="10" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_8" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_8" order="20" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9" order="30" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_10" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_10" order="40" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_11" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_11" order="50" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12" order="60" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13" order="70" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_14" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_SharePrice_14" order="80" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_EscrowSharePercentage" xlink:label="loc_hrmn_EscrowSharePercentage_15" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_hrmn_EscrowSharePercentage_15" order="90" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockOutstandingDescription" xlink:label="loc_hrmn_CommonStockOutstandingDescription_16" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_hrmn_CommonStockOutstandingDescription_16" order="100" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialBusinessCombinationDescription" xlink:label="loc_hrmn_InitialBusinessCombinationDescription_17" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_hrmn_InitialBusinessCombinationDescription_17" order="110" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xlink:label="loc_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering_18" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering_18" order="120" use="optional"  />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:label="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_19" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_19" order="130" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_20" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_20" order="140" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_21" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_CommonStockSharesIssued_21" order="150" use="optional"  />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_22" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_22" order="160" use="optional"  />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hrmn-20160331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DocumentAndEntityInformationAbstract" xlink:label="loc_G5FI14K6FH5G_hrmn_DocumentAndEntityInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_DocumentAndEntityInformationAbstract" xlink:to="lab_I7HK36M8HJ7I_hrmn_DocumentAndEntityInformationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_3JGJGHJ574H990HGF7K9_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_dei_EntityRegistrantName" xlink:to="lab_5LILIJL796J112JIH9M1_dei_EntityRegistrantName"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_G5FI14K6FH5G_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_dei_EntityCentralIndexKey" xlink:to="lab_I7HK36M8HJ7I_dei_EntityCentralIndexKey"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_3JGJGHJ574H990HGF7K9_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_dei_AmendmentFlag" xlink:to="lab_5LILIJL796J112JIH9M1_dei_AmendmentFlag"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_G5FI14K6FH5G_dei_CurrentFiscalYearEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_dei_CurrentFiscalYearEndDate" xlink:to="lab_I7HK36M8HJ7I_dei_CurrentFiscalYearEndDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_3JGJGHJ574H990HGF7K9_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_dei_DocumentType" xlink:to="lab_5LILIJL796J112JIH9M1_dei_DocumentType"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_G5FI14K6FH5G_dei_DocumentPeriodEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_dei_DocumentPeriodEndDate" xlink:to="lab_I7HK36M8HJ7I_dei_DocumentPeriodEndDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_3JGJGHJ574H990HGF7K9_dei_DocumentFiscalYearFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_dei_DocumentFiscalYearFocus" xlink:to="lab_5LILIJL796J112JIH9M1_dei_DocumentFiscalYearFocus"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_G5FI14K6FH5G_dei_DocumentFiscalPeriodFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_dei_DocumentFiscalPeriodFocus" xlink:to="lab_I7HK36M8HJ7I_dei_DocumentFiscalPeriodFocus"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_3JGJGHJ574H990HGF7K9_dei_EntityFilerCategory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_dei_EntityFilerCategory" xlink:to="lab_5LILIJL796J112JIH9M1_dei_EntityFilerCategory"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_G5FI14K6FH5G_dei_EntityCommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_I7HK36M8HJ7I_dei_EntityCommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_StatementOfFinancialPositionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_G5FI14K6FH5G_us-gaap_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_AssetsAbstract" xlink:to="lab_I7HK36M8HJ7I_us-gaap_AssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_AssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current Assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_AssetsCurrentAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_AssetsCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PrepaidExpenseCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid Expense, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PrepaidExpenseCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_G5FI14K6FH5G_us-gaap_AssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_AssetsCurrent" xlink:to="lab_I7HK36M8HJ7I_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xml:lang="en-US">Cash Cash Equivalents And Securities Held In Trust</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xml:lang="en-US">Cash, cash equivalents and securities held in Trust</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xml:lang="en-US">Cash, cash equivalents and securities held in trust.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_G5FI14K6FH5G_us-gaap_PrepaidExpenseCurrentAndNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xml:lang="en-US">Prepaid Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xml:lang="en-US">Prepaid expenses - long term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="lab_I7HK36M8HJ7I_us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_Assets" xml:lang="en-US">Total assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_Assets" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_G5FI14K6FH5G_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES &amp; STOCKHOLDERS EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_I7HK36M8HJ7I_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_LiabilitiesCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_LiabilitiesCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_G5FI14K6FH5G_us-gaap_AccountsPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_AccountsPayableCurrent" xlink:to="lab_I7HK36M8HJ7I_us-gaap_AccountsPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_LiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_LiabilitiesCurrent" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DeferredUnderwritersFee" xlink:label="loc_G5FI14K6FH5G_hrmn_DeferredUnderwritersFee" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_DeferredUnderwritersFee" xml:lang="en-US">Deferred Underwriters Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_DeferredUnderwritersFee" xml:lang="en-US">Deferred Underwriters Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_DeferredUnderwritersFee" xml:lang="en-US">Deferred underwriters fee.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_DeferredUnderwritersFee" xlink:to="lab_I7HK36M8HJ7I_hrmn_DeferredUnderwritersFee"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_Liabilities" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_G5FI14K6FH5G_us-gaap_CommitmentsAndContingencies" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CommitmentsAndContingencies" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CommitmentsAndContingencies"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Common Stock, subject to possible conversion (10,585,784 shares at conversion value)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_G5FI14K6FH5G_us-gaap_StockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_StockholdersEquityAbstract" xlink:to="lab_I7HK36M8HJ7I_us-gaap_StockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock, $.0001 par value, 1,000,000 authorized, 0 outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockValue" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_G5FI14K6FH5G_us-gaap_CommonStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockValue" xml:lang="en-US">Common stock, value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockValue" xml:lang="en-US">Common stock, $.0001 par value; Authorized 27,500,000 shares, 4,498,966 issued and outstanding at March 31, 2016 (excluding 10,585,784 shares subject to possible conversion) and 4,498,966 issued and outstanding at December 31, 2015.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CommonStockValue" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_AdditionalPaidInCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional Paid in Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_AdditionalPaidInCapital" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_AdditionalPaidInCapital"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_G5FI14K6FH5G_us-gaap_RetainedEarningsAccumulatedDeficit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_I7HK36M8HJ7I_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_StockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockholdersEquity" xml:lang="en-US">Total stockholders' equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockholdersEquity" xml:lang="en-US">Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_StockholdersEquity" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_G5FI14K6FH5G_us-gaap_LiabilitiesAndStockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and stockholders' equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_I7HK36M8HJ7I_us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_G5FI14K6FH5G_us-gaap_PreferredStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_I7HK36M8HJ7I_us-gaap_PreferredStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:label="loc_G5FI14K6FH5G_hrmn_CommonStockSharesSubjectToPossibleConversion" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommonStockSharesSubjectToPossibleConversion" xml:lang="en-US">Common Stock Shares Subject To Possible Conversion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommonStockSharesSubjectToPossibleConversion" xml:lang="en-US">Common stock shares subject to possible conversion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommonStockSharesSubjectToPossibleConversion" xml:lang="en-US">Common stock shares subject to possible conversion.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:to="lab_I7HK36M8HJ7I_hrmn_CommonStockSharesSubjectToPossibleConversion"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_CommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_CommonStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_G5FI14K6FH5G_us-gaap_CommonStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CommonStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_CommonStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_CommonStockSharesIssued" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_CommonStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_G5FI14K6FH5G_us-gaap_CommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncomeStatementAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_IncomeStatementAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_G5FI14K6FH5G_us-gaap_GeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_I7HK36M8HJ7I_us-gaap_GeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_OtherGeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_OtherGeneralAndAdministrativeExpense" xml:lang="en-US">Other General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_OtherGeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative costs - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_OtherGeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_G5FI14K6FH5G_us-gaap_OperatingIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_OperatingIncomeLoss" xlink:to="lab_I7HK36M8HJ7I_us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_InterestIncomeExpenseNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest Income (Expense), Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest Income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_InterestIncomeExpenseNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_G5FI14K6FH5G_us-gaap_NetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_NetIncomeLoss" xlink:to="lab_I7HK36M8HJ7I_us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted average shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_G5FI14K6FH5G_us-gaap_EarningsPerShareBasicAndDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Basic and diluted net loss per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_I7HK36M8HJ7I_us-gaap_EarningsPerShareBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_G5FI14K6FH5G_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile Net Loss to net cash provided by operations:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xlink:label="loc_G5FI14K6FH5G_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xml:lang="en-US">Interest Earned On Cash And Securities In Trust</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xml:lang="en-US">Interest earned on cash and securities in trust</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xml:lang="en-US">Interest earned on cash and securities in trust.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xlink:to="lab_I7HK36M8HJ7I_hrmn_InterestEarnedOnCashAndSecuritiesInTrust"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Changes in operating assets and liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_G5FI14K6FH5G_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_I7HK36M8HJ7I_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncreaseDecreaseInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_IncreaseDecreaseInAccountsPayable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_G5FI14K6FH5G_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash provided by Operating Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_G5FI14K6FH5G_us-gaap_PaymentsForProceedsFromInvestments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PaymentsForProceedsFromInvestments" xml:lang="en-US">Payments for (Proceeds from) Investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PaymentsForProceedsFromInvestments" xml:lang="en-US">Investment in restricted cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PaymentsForProceedsFromInvestments" xml:lang="en-US">Investment in cash, cash equivalents and securities in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_PaymentsForProceedsFromInvestments" xlink:to="lab_I7HK36M8HJ7I_us-gaap_PaymentsForProceedsFromInvestments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in Investing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_G5FI14K6FH5G_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_I7HK36M8HJ7I_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PaymentOfOfferingCosts" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_PaymentOfOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PaymentOfOfferingCosts" xml:lang="en-US">Payment Of Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PaymentOfOfferingCosts" xml:lang="en-US">Payment of offering costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PaymentOfOfferingCosts" xml:lang="en-US">Payment of offering costs.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PaymentOfOfferingCosts" xml:lang="en-US">Payment of offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_PaymentOfOfferingCosts" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_PaymentOfOfferingCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_G5FI14K6FH5G_us-gaap_ProceedsFromIssuanceOfCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from sale of shares of common stock to initial stockholders</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_I7HK36M8HJ7I_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Proceeds from Public Offering, net of offering costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Net proceed from offerings</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" xlink:label="loc_G5FI14K6FH5G_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" xml:lang="en-US">Proceeds from Issuance of Preferred Limited Partners Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" xml:lang="en-US">Proceeds from Insider Units</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" xlink:to="lab_I7HK36M8HJ7I_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by Financing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Net increase in cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_SupplementalCashFlowInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_SupplementalCashFlowInformationAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_AccrualOfDeferredUnderwritingFee" xlink:label="loc_G5FI14K6FH5G_hrmn_AccrualOfDeferredUnderwritingFee" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_AccrualOfDeferredUnderwritingFee" xml:lang="en-US">Accrual Of Deferred Underwriting Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_AccrualOfDeferredUnderwritingFee" xml:lang="en-US">Accrual of deferred underwriting fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_AccrualOfDeferredUnderwritingFee" xml:lang="en-US">The amount of accrual of deferred underwriting fee that were incurred during a noncash or partial noncash transaction.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_AccrualOfDeferredUnderwritingFee" xlink:to="lab_I7HK36M8HJ7I_hrmn_AccrualOfDeferredUnderwritingFee"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization and Plan of Business Operations [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_G5FI14K6FH5G_us-gaap_NatureOfOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NatureOfOperations" xml:lang="en-US">Nature of Operations [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_NatureOfOperations" xml:lang="en-US">Organization and Plan of Business Operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_NatureOfOperations" xlink:to="lab_I7HK36M8HJ7I_us-gaap_NatureOfOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_AccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_G5FI14K6FH5G_us-gaap_SignificantAccountingPoliciesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_I7HK36M8HJ7I_us-gaap_SignificantAccountingPoliciesTextBlock"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_InitialPublicOfferingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_InitialPublicOfferingAbstract" xml:lang="en-US">Initial Public Offering [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_InitialPublicOfferingAbstract" xml:lang="en-US">Initial Public Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_InitialPublicOfferingAbstract" xml:lang="en-US">Initial public offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_InitialPublicOfferingAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_InitialPublicOfferingAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingTextBlock" xlink:label="loc_G5FI14K6FH5G_hrmn_InitialPublicOfferingTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextBlock" xml:lang="en-US">Initial Public Offering [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextBlock" xml:lang="en-US">Initial Public Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextBlock" xml:lang="en-US">Initial public offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_InitialPublicOfferingTextBlock" xlink:to="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextBlock"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_PrivateUnitsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUnitsAbstract" xml:lang="en-US">Private Units [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUnitsAbstract" xml:lang="en-US">Private units.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_PrivateUnitsAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUnitsAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsTextBlock" xlink:label="loc_G5FI14K6FH5G_hrmn_PrivateUnitsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_PrivateUnitsTextBlock" xml:lang="en-US">Private Units [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_PrivateUnitsTextBlock" xml:lang="en-US">Private Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_PrivateUnitsTextBlock" xml:lang="en-US">Private units.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_PrivateUnitsTextBlock" xlink:to="lab_I7HK36M8HJ7I_hrmn_PrivateUnitsTextBlock"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" xml:lang="en-US">Notes Payable and Advance From Stockholders [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" xml:lang="en-US">Notes payable and advances from shareholders.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" xlink:label="loc_G5FI14K6FH5G_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" xml:lang="en-US">Notes Payable And Advances From Shareholders [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" xml:lang="en-US">Notes Payable and Advance From Stockholders</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" xml:lang="en-US">The entire disclosure for notes payable and advances from shareholders.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" xlink:to="lab_I7HK36M8HJ7I_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Administrative services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_G5FI14K6FH5G_us-gaap_CommitmentsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommitmentsDisclosureTextBlock" xml:lang="en-US">Commitments Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommitmentsDisclosureTextBlock" xml:lang="en-US">Commitments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CommitmentsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_EquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_EquityAbstract" xml:lang="en-US">Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_EquityAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_EquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_G5FI14K6FH5G_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_I7HK36M8HJ7I_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Presentation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" xml:lang="en-US">Cash Cash Equivalents Andsecurities Held In Trust Account [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" xml:lang="en-US">Cash, cash equivalents and securities held in Trust Account</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" xml:lang="en-US">Cash, cash equivalents and securities held in trust account.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_G5FI14K6FH5G_us-gaap_FairValueOfFinancialInstrumentsPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair value of financial instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_I7HK36M8HJ7I_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_EarningsPerSharePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Net loss per common share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_EarningsPerSharePolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" xlink:label="loc_G5FI14K6FH5G_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" xml:lang="en-US">Common Stock Subject To Possible Conversion [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" xml:lang="en-US">Common stock subject to possible conversion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" xml:lang="en-US">Common stock subject to possible conversion.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" xlink:to="lab_I7HK36M8HJ7I_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncomeTaxPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_IncomeTaxPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_G5FI14K6FH5G_us-gaap_UseOfEstimates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_UseOfEstimates" xlink:to="lab_I7HK36M8HJ7I_us-gaap_UseOfEstimates"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recent Accounting Pronouncements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_G5FI14K6FH5G_us-gaap_SubsequentEventsPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_I7HK36M8HJ7I_us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xml:lang="en-US">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_G5FI14K6FH5G_us-gaap_TitleOfIndividualAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_TitleOfIndividualAxis" xlink:to="lab_I7HK36M8HJ7I_us-gaap_TitleOfIndividualAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_G5FI14K6FH5G_us-gaap_ChiefExecutiveOfficerMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_ChiefExecutiveOfficerMember" xlink:to="lab_I7HK36M8HJ7I_us-gaap_ChiefExecutiveOfficerMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_SubsidiarySaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_SubsidiarySaleOfStockAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_G5FI14K6FH5G_us-gaap_SaleOfStockNameOfTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockNameOfTransactionDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_IPOMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_IPOMember" xml:lang="en-US">IPO [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_IPOMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_IPOMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_G5FI14K6FH5G_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" xml:lang="en-US">Organization And Plan Of Business Operations Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" xml:lang="en-US">Organization and Plan of Business Operations (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OfferingShareValueClosed" xlink:label="loc_G5FI14K6FH5G_hrmn_OfferingShareValueClosed" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_OfferingShareValueClosed" xml:lang="en-US">Offering Share Value Closed</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_OfferingShareValueClosed" xml:lang="en-US">Offering share closed, Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_OfferingShareValueClosed" xml:lang="en-US">Offering share value closed.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_OfferingShareValueClosed" xlink:to="lab_I7HK36M8HJ7I_hrmn_OfferingShareValueClosed"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OfferingSharesClosed" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_OfferingSharesClosed" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_OfferingSharesClosed" xml:lang="en-US">Offering Shares Closed</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_OfferingSharesClosed" xml:lang="en-US">Offering shares closed</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_OfferingSharesClosed" xml:lang="en-US">Offering shares closed.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_OfferingSharesClosed" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_OfferingSharesClosed"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_G5FI14K6FH5G_us-gaap_OptionIndexedToIssuersEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OptionIndexedToIssuersEquityShares" xml:lang="en-US">Option Indexed to Issuer's Equity, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OptionIndexedToIssuersEquityShares" xml:lang="en-US">Exercise of over-allotment option</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_OptionIndexedToIssuersEquityShares" xlink:to="lab_I7HK36M8HJ7I_us-gaap_OptionIndexedToIssuersEquityShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Common stock sold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Sale of 11,500,000 units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Gross proceeds from offerings</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SaleOfPublicOfferingPricePerShare" xlink:label="loc_G5FI14K6FH5G_hrmn_SaleOfPublicOfferingPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_SaleOfPublicOfferingPricePerShare" xml:lang="en-US">Sale Of Public Offering Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_SaleOfPublicOfferingPricePerShare" xml:lang="en-US">Sale of public offering price per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_SaleOfPublicOfferingPricePerShare" xml:lang="en-US">Sale of public offering price per share.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_SaleOfPublicOfferingPricePerShare" xlink:to="lab_I7HK36M8HJ7I_hrmn_SaleOfPublicOfferingPricePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Proceeds from private placement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_G5FI14K6FH5G_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xml:lang="en-US">Business Acquisition, Transaction Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xml:lang="en-US">Transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_I7HK36M8HJ7I_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PaymentsForUnderwritingExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PaymentsForUnderwritingExpense" xml:lang="en-US">Payments for Underwriting Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PaymentsForUnderwritingExpense" xml:lang="en-US">Deferred underwriting expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PaymentsForUnderwritingExpense" xml:lang="en-US">Deferred underwriting payments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PaymentsForUnderwritingExpense" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PaymentsForUnderwritingExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentMaturityDateDescription" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDateDescription" xml:lang="en-US">Debt Instrument, Maturity Date, Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDateDescription" xml:lang="en-US">Maturity date, description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDateDescription" xml:lang="en-US">Debt intrument Description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDateDescription"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsControlPremium" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_FairValueInputsControlPremium" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_FairValueInputsControlPremium" xml:lang="en-US">Fair Value Inputs, Control Premium</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_FairValueInputsControlPremium" xml:lang="en-US">Percentage of fair market value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_FairValueInputsControlPremium" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_FairValueInputsControlPremium"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_G5FI14K6FH5G_us-gaap_FiniteLivedIntangibleAssetsNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Intangible assets, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_I7HK36M8HJ7I_us-gaap_FiniteLivedIntangibleAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesDescription" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_BusinessCombinationAcquiredReceivablesDescription" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessCombinationAcquiredReceivablesDescription" xml:lang="en-US">Business Combination, Acquired Receivables, Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessCombinationAcquiredReceivablesDescription" xml:lang="en-US">Initial business combination, description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_BusinessCombinationAcquiredReceivablesDescription" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessCombinationAcquiredReceivablesDescription"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_G5FI14K6FH5G_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xml:lang="en-US">Business Acquisition, Description of Acquired Entity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xml:lang="en-US">Business combination, description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="lab_I7HK36M8HJ7I_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_BusinessCombinationPublicSharesConversionPercentage" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_BusinessCombinationPublicSharesConversionPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_BusinessCombinationPublicSharesConversionPercentage" xml:lang="en-US">Business Combination, Public Shares Conversion Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_BusinessCombinationPublicSharesConversionPercentage" xml:lang="en-US">Public shares conversion, percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_BusinessCombinationPublicSharesConversionPercentage" xml:lang="en-US">Percentage of public shares conversion.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_BusinessCombinationPublicSharesConversionPercentage" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_BusinessCombinationPublicSharesConversionPercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:label="loc_G5FI14K6FH5G_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xml:lang="en-US">Business combination ownership percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_I7HK36M8HJ7I_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xml:lang="en-US">Business Acquisition Purchase Price Net Tangible Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xml:lang="en-US">Tangible assets net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xml:lang="en-US">The amount of acquisition cost of a business combination allocated to net tangible assets.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAxis" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CashAndCashEquivalentsAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_G5FI14K6FH5G_us-gaap_USTreasurySecuritiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_USTreasurySecuritiesMember" xml:lang="en-US">US Treasury Securities [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_I7HK36M8HJ7I_us-gaap_USTreasurySecuritiesMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PrivatePlacementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PrivatePlacementMember" xml:lang="en-US">Private Placement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PrivatePlacementMember" xml:lang="en-US">Private [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PrivatePlacementMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PrivatePlacementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_G5FI14K6FH5G_us-gaap_StatementEquityComponentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_I7HK36M8HJ7I_us-gaap_StatementEquityComponentsAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_EquityComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_EquityComponentDomain" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_EquityComponentDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_G5FI14K6FH5G_us-gaap_CommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CommonStockMember" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CommonStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xml:lang="en-US">Defined Benefit Plan, Asset Categories [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_G5FI14K6FH5G_us-gaap_PlanAssetCategoriesDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_PlanAssetCategoriesDomain" xml:lang="en-US">Plan Asset Categories [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_I7HK36M8HJ7I_us-gaap_PlanAssetCategoriesDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PrivateEquityFundsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PrivateEquityFundsMember" xml:lang="en-US">Private Equity Funds [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PrivateEquityFundsMember" xml:lang="en-US">Private Units [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PrivateEquityFundsMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PrivateEquityFundsMember"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_G5FI14K6FH5G_hrmn_SignificantAccountingPoliciesTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_SignificantAccountingPoliciesTextualAbstract" xml:lang="en-US">Significant Accounting Policies Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_SignificantAccountingPoliciesTextualAbstract" xml:lang="en-US">Significant Accounting Policies (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_SignificantAccountingPoliciesTextualAbstract" xlink:to="lab_I7HK36M8HJ7I_hrmn_SignificantAccountingPoliciesTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_USGovernmentSecuritiesAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_USGovernmentSecuritiesAtCarryingValue" xml:lang="en-US">US Government Securities, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_USGovernmentSecuritiesAtCarryingValue" xml:lang="en-US">Treasury bills</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_USGovernmentSecuritiesAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentMaturityDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Debt Instrument, Maturity Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Maturity date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Advances repaid date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentMaturityDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xml:lang="en-US">Accounts Payable and Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xml:lang="en-US">Accrued interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_G5FI14K6FH5G_us-gaap_AccountsReceivableNetNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AccountsReceivableNetNoncurrent" xml:lang="en-US">Accounts Receivable, Net, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_AccountsReceivableNetNoncurrent" xml:lang="en-US">Earned interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_AccountsReceivableNetNoncurrent" xlink:to="lab_I7HK36M8HJ7I_us-gaap_AccountsReceivableNetNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_Cash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_Cash" xml:lang="en-US">Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_Cash" xml:lang="en-US">Cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_Cash" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_Cash"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_G5FI14K6FH5G_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Common stock sold, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Sale of 11,500,000 units, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Initial public offering shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Initial public offering shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Sale of units</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_I7HK36M8HJ7I_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_StockIssuedDuringPeriodSharesOther" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Sale of 558,500 private units, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Sale of private units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Private units shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/zeroLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Private units shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_StockIssuedDuringPeriodSharesOther"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_G5FI14K6FH5G_us-gaap_CashFDICInsuredAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashFDICInsuredAmount" xml:lang="en-US">Cash, FDIC Insured Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_CashFDICInsuredAmount" xml:lang="en-US">Federal depository insurance coverage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_CashFDICInsuredAmount" xlink:to="lab_I7HK36M8HJ7I_us-gaap_CashFDICInsuredAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_G5FI14K6FH5G_us-gaap_WarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_WarrantMember" xlink:to="lab_I7HK36M8HJ7I_us-gaap_WarrantMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_SubsidiarySaleOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SubsidiarySaleOfStockLineItems" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_SubsidiarySaleOfStockLineItems"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingTextualAbstract" xlink:label="loc_G5FI14K6FH5G_hrmn_InitialPublicOfferingTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextualAbstract" xml:lang="en-US">Initial Public Offering Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextualAbstract" xml:lang="en-US">Initial Public Offering (Textual)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextualAbstract" xml:lang="en-US">Initial public offering textual</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_InitialPublicOfferingTextualAbstract" xlink:to="lab_I7HK36M8HJ7I_hrmn_InitialPublicOfferingTextualAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xml:lang="en-US">Sale of 11,500,000 units shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xml:lang="en-US">Sale of 11,500,000 units shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xml:lang="en-US">Stock issued during the period sale of units shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xml:lang="en-US">Stock issued during the period sale of units shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_G5FI14K6FH5G_us-gaap_SharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SharePrice" xml:lang="en-US">Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SharePrice" xml:lang="en-US">Offering price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_SharePrice" xlink:to="lab_I7HK36M8HJ7I_us-gaap_SharePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_SharesIssuedPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares issued, price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_SharesIssuedPricePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_G5FI14K6FH5G_us-gaap_SaleOfStockPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of Stock, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of stock, price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockPricePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xml:lang="en-US">Business Acquisition, Effective Date of Acquisition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xml:lang="en-US">Business acquisition, effective date of acquisition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:label="loc_G5FI14K6FH5G_us-gaap_BusinessCombinationReasonForBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessCombinationReasonForBusinessCombination" xml:lang="en-US">Business Combination, Reason for Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_BusinessCombinationReasonForBusinessCombination" xml:lang="en-US">Business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:to="lab_I7HK36M8HJ7I_us-gaap_BusinessCombinationReasonForBusinessCombination"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_TermOfWarrant" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_TermOfWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_TermOfWarrant" xml:lang="en-US">Term Of Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_TermOfWarrant" xml:lang="en-US">Term of warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_TermOfWarrant" xml:lang="en-US">Term of warrant.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_TermOfWarrant" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_TermOfWarrant"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentRedemptionPricePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentRedemptionPricePercentage" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentRedemptionPricePercentage" xml:lang="en-US">Company's initial stock redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentRedemptionPricePercentage"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUtilitiesInventoryTable" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_PrivateUtilitiesInventoryTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUtilitiesInventoryTable" xml:lang="en-US">Private Utilities Inventory [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUtilitiesInventoryTable" xml:lang="en-US">Detailed information about the type of inventory held by the utility and the carrying value of this inventory.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_PrivateUtilitiesInventoryTable" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUtilitiesInventoryTable"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUtilitiesInventoryLineItems" xlink:label="loc_G5FI14K6FH5G_hrmn_PrivateUtilitiesInventoryLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_PrivateUtilitiesInventoryLineItems" xml:lang="en-US">Private Utilities Inventory [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_PrivateUtilitiesInventoryLineItems" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_PrivateUtilitiesInventoryLineItems" xlink:to="lab_I7HK36M8HJ7I_hrmn_PrivateUtilitiesInventoryLineItems"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsTextualAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_PrivateUnitsTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUnitsTextualAbstract" xml:lang="en-US">Private Units Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUnitsTextualAbstract" xml:lang="en-US">Private Units (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_PrivateUnitsTextualAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_PrivateUnitsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_G5FI14K6FH5G_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of private units</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_I7HK36M8HJ7I_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xml:lang="en-US">Sale of private units, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_G5FI14K6FH5G_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_I7HK36M8HJ7I_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_G5FI14K6FH5G_us-gaap_RelatedPartyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_RelatedPartyDomain" xlink:to="lab_I7HK36M8HJ7I_us-gaap_RelatedPartyDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefOperatingOfficerMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_ChiefOperatingOfficerMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_ChiefOperatingOfficerMember" xml:lang="en-US">Chief Operating Officer [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_ChiefOperatingOfficerMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_ChiefOperatingOfficerMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_G5FI14K6FH5G_us-gaap_RelatedPartyTransactionLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_I7HK36M8HJ7I_us-gaap_RelatedPartyTransactionLineItems"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" xml:lang="en-US">Notes Payable And Advances From Shareholders Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" xml:lang="en-US">Notes Payable and Advance From Stockholders (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentAnnualPrincipalPayment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentAnnualPrincipalPayment" xml:lang="en-US">Debt Instrument, Annual Principal Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentAnnualPrincipalPayment" xml:lang="en-US">Principal amount unsecured promissory note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="lab_I7HK36M8HJ7I_us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_DebtInstrumentIssuanceDate1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_DebtInstrumentIssuanceDate1" xml:lang="en-US">Debt Instrument, Issuance Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_DebtInstrumentIssuanceDate1" xml:lang="en-US">Debt instrument issuance date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_DebtInstrumentIssuanceDate1" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_DebtInstrumentIssuanceDate1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_G5FI14K6FH5G_us-gaap_RangeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_RangeAxis" xlink:to="lab_I7HK36M8HJ7I_us-gaap_RangeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_RangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_RangeMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_RangeMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_G5FI14K6FH5G_us-gaap_MaximumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_MaximumMember" xlink:to="lab_I7HK36M8HJ7I_us-gaap_MaximumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_MinimumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_MinimumMember" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_MinimumMember"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommitmentsTextualAbstract" xlink:label="loc_G5FI14K6FH5G_hrmn_CommitmentsTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommitmentsTextualAbstract" xml:lang="en-US">Commitments Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_CommitmentsTextualAbstract" xml:lang="en-US">Commitments (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_CommitmentsTextualAbstract" xlink:to="lab_I7HK36M8HJ7I_hrmn_CommitmentsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DiscountOnUnderwritersPublicOffer" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_DiscountOnUnderwritersPublicOffer" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_DiscountOnUnderwritersPublicOffer" xml:lang="en-US">Discount On Underwriters Public Offer</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_DiscountOnUnderwritersPublicOffer" xml:lang="en-US">Underwriting discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_DiscountOnUnderwritersPublicOffer" xml:lang="en-US">Discount on underwriters public offer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_DiscountOnUnderwritersPublicOffer" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_DiscountOnUnderwritersPublicOffer"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_G5FI14K6FH5G_us-gaap_OtherUnderwritingExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OtherUnderwritingExpense" xml:lang="en-US">Other Underwriting Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OtherUnderwritingExpense" xml:lang="en-US">Other Underwriting Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_us-gaap_OtherUnderwritingExpense" xml:lang="en-US">Underlying securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_us-gaap_OtherUnderwritingExpense" xlink:to="lab_I7HK36M8HJ7I_us-gaap_OtherUnderwritingExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xml:lang="en-US">Business Combination, Acquisition Related Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xml:lang="en-US">Financial advisory fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_StockholdersEquityTextualAbstract" xlink:label="loc_G5FI14K6FH5G_hrmn_StockholdersEquityTextualAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_StockholdersEquityTextualAbstract" xml:lang="en-US">Stockholders Equity Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_StockholdersEquityTextualAbstract" xml:lang="en-US">Stockholders Equity (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_StockholdersEquityTextualAbstract" xlink:to="lab_I7HK36M8HJ7I_hrmn_StockholdersEquityTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_us-gaap_PreferredStockSharesIssued" xlink:to="lab_5LILIJL796J112JIH9M1_us-gaap_PreferredStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_EscrowSharePercentage" xlink:label="loc_G5FI14K6FH5G_hrmn_EscrowSharePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_EscrowSharePercentage" xml:lang="en-US">Escrow Share Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_EscrowSharePercentage" xml:lang="en-US">Percentage of escrow share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_EscrowSharePercentage" xml:lang="en-US">Escrow share percentage.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_EscrowSharePercentage" xlink:to="lab_I7HK36M8HJ7I_hrmn_EscrowSharePercentage"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockOutstandingDescription" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_CommonStockOutstandingDescription" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CommonStockOutstandingDescription" xml:lang="en-US">Common Stock Outstanding Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CommonStockOutstandingDescription" xml:lang="en-US">Common stock authorized a stock dividend outstanding description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_CommonStockOutstandingDescription" xml:lang="en-US">Common stock outstanding description.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_CommonStockOutstandingDescription" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_CommonStockOutstandingDescription"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialBusinessCombinationDescription" xlink:label="loc_G5FI14K6FH5G_hrmn_InitialBusinessCombinationDescription" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialBusinessCombinationDescription" xml:lang="en-US">Initial Business Combination Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialBusinessCombinationDescription" xml:lang="en-US">Initial business combination description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I7HK36M8HJ7I_hrmn_InitialBusinessCombinationDescription" xml:lang="en-US">Description of the initial business combination.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G5FI14K6FH5G_hrmn_InitialBusinessCombinationDescription" xlink:to="lab_I7HK36M8HJ7I_hrmn_InitialBusinessCombinationDescription"/>
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xlink:label="loc_3JGJGHJ574H990HGF7K9_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xml:lang="en-US">Shares Placed Into An Escrow Account On The Closing Of The Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xml:lang="en-US">Shares placed into an escrow account on the closing of the Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_5LILIJL796J112JIH9M1_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xml:lang="en-US">Shares placed into an escrow account on the closing of the Offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_3JGJGHJ574H990HGF7K9_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xlink:to="lab_5LILIJL796J112JIH9M1_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering"/>
</labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hrmn-20160331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#DocumentAndEntityInformation" roleURI="http://www.harmonymergercorp.com/role/DocumentAndEntityInformation"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedBalanceSheets" roleURI="http://www.harmonymergercorp.com/role/CondensedBalanceSheets"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedBalanceSheetsParenthetical" roleURI="http://www.harmonymergercorp.com/role/CondensedBalanceSheetsParenthetical"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedStatementsOfOperationsUnaudited" roleURI="http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CondensedStatementsOfCashFlowsUnaudited" roleURI="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#OrganizationAndPlanOfBusinessOperations" roleURI="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperations"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#SignificantAccountingPolicies" roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPolicies"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#InitialPublicOffering" roleURI="http://www.harmonymergercorp.com/role/InitialPublicOffering"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#PrivateUnits" roleURI="http://www.harmonymergercorp.com/role/PrivateUnits"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#NotesPayableAndAdvanceFromStockholders" roleURI="http://www.harmonymergercorp.com/role/NotesPayableAndAdvanceFromStockholders"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#Commitments" roleURI="http://www.harmonymergercorp.com/role/Commitments"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#StockholdersEquity" roleURI="http://www.harmonymergercorp.com/role/StockholdersEquity"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesPolicies"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#OrganizationAndPlanOfBusinessOperationsDetails" roleURI="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperationsDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#SignificantAccountingPoliciesDetails" roleURI="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#InitialPublicOfferingDetails" roleURI="http://www.harmonymergercorp.com/role/InitialPublicOfferingDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#PrivateUnitsDetails" roleURI="http://www.harmonymergercorp.com/role/PrivateUnitsDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#NotesPayableandAdvanceFromStockholdersDetails" roleURI="http://www.harmonymergercorp.com/role/NotesPayableandAdvanceFromStockholdersDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#CommitmentsDetails" roleURI="http://www.harmonymergercorp.com/role/CommitmentsDetails"/>
<roleRef xlink:type="simple" xlink:href="hrmn-20160331.xsd#StockholdersEquityDetails" roleURI="http://www.harmonymergercorp.com/role/StockholdersEquityDetails"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/DocumentAndEntityInformation">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DocumentAndEntityInformationAbstract" xlink:label="loc_hrmn_DocumentAndEntityInformationAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_3" order="20" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_4" order="30" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_5" order="40" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_6" order="50" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_7" order="60" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8" order="70" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_9" order="80" use="optional" />
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_10" order="90" use="optional" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_AssetsCurrent_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust" xlink:label="loc_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseCurrentAndNoncurrent_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_10" xlink:to="loc_us-gaap_AccountsPayableCurrent_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_10" xlink:to="loc_us-gaap_LiabilitiesCurrent_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DeferredUnderwritersFee" xlink:label="loc_hrmn_DeferredUnderwritersFee_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_hrmn_DeferredUnderwritersFee_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_us-gaap_Liabilities_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_us-gaap_StockholdersEquityAbstract_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_17" xlink:to="loc_us-gaap_PreferredStockValue_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_19" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_17" xlink:to="loc_us-gaap_CommonStockValue_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_20" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_17" xlink:to="loc_us-gaap_AdditionalPaidInCapital_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_17" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_22" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_17" xlink:to="loc_us-gaap_StockholdersEquity_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_23" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:label="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InterestEarnedOnCashAndSecuritiesInTrust" xlink:label="loc_hrmn_InterestEarnedOnCashAndSecuritiesInTrust_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_hrmn_InterestEarnedOnCashAndSecuritiesInTrust_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9" xlink:to="loc_us-gaap_PaymentsForProceedsFromInvestments_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PaymentOfOfferingCosts" xlink:label="loc_hrmn_PaymentOfOfferingCosts_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" xlink:to="loc_hrmn_PaymentOfOfferingCosts_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_19" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_20" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_21" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_AccrualOfDeferredUnderwritingFee" xlink:label="loc_hrmn_AccrualOfDeferredUnderwritingFee_22" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_21" xlink:to="loc_hrmn_AccrualOfDeferredUnderwritingFee_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_NatureOfOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/SignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/InitialPublicOffering">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingAbstract" xlink:label="loc_hrmn_InitialPublicOfferingAbstract_0" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingTextBlock" xlink:label="loc_hrmn_InitialPublicOfferingTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingAbstract_0" xlink:to="loc_hrmn_InitialPublicOfferingTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/PrivateUnits">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsAbstract" xlink:label="loc_hrmn_PrivateUnitsAbstract_0" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsTextBlock" xlink:label="loc_hrmn_PrivateUnitsTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUnitsAbstract_0" xlink:to="loc_hrmn_PrivateUnitsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/NotesPayableAndAdvanceFromStockholders">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" xlink:label="loc_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract_0" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock" xlink:label="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract_0" xlink:to="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/Commitments">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/StockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock" xlink:label="loc_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock" xlink:label="loc_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperationsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" xlink:to="loc_us-gaap_IPOMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract" xlink:label="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8" xlink:to="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OfferingShareValueClosed" xlink:label="loc_hrmn_OfferingShareValueClosed_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_hrmn_OfferingShareValueClosed_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_OfferingSharesClosed" xlink:label="loc_hrmn_OfferingSharesClosed_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_hrmn_OfferingSharesClosed_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityShares_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityShares_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SaleOfPublicOfferingPricePerShare" xlink:label="loc_hrmn_SaleOfPublicOfferingPricePerShare_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_hrmn_SaleOfPublicOfferingPricePerShare_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_PaymentsForUnderwritingExpense_18" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_19" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_19" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsControlPremium" xlink:label="loc_us-gaap_FairValueInputsControlPremium_20" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_FairValueInputsControlPremium_20" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_21" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_22" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_CommonStockValue_22" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesDescription" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_23" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_23" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_24" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_24" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_BusinessCombinationPublicSharesConversionPercentage" xlink:label="loc_hrmn_BusinessCombinationPublicSharesConversionPercentage_25" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_hrmn_BusinessCombinationPublicSharesConversionPercentage_25" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_26" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_26" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets" xlink:label="loc_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets_27" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract_9" xlink:to="loc_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets_27" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" xlink:to="loc_us-gaap_IPOMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6" xlink:to="loc_us-gaap_PrivatePlacementMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9" xlink:to="loc_us-gaap_EquityComponentDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_10" xlink:to="loc_us-gaap_CommonStockMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_12" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="loc_us-gaap_PrivateEquityFundsMember_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_13" xlink:to="loc_us-gaap_PrivateEquityFundsMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_15" xlink:to="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:label="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:label="loc_us-gaap_USGovernmentSecuritiesAtCarryingValue_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_USGovernmentSecuritiesAtCarryingValue_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_19" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_20" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_22" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_Cash_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_23" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_24" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaap_CashFDICInsuredAmount_25" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_SignificantAccountingPoliciesTextualAbstract_16" xlink:to="loc_us-gaap_CashFDICInsuredAmount_25" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/InitialPublicOfferingDetails">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingAbstract" xlink:label="loc_hrmn_InitialPublicOfferingAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingAbstract_0" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_us-gaap_IPOMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5" xlink:to="loc_us-gaap_EquityComponentDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6" xlink:to="loc_us-gaap_WarrantMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialPublicOfferingTextualAbstract" xlink:label="loc_hrmn_InitialPublicOfferingTextualAbstract_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8" xlink:to="loc_hrmn_InitialPublicOfferingTextualAbstract_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares" xlink:label="loc_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_SharePrice_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationReasonForBusinessCombination" xlink:label="loc_us-gaap_BusinessCombinationReasonForBusinessCombination_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_BusinessCombinationReasonForBusinessCombination_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_TermOfWarrant" xlink:label="loc_hrmn_TermOfWarrant_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_hrmn_TermOfWarrant_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_InitialPublicOfferingTextualAbstract_9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_18" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/PrivateUnitsDetails">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsAbstract" xlink:label="loc_hrmn_PrivateUnitsAbstract_0" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUtilitiesInventoryTable" xlink:label="loc_hrmn_PrivateUtilitiesInventoryTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUnitsAbstract_0" xlink:to="loc_hrmn_PrivateUtilitiesInventoryTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUtilitiesInventoryTable_1" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="loc_us-gaap_PrivateEquityFundsMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_3" xlink:to="loc_us-gaap_PrivateEquityFundsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUtilitiesInventoryLineItems" xlink:label="loc_hrmn_PrivateUtilitiesInventoryLineItems_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUtilitiesInventoryTable_1" xlink:to="loc_hrmn_PrivateUtilitiesInventoryLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_PrivateUnitsTextualAbstract" xlink:label="loc_hrmn_PrivateUnitsTextualAbstract_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUtilitiesInventoryLineItems_5" xlink:to="loc_hrmn_PrivateUnitsTextualAbstract_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_6" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_6" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_6" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesDescription" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_PrivateUnitsTextualAbstract_6" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesDescription_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/NotesPayableandAdvanceFromStockholdersDetails">
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersAbstract" xlink:label="loc_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefOperatingOfficerMember" xlink:label="loc_us-gaap_ChiefOperatingOfficerMember_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefOperatingOfficerMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract" xlink:label="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6" xlink:to="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_7" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_7" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract_7" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/CommitmentsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RangeAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_5" xlink:to="loc_us-gaap_RangeMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_6" xlink:to="loc_us-gaap_MaximumMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_6" xlink:to="loc_us-gaap_MinimumMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommitmentsTextualAbstract" xlink:label="loc_hrmn_CommitmentsTextualAbstract_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9" xlink:to="loc_hrmn_CommitmentsTextualAbstract_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_DiscountOnUnderwritersPublicOffer" xlink:label="loc_hrmn_DiscountOnUnderwritersPublicOffer_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_CommitmentsTextualAbstract_10" xlink:to="loc_hrmn_DiscountOnUnderwritersPublicOffer_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_CommitmentsTextualAbstract_10" xlink:to="loc_us-gaap_PaymentsForUnderwritingExpense_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:label="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_CommitmentsTextualAbstract_10" xlink:to="loc_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherUnderwritingExpense" xlink:label="loc_us-gaap_OtherUnderwritingExpense_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_CommitmentsTextualAbstract_10" xlink:to="loc_us-gaap_OtherUnderwritingExpense_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_CommitmentsTextualAbstract_10" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.harmonymergercorp.com/role/StockholdersEquityDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_4" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3" xlink:to="loc_us-gaap_IPOMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_5" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_StockholdersEquityTextualAbstract" xlink:label="loc_hrmn_StockholdersEquityTextualAbstract_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_5" xlink:to="loc_hrmn_StockholdersEquityTextualAbstract_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_10" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_11" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_13" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_14" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_SharePrice_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_EscrowSharePercentage" xlink:label="loc_hrmn_EscrowSharePercentage_16" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_hrmn_EscrowSharePercentage_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockOutstandingDescription" xlink:label="loc_hrmn_CommonStockOutstandingDescription_17" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_hrmn_CommonStockOutstandingDescription_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_InitialBusinessCombinationDescription" xlink:label="loc_hrmn_InitialBusinessCombinationDescription_18" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_hrmn_InitialBusinessCombinationDescription_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering" xlink:label="loc_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering_19" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="hrmn-20160331.xsd#hrmn_CommonStockSharesSubjectToPossibleConversion" xlink:label="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_20" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_hrmn_CommonStockSharesSubjectToPossibleConversion_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_21" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_22" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_CommonStockSharesIssued_22" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_23" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hrmn_StockholdersEquityTextualAbstract_6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_23" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6786824368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>May. 20, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Harmony Merger Corp.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001612720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,084,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6787095696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 157,422<span></span>
</td>
<td class="nump">$ 324,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">48,555<span></span>
</td>
<td class="nump">46,687<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets:</a></td>
<td class="nump">205,977<span></span>
</td>
<td class="nump">371,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust', window );">Cash, cash equivalents and securities held in Trust</a></td>
<td class="nump">117,420,942<span></span>
</td>
<td class="nump">117,374,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Prepaid expenses - long term</a></td>
<td class="nump">65,756<span></span>
</td>
<td class="nump">66,373<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets:</a></td>
<td class="nump">117,692,675<span></span>
</td>
<td class="nump">117,812,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">53,193<span></span>
</td>
<td class="nump">17,259<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities:</a></td>
<td class="nump">53,193<span></span>
</td>
<td class="nump">17,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_DeferredUnderwritersFee', window );">Deferred Underwriters Fee</a></td>
<td class="nump">4,325,000<span></span>
</td>
<td class="nump">4,325,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 4,378,193<span></span>
</td>
<td class="nump">$ 4,342,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Common Stock, subject to possible conversion (10,585,784 shares at conversion value)</a></td>
<td class="nump">$ 108,086,324<span></span>
</td>
<td class="nump">$ 108,043,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.0001 par value, 1,000,000 authorized, 0 outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.0001 par value; Authorized 27,500,000 shares, 4,498,966 issued and outstanding at March 31, 2016 (excluding 10,585,784 shares subject to possible conversion) and 4,498,966 issued and outstanding at December 31, 2015.</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">5,648,423<span></span>
</td>
<td class="nump">5,690,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(420,715)<span></span>
</td>
<td class="num">(264,510)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">5,228,158<span></span>
</td>
<td class="nump">5,426,749<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 117,692,675<span></span>
</td>
<td class="nump">$ 117,812,946<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, cash equivalents and securities held in trust.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CashCashEquivalentsAndSecuritiesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_DeferredUnderwritersFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriters fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_DeferredUnderwritersFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6779511792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockSharesSubjectToPossibleConversion', window );">Common stock shares subject to possible conversion</a></td>
<td class="nump">10,585,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">27,500,000<span></span>
</td>
<td class="nump">27,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">4,498,966<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">4,498,966<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CommonStockSharesSubjectToPossibleConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares subject to possible conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CommonStockSharesSubjectToPossibleConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6790057344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations (unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative costs</a></td>
<td class="nump">$ 164,801<span></span>
</td>
<td class="nump">$ 8,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative costs - related party</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(202,301)<span></span>
</td>
<td class="num">$ (8,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest Income</a></td>
<td class="nump">46,096<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (156,205)<span></span>
</td>
<td class="num">$ (8,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding</a></td>
<td class="nump">4,498,966<span></span>
</td>
<td class="nump">2,726,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6786965040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (156,205)<span></span>
</td>
<td class="num">$ (8,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile Net Loss to net cash provided by operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InterestEarnedOnCashAndSecuritiesInTrust', window );">Interest earned on cash and securities in trust</a></td>
<td class="num">(46,047)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(1,251)<span></span>
</td>
<td class="num">$ (119,345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">35,934<span></span>
</td>
<td class="nump">81,977<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by Operating Activities</a></td>
<td class="num">$ (167,569)<span></span>
</td>
<td class="num">(45,561)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromInvestments', window );">Investment in cash, cash equivalents and securities in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,300,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in Investing Activities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(117,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_PaymentOfOfferingCosts', window );">Payment of offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(43,208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of shares of common stock to initial stockholders</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">75,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Public Offering, net of offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">112,605,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits', window );">Proceeds from Insider Units</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,585,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by Financing Activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">118,223,131<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="num">$ (167,569)<span></span>
</td>
<td class="nump">877,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">324,991<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 157,422<span></span>
</td>
<td class="nump">878,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_AccrualOfDeferredUnderwritingFee', window );">Accrual of deferred underwriting fee</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (4,325,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_AccrualOfDeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accrual of deferred underwriting fee that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_AccrualOfDeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_InterestEarnedOnCashAndSecuritiesInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest earned on cash and securities in trust.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_InterestEarnedOnCashAndSecuritiesInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_PaymentOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_PaymentOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of preferred limited partners units during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredLimitedPartnersUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6782855328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Plan of Business Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization and Plan of Business Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Plan of Business Operations</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 1 &#8212; Organization and Plan of Business Operations</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Harmony Merger Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on May 21, 2014 as a blank check company whose objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, one or more businesses or entities (a &#8220;Business Combination&#8221;).</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">All activity through March&#160;31, 2016 relates to the Company&#8217;s formation, initial public offering and identifying suitable candidates for a Business Combination.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The registration statement for the Company&#8217;s initial public offering was declared effective on March 23, 2015. The Company consummated a public offering of 11,500,000 units (&#8220;Units&#8221;) on March 27, 2015 (the &#8220;Offering&#8221;), including the exercise of the over-allotment option (&#8220;Overallotment&#8221;) of 1,500,000 Units, generating gross proceeds of $115,000,000 and net proceeds of $112,605,665 after deducting $2,394,335 of transaction costs (up to an additional $4,325,000 of deferred underwriting expenses may be paid upon the completion of a business combination), which is discussed in Note 3. In addition, the Company generated gross and net proceeds of $5,585,000 from a private placement (the &#8220;Private Placement&#8221;) of units (&#8220;Private Units&#8221;) to certain of the Initial Stockholders (defined below) and Cantor Fitzgerald &amp; Co., the representative of the underwriters in the Offering (&#8220;Cantor&#8221;), which is described in Note 4.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Offering and Private Placement, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination. The Company&#8217;s securities are listed on the Nasdaq Capital Market (&#8220;NASDAQ&#8221;). Pursuant to the NASDAQ listing rules, the Company&#8217;s initial Business Combination must be with a target business or businesses whose collective fair market value is at least equal to 80% of the balance in the trust account at the time of the execution of a definitive agreement for such Business Combination, although this may entail simultaneous acquisitions of several target businesses. There is no assurance that the Company will be able to effect a Business Combination successfully.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Following the closing of the Offering and the Private Placement on March 27, 2015, an amount of $117,300,000 (or $10.20 per share sold to the public in the Offering included in the Units (&#8220;Public Shares&#8221;)) from the sale of the Units and Private Units is being held in a trust account (&#8220;Trust Account&#8221;) and may be invested in money market funds meeting the applicable conditions of Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, and that invest solely in U.S. treasuries or United States bonds, treasuries or notes
 having a maturity of 180 days or less. The $117,300,000 placed into the Trust Account may not be released until the earlier of (i) the consummation of the Company&#8217;s initial Business Combination and (ii) the Company&#8217;s failure to consummate a Business Combination within the prescribed time. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to pay the Company&#8217;s tax obligations. Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company, after signing a Business Combination, is required to provide stockholders who acquired Public Shares in the Offering (&#8220;Public Stockholders&#8221;) with the opportunity to convert their Public Shares for a pro rata share of the Trust Account. In the event that stockholders owning approximately 92.05% or more of the Public Shares exercise their conversion rights described below, the Business Combination will not be consummated. The actual percentages, however, will only be able to be determined once a target business is located and the Company can assess all of the assets and liabilities of the combined company upon consummation of the proposed Business Combination, subject to the requirement that the Company must have at least $5,000,001 of net tangible assets upon close of such Business Combination. As a result, the actual percentage of shares that can be converted may be significantly lower than the above estimates. The stockholders of the Company prior to the Offering (the &#8220;Initial Stockholders&#8221;) have agreed to vote any shares they then hold in favor of any proposed Business Combination and will waive any conversion rights with respect to these shares and the shares included in the Private Units pursuant to letter agreements executed in connection with the Offering.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In connection with any proposed Business Combination, the Company will seek stockholder approval of an initial Business Combination at a meeting called for such purpose at which Public Stockholders may seek to convert their Public Shares, regardless of whether they vote for or against the proposed Business Combination. If the Company seeks stockholder approval of an initial Business Combination, any Public Stockholder voting either for or against such proposed Business Combination will be entitled to demand that his Public Shares be converted into a full pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay its taxes). Holders of warrants sold as part of the Units will not be entitled to vote on the proposed Business Combination and will have no conversion or liquidation rights with respect to their shares of common stock underlying such warrants.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company will consummate a Business Combination only if holders of less than approximately 92.05% of the Public Shares, subject to adjustment as described above, elect to convert their shares to a pro-rata portion of the amount held in the Trust Account and a majority of the outstanding shares of common stock voted, are voted in favor of the Business Combination. Notwithstanding the foregoing, the Amended and Restated Certificate of Incorporation of the Company provides that a Public Stockholder, together with any affiliate or other person with whom such Public Stockholder is acting in concert or as a &#8220;group&#8221; (within the meaning of Section 13 of the Securities Act of 1934, as amended), will be restricted from seeking conversion rights with respect to an aggregate of more than 20% of the Public Shares (but only with respect to the amount over 20% of the Public Shares). A &#8220;group&#8221; will be deemed to exist if Public Stockholders (i) file a Schedule 13D or 13G indicating the presence of a group or (ii) acknowledge to the Company that they are acting, or intend to act, as a group.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Pursuant to the Company&#8217;s Amended and Restated Certificate of Incorporation, if the Company is unable to complete its initial Business Combination by March 27, 2017, the Company will (i) cease all operations except for the purpose
 of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of common stock and the Company&#8217;s board of directors, dissolve and liquidate. If the Company is unable to consummate an initial Business Combination and is forced to redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay any of its taxes. Holders of warrants will receive no proceeds in connection with the liquidation. The Initial Stockholders and the holders of Private Units will not participate in any redemption distribution with respect to their initial shares and Private Units, including the common stock included in the Private Units.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">If the Company is unable to complete its initial Business Combination and expends all of the net proceeds of the Offering not deposited in the Trust Account, without taking into account any interest earned on the Trust Account, the Company expects that the initial per-share redemption price for common stock will be $10.20. The proceeds deposited in the Trust Account could, however, become subject to claims of the Company&#8217;s creditors that are in preference to the claims of the Company&#8217;s stockholders. In addition, if the Company is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against it that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be included in its bankruptcy estate and subject to the claims of third parties with priority over the claims of the Company&#8217;s common stockholders. Therefore, the actual per-share redemption price may be less than $10.20.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Eric S. Rosenfeld, the Company&#8217;s Chief Executive Officer, has agreed that he will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduces the amount of funds in the Trust Account to below $10.20 per public share, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the indemnity of the underwriters of the Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, Mr. Rosenfeld will not be responsible to the extent of any liability for such third party claims. Furthermore, he will not be personally liable to Public Stockholders and instead will only have liability to the Company. The Company has not independently verified whether Mr. Rosenfeld has sufficient funds to satisfy his indemnity obligations and, therefore, Mr. Rosenfeld may not be able to satisfy those obligations. The Company has not asked Mr. Rosenfeld to reserve for such eventuality. Accordingly, if the Company liquidates, the per-share distribution from the trust account could be less than $10.20 due to claims or potential claims of creditors.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Mr. Rosenfeld has also agreed to enter into an agreement in accordance with the guidelines of Rule 10b5-1of the Exchange Act, pursuant to which he will place limit orders for an aggregate of up to $500,000 of common stock of the Company commencing on the later of (1) two business days after a Form 8-K disclosing all material information relating to an initial Business Combination, and (2) 60 days after the termination of the &#8220;restricted period&#8221; in connection with Offering under Regulation M of the Exchange Act, and ending on the record date for the shareholder meeting at which such initial Business Combination is to be approved, or earlier in certain circumstances as described in the limit order agreement, which is referred to as the buyback period. These limit orders will require Mr. Rosenfeld to purchase any shares of common stock of the Company offered for sale (and not purchased by another investor) at or below a price equal to the per-share amount held in the Trust Account as reported in such Form 8-K, until the earlier of (1) the expiration of the buyback period or (2) the date such purchases reach $500,000 in total. The Company will provide at least 20 business days between the beginning of the buyback period and the record date for the shareholder meeting for such initial Business Combination. It is intended that the purchases will satisfy the conditions of Rule 10b-18(b) under the Exchange Act to the extent possible and the concernbroker&#8217;s purchase obligation will otherwise be subject to applicable law, including Regulation M under the Exchange Act, which may prohibit or limit purchases pursuant to the limit order agreement in certain circumstances. Any shares purchased by Mr. Rosenfeld pursuant to this arrangement will be voted in favor of the proposed
 Business Combination. Additionally, Mr. Rosenfeld has agreed not to convert any buyback shares into the right to receive a pro rata portion of the funds held in the Trust Account or to transfer, assign or sell any buyback shares (except to the same permitted transferees as the insider shares and provided the transferees agree to the same transfer restrictions) until (A) the earlier of one year after the completion of an Initial Business combination and the date on which the closing price of common stock of the Company exceeds $12.50 for any 20 trading days within a 30-trading day period following the completion of an Initial Business combination with respect to 50% of the buyback shares and (B) one year after the completion of an Initial Business combination with respect to the remaining 50% of the buyback shares.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company anticipates that in order to fund its working capital requirements, the Company will need to use all of the remaining funds not held in trust, the interest earned on the funds held in the trust account, as well as enter into contingent fee arrangements with its vendors. The Company may need to enter into contingent fee arrangements with vendors or raise additional capital through loans or additional investments from initial shareholders, officers, directors, or third parties. None of the initial shareholders, officers or directors is under any obligation to advance funds to, or invest in, the Company. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and controlling overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company has no present revenue, and the Company&#8217;s cash and working capital as of March&#160;31, 2016 are not sufficient to complete its planned activities for the upcoming year. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=SL51803626-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6598570384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 2 &#8212; Significant Accounting Policies</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Basis of Presentation</i></b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed financial statements have been prepared for interim financial information and the instructions to Form 10-Q.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included.&#160;&#160;The Company has evaluated subsequent events through the issuance of this Form 10-Q.&#160;&#160;Operating results for the quarter ended March&#160;31, 2016&#160;are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2016 or any other period. The accompanying condensed financial statements should be read in conjunction with the Company&#8217;s financial statements and notes thereto included in the Company&#8217;s prospectus filed with the Securities and Exchange Commission on March 24, 2015.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Cash, cash equivalents and securities held in Trust Account</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">At March&#160;31, 2016, substantially all of the assets in the Trust Account were held in United States Treasury Bills with a maturity of April 21, 2016. $117,340,445 in US Treasury Bills were purchased on October 27, 2015. At March&#160;31, 2016 the trust account had earned $46,047 and accrued $78,926 in interest and held $1,571 in cash. This account is classified as restricted.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Fair value of financial instruments</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the balance sheet, primarily
 due to their short-term nature.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Net loss per common share</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>&#160;</i></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company complies with accounting and disclosure requirements of ASC 260, &#8220;Earnings Per Share.&#8221; Net loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of (i) warrants sold in the Initial Public Offering to purchase 11,500,000 shares of the Company and (ii) warrants sold in the Private Units to purchase 558,500 shares of the Company, in the calculation of diluted loss per share, since the exercise of the warrants is contingent on the occurrence of future events. 10,585,784<b>&#160;</b>shares of common stock subject to possible conversion at March&#160;31, 2016, were also excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the trust earnings. At March&#160;31, 2016, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Common stock subject to possible conversion</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company accounts for its common stock subject to possible conversion in accordance with the guidance enumerated in ASC 480 &#8220;Distinguishing Liabilities from Equity&#8221;.&#160;&#160;&#160;Common stock subject to mandatory conversion is classified as a liability instrument and is measured at fair value. Conditionally convertible common stock (including common stock that features conversion rights that are either within the control of the holder or subject to conversion upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain conversion rights that are considered by the Company to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly at March&#160;31, 2016, the common stock subject to possible conversion is presented as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Income Taxes</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company accounts for income taxes under ASC 740 Income Taxes (&#8220;ASC 740&#8221;). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an
 enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company is required to file income tax returns in the United States (federal) and in various state and local jurisdictions. Based on the Company&#8217;s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company&#8217;s financial statements. Since the Company was incorporated on May 21, 2014, the evaluation was performed for the 2014 and 2015 tax years, which would be the only period subject to examination. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#8217;s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest as of or during the three months ended March&#160;31, 2016. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Use of Estimates</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Recent Accounting Pronouncements</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Subsequent Events</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Management has evaluated subsequent events to determine if events or transactions occurring through the date these financial statements were issued, require potential adjustment to or disclosure in the financial statements and has concluded that no subsequent events have occurred that would require recognition in the financial statements or disclosure in the notes to the financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6782812320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialPublicOfferingAbstract', window );"><strong>Initial Public Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialPublicOfferingTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 3 &#8212; Initial Public Offering</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><br /></b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">On March 27, 2015, the Company sold 11,500,000 Units at a price of $10.00 per unit in the Offering. Each Unit consists of one share of common stock and one warrant (&#8220;Warrant&#8221;) to purchase one share of common stock at a price of $11.50 per share. The Warrants are exercisable commencing on the later of 30 days after the Company&#8217;s completion of a Business Combination or March 23, 2016 and expire five years from the completion of a Business Combination. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days&#8217; notice, only in the event that the last sale price of the shares of common stock is at least $17.50 per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given. If the Company redeems the Warrants as described above, it will have the option to require any holder that wishes to exercise his Warrant to do so on a &#8220;cashless basis.&#8221; In accordance with the warrant agreement relating to the Warrants sold in the Offering, the Company is only required to use its best efforts to file the registration statement covering the shares underlying the Warrants within 15 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement. If a registration statement is not effective within 90 days following the consummation of a Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise Warrants on a cashless basis. If the Company is unable to consummate a Business Combination, the Company will redeem 100% of the Public Shares using the funds in the Trust Account as described in Note 1. In such event, the Warrants will be worthless. In no event will the Company be required to net cash settle the Warrants.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_InitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_InitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6776086992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Units<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_PrivateUnitsAbstract', window );"><strong>Private Units [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_PrivateUnitsTextBlock', window );">Private Units</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 4 &#8212; Private Units</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Simultaneously with the Offering, certain of the Initial Stockholders of the Company and Cantor purchased an aggregate of 558,500 Private Units at $10.00 per Private Unit (for an aggregate purchase price of $5,585,000) from the Company.&#160;All of the proceeds received from these purchases were placed in the Trust Account.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Private Units are identical to the Units sold in the Offering, except the Warrants included in the Private Units are non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their permitted transferees. In addition, for as long as any of the warrants underlying the Private Units are held by Cantor or its designees or affiliates, they may not be exercised after five years from the effective date of the registration statement relating to the Offering. Additionally the initial stockholders have agreed to vote the shares of common stock included therein in favor of any proposed Business Combination. All of the purchasers of the Private Units have agreed (i) not to convert any shares of common stock included therein into the right to receive cash from the Trust Account in connection with a stockholder vote to approve the proposed initial Business Combination and (ii) that the shares of common stock included therein shall not participate in any liquidating distribution upon winding up if a Business Combination is not consummated. Additionally, the holders have agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to certain permitted transferees) until the completion of the initial Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_PrivateUnitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_PrivateUnitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_PrivateUnitsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_PrivateUnitsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6585197504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable and Advance From Stockholders<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract', window );"><strong>Notes Payable and Advance From Stockholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock', window );">Notes Payable and Advance From Stockholders</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 5 &#8212; Notes Payable and Advance From Stockholders</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company issued a $50,000 principal amount unsecured promissory note to Eric S. Rosenfeld, the Company&#8217;s Chief Executive Officer and an Initial Stockholder, on May 30, 2014. The note was non-interest bearing and payable on the earlier of (i) May 31, 2015, (ii) the consummation of the Offering or (iii) the date on which the Company determined not to proceed with the Offering. This loan became payable upon the consummation of the Offering and was paid to Mr. Rosenfeld in April 2015.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_NotesPayableAndAdvancesFromShareholdersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes payable and advances from shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_NotesPayableAndAdvancesFromShareholdersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for notes payable and advances from shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_NotesPayableAndAdvancesFromShareholdersTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6603985904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 6 &#8212; Commitments</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has entered into an agreement with the underwriters of the Offering (&#8220;Underwriting Agreement&#8221;) that required the Company to pay an underwriting discount of 2.0% of the gross proceeds of the Offering as an underwriting discount (excluding proceeds received from the exercise of the over-allotment option, on which the Company will not pay any upfront underwriting discount) and a deferred underwriting discount of up to 3.5% (or up to 5.5% on any proceeds received from the exercise of the over-allotment option) for an aggregate underwriting discount of up to 5.5% of the gross proceeds of the Offering. The Underwriting Agreement provides that up to $926,786 of the deferred underwriting discount may be payable to certain parties who are instrumental in advising the Company in connection with the closing of the Business Combination on either a contingent or non-contingent basis; provided, however that any portion of the deferred underwriting commission relating to an allocation made on a contingent basis where the contingency is not met shall not be paid to any party. The Underwriting Agreement provides that the deferred underwriting discount will only be payable if the Company successfully completes its initial Business Combination.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has entered into an agreement with Canaccord Genuity Inc. (&#8220;Canaccord Genuity&#8221;) pursuant to which Canaccord Genuity will provide the Company with certain financial advisory services in connection with a preliminary review of potential merger and acquisition opportunities, or other services as reasonably requested by the Company and mutually agreeable by Canaccord Genuity, for a period of 18 months from the consummation of the Offering. In consideration of such services, the Company paid Canaccord Genuity a fee of $135,000 in cash upon consummation of the Offering. Such amount was paid in April 2015. The son of the Company&#8217;s Chief Executive Officer is an employee of Canaccord Genuity.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company presently occupies office space provided by an entity controlled by the Company&#8217;s Chairman and Chief Executive Officer. Such entity has agreed that until the earlier of Company&#8217;s consummation of a Business Combination or the liquidation of the Trust Account, it will make such office space, as well as general and administrative services including utilities and administrative support, available to the Company as may be required by the Company from time to time. The Company pays an aggregate of $12,500 per month for such services.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Initial Stockholders and the holders of the Private Units (or underlying securities) will be entitled to registration rights with respect to the founding shares and the Private Units (or underlying securities) pursuant to a registration rights agreement signed in connection with the Offering. The holders of the majority of the Initial Shares (defined below) are entitled to demand that the Company register these shares at any time commencing three months prior to the first anniversary of the consummation of a Business Combination. The holders of the Private Units (or underlying securities) and Cantor are entitled to demand that the Company register these securities at any time after the Company consummates a Business Combination. In addition, the Initial Stockholders and holders of the Private Units (or underlying securities) have certain &#8220;piggy-back&#8221; registration rights on registration statements filed after the Company&#8217;s consummation of a Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6593229904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 7 &#8212; Stockholders&#8217; Equity</b>&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Preferred Stock</i>&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">As of March&#160;31, 2016, there are no shares of preferred stock issued or outstanding.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Common Stock</i>&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company is authorized to issue 27,500,000 shares of common stock with a par value of $0.0001 per share.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In connection with the organization of the Company, a total of 2,875,000 shares of the Company&#8217;s shares of common stock were sold to the Initial Stockholders at a price of approximately $0.01 per share for an aggregate of $25,000. Effective November 7, 2014, the Company&#8217;s Board of Directors authorized a stock dividend of approximately 0.05 shares of common stock for each outstanding share of common stock.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/15.33px 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Initial Stockholders&#8217; 3,026,250 shares (&#8220;Initial Shares&#8221;) were placed into an escrow account on the closing of the Offering. Subject to certain limited exceptions, these shares will not be released from escrow until with respect to 50% of the shares, the earlier of one year after the date of the consummation of an initial Business Combination and the date on which the closing price of the common stock exceeds $12.50 per share for any 20 trading days within a 30-trading day period following the consummation of an initial Business Combination and, with respect to the remaining 50% of the shares, one year after the date of the consummation of an initial Business Combination, or earlier if, subsequent to the Company&#8217;s initial Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Pursuant to letter agreements executed with the Company and the underwriter, the Initial Stockholders have waived their right to receive distributions with respect to their Initial Shares upon the Company&#8217;s redemption of 100% of the outstanding public shares held by the Public Stockholders. As of March&#160;31, 2016, 4,498,966 shares of common stock were issued and outstanding which excludes 10,585,784 shares subject to possible conversion.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6787011888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Basis of Presentation</i></b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed financial statements have been prepared for interim financial information and the instructions to Form 10-Q.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included.&#160;&#160;The Company has evaluated subsequent events through the issuance of this Form 10-Q.&#160;&#160;Operating results for the quarter ended March&#160;31, 2016&#160;are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2016 or any other period. The accompanying condensed financial statements should be read in conjunction with the Company&#8217;s financial statements and notes thereto included in the Company&#8217;s prospectus filed with the Securities and Exchange Commission on March 24, 2015.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Cash and Cash Equivalents</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock', window );">Cash, cash equivalents and securities held in Trust Account</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Cash, cash equivalents and securities held in Trust Account</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">At March&#160;31, 2016, substantially all of the assets in the Trust Account were held in United States Treasury Bills with a maturity of April 21, 2016. $117,340,445 in US Treasury Bills were purchased on October 27, 2015. At March&#160;31, 2016 the trust account had earned $46,047 and accrued $78,926 in interest and held $1,571 in cash. This account is classified as restricted.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Fair value of financial instruments</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net loss per common share</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Net loss per common share</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>&#160;</i></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company complies with accounting and disclosure requirements of ASC 260, &#8220;Earnings Per Share.&#8221; Net loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of (i) warrants sold in the Initial Public Offering to purchase 11,500,000 shares of the Company and (ii) warrants sold in the Private Units to purchase 558,500 shares of the Company, in the calculation of diluted loss per share, since the exercise of the warrants is contingent on the occurrence of future events. 10,585,784<b>&#160;</b>shares of common stock subject to possible conversion at March&#160;31, 2016, were also excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the trust earnings. At March&#160;31, 2016, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock', window );">Common stock subject to possible conversion</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Common stock subject to possible conversion</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company accounts for its common stock subject to possible conversion in accordance with the guidance enumerated in ASC 480 &#8220;Distinguishing Liabilities from Equity&#8221;.&#160;&#160;&#160;Common stock subject to mandatory conversion is classified as a liability instrument and is measured at fair value. Conditionally convertible common stock (including common stock that features conversion rights that are either within the control of the holder or subject to conversion upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217; equity. The Company&#8217;s common stock features certain conversion rights that are considered by the Company to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly at March&#160;31, 2016, the common stock subject to possible conversion is presented as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"><b>Income Taxes</b></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">The Company accounts for income taxes under ASC 740 Income Taxes (&#8220;ASC 740&#8221;). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company is required to file income tax returns in the United States (federal) and in various state and local jurisdictions. Based on the Company&#8217;s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company&#8217;s financial statements. Since the Company was incorporated on May 21, 2014, the evaluation was performed for the 2014 and 2015 tax years, which would be the only period subject to examination. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material change to its financial position.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">The Company&#8217;s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest as of or during the three months ended March&#160;31, 2016. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Use of Estimates</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Recent Accounting Pronouncements</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Subsequent Events</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Management has evaluated subsequent events to determine if events or transactions occurring through the date these financial statements were issued, require potential adjustment to or disclosure in the financial statements and has concluded that no subsequent events have occurred that would require recognition in the financial statements or disclosure in the notes to the financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, cash equivalents and securities held in trust account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CashCashEquivalentsAndSecuritiesHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock subject to possible conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CommonStockSubjectToPossibleConversionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6787714656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Plan of Business Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract', window );"><strong>Organization and Plan of Business Operations (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Gross proceeds from offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceed from offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 112,605,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SaleOfPublicOfferingPricePerShare', window );">Sale of public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 926,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesDescription', window );">Initial business combination, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company's Amended and Restated Certificate of Incorporation, if the Company is unable to complete its initial Business Combination by March 27, 2017, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of common stock and the Company's board of directors, dissolve and liquidate. If the Company is unable to consummate an initial Business Combination and is forced to redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay any of its taxes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Business combination, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company has entered into an agreement with Canaccord Genuity Inc. ("Canaccord Genuity") pursuant to which Canaccord Genuity will provide the Company with certain financial advisory services in connection with a preliminary review of potential merger and acquisition opportunities, or other services as reasonably requested by the Company and mutually agreeable by Canaccord Genuity, for a period of 18 months from the consummation of the Offering.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business combination ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets', window );">Tangible assets net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract', window );"><strong>Organization and Plan of Business Operations (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_OfferingShareValueClosed', window );">Offering share closed, Value</a></td>
<td class="nump">$ 117,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_OfferingSharesClosed', window );">Offering shares closed</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityShares', window );">Exercise of over-allotment option</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Gross proceeds from offerings</a></td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceed from offerings</a></td>
<td class="nump">$ 112,605,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SaleOfPublicOfferingPricePerShare', window );">Sale of public offering price per share</a></td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from private placement</a></td>
<td class="nump">$ 5,585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">2,394,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting expenses</a></td>
<td class="nump">$ 4,325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Maturity date, description</a></td>
<td class="text">180 days or less.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsControlPremium', window );">Percentage of fair market value</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract', window );"><strong>Organization and Plan of Business Operations (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SaleOfPublicOfferingPricePerShare', window );">Sale of public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsControlPremium', window );">Percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Business combination, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(A) the earlier of one year after the completion of an Initial Business combination and the date on which the closing price of common stock of the Company exceeds $12.50 for any 20 trading days within a 30-trading day period following the completion of an Initial Business combination with respect to 50% of the buyback shares and (B) one year after the completion of an Initial Business combination with respect to the remaining 50% of the buyback shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_BusinessCombinationPublicSharesConversionPercentage', window );">Public shares conversion, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition cost of a business combination allocated to net tangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_BusinessAcquisitionPurchasePriceNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_BusinessCombinationPublicSharesConversionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_BusinessCombinationPublicSharesConversionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_OfferingShareValueClosed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering share value closed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_OfferingShareValueClosed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_OfferingSharesClosed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering shares closed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_OfferingSharesClosed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_OrganizationAndPlanOfBusinessOperationsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_SaleOfPublicOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of public offering price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_SaleOfPublicOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a narrative description of the nature of receivables acquired in a business combination (as defined) including the nature of the receivables (such as loans, capital leases), the fair value of the acquired receivables, the gross contractual amount to be collected, and the amount estimated to be doubtful of collection, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsControlPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage above fair value that an investor seeking to acquire control of an entity will pay, used as an input to measure fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsControlPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)(2),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6445032&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6779700160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockSharesSubjectToPossibleConversion', window );">Common stock shares subject to possible conversion</a></td>
<td class="nump">10,585,784<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Private Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Private units shares</a></td>
<td class="nump">558,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockSharesSubjectToPossibleConversion', window );">Common stock shares subject to possible conversion</a></td>
<td class="nump">10,585,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Initial public offering shares</a></td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Initial public offering shares</a></td>
<td class="nump">11,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_USGovernmentSecuritiesAtCarryingValue', window );">Treasury bills | $</a></td>
<td class="nump">$ 117,340,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Apr. 21,  2016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued interest | $</a></td>
<td class="nump">$ 78,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetNoncurrent', window );">Earned interest | $</a></td>
<td class="nump">46,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash | $</a></td>
<td class="nump">$ 1,571<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CommonStockSharesSubjectToPossibleConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares subject to possible conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CommonStockSharesSubjectToPossibleConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_SignificantAccountingPoliciesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_SignificantAccountingPoliciesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, more than one year from the balance sheet date, for goods or services that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_USGovernmentSecuritiesAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt (bills, notes or bonds) that are issued by the government of the United States which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_USGovernmentSecuritiesAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6787772864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Initial Public Offering (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 27, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialPublicOfferingTextualAbstract', window );"><strong>Initial Public Offering (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialPublicOfferingTextualAbstract', window );"><strong>Initial Public Offering (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialPublicOfferingTextualAbstract', window );"><strong>Initial Public Offering (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares', window );">Stock issued during the period sale of units shares</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Company's initial stock redemption</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialPublicOfferingTextualAbstract', window );"><strong>Initial Public Offering (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Business acquisition, effective date of acquisition</a></td>
<td class="text">Mar. 23,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationReasonForBusinessCombination', window );">Business combination</a></td>
<td class="text">Warrant upon 30 days' notice, only in the event that the last sale price of the shares of common stock is at least $17.50 per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given. If the Company redeems the Warrants as described above, it will have the option to require any holder that wishes to exercise his Warrant to do so on a "cashless basis." In accordance with the warrant agreement relating to the Warrants sold in the Offering, the Company is only required to use its best efforts to file the registration statement covering the shares underlying the Warrants within 15 days after the closing of the Business Combination and to maintain the effectiveness of such registration statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_TermOfWarrant', window );">Term of warrant</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_InitialPublicOfferingTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial public offering textual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_InitialPublicOfferingTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during the period sale of units shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_StockIssuedDuringThePeriodSaleOfUnitsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_TermOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_TermOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e845-128460<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Acquisition Date<br> -URI http://asc.fasb.org/extlink&amp;oid=6919109<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e848-128460<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationReasonForBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a description of the primary reason for the business combination which may consist of general categories such as top-line growth, synergistic benefits, market share, and diversification and the more detailed factors that might apply.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationReasonForBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6620555312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Units (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_PrivateUnitsTextualAbstract', window );"><strong>Private Units (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of private units | shares</a></td>
<td class="nump">558,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of private units, Amount | $</a></td>
<td class="nump">$ 5,585,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesDescription', window );">Initial business combination, description</a></td>
<td class="text">The Company's Amended and Restated Certificate of Incorporation, if the Company is unable to complete its initial Business Combination by March 27, 2017, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of common stock and the Company's board of directors, dissolve and liquidate. If the Company is unable to consummate an initial Business Combination and is forced to redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not released to the Company to pay any of its taxes<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember', window );">Private Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_PrivateUnitsTextualAbstract', window );"><strong>Private Units (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesDescription', window );">Initial business combination, description</a></td>
<td class="text">(i) not to convert any shares of common stock included therein into the right to receive cash from the Trust Account in connection with a stockholder vote to approve the proposed initial Business Combination and (ii) that the shares of common stock included therein shall not participate in any liquidating distribution upon winding up if a Business Combination is not consummated. Additionally, the holders have agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to certain permitted transferees) until the completion of the initial Business Combination.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_PrivateUnitsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_PrivateUnitsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a narrative description of the nature of receivables acquired in a business combination (as defined) including the nature of the receivables (such as loans, capital leases), the fair value of the acquired receivables, the gross contractual amount to be collected, and the amount estimated to be doubtful of collection, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6736312768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable and Advance From Stockholders (Details) - Chief Executive Officer [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract', window );"><strong>Notes Payable and Advance From Stockholders (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal amount unsecured promissory note</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt instrument issuance date</a></td>
<td class="text">May 30,  2014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt intrument Description</a></td>
<td class="text">The note was non-interest bearing and payable on the earlier of (i) May 31, 2015, (ii) the consummation of the Offering or (iii) the date on which the Company determined not to proceed with the Offering. This loan became payable upon the consummation of the Offering and was paid to Mr. Rosenfeld in April 2015.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_NotesPayableAndAdvancesFromShareholdersTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6787182256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommitmentsTextualAbstract', window );"><strong>Commitments (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_DiscountOnUnderwritersPublicOffer', window );">Underwriting discount</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Deferred underwriting payments</a></td>
<td class="nump">$ 926,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Business combination, description</a></td>
<td class="text">The Company has entered into an agreement with Canaccord Genuity Inc. ("Canaccord Genuity") pursuant to which Canaccord Genuity will provide the Company with certain financial advisory services in connection with a preliminary review of potential merger and acquisition opportunities, or other services as reasonably requested by the Company and mutually agreeable by Canaccord Genuity, for a period of 18 months from the consummation of the Offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Financial advisory fees</a></td>
<td class="nump">$ 135,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommitmentsTextualAbstract', window );"><strong>Commitments (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_DiscountOnUnderwritersPublicOffer', window );">Underwriting discount</a></td>
<td class="nump">5.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommitmentsTextualAbstract', window );"><strong>Commitments (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_DiscountOnUnderwritersPublicOffer', window );">Underwriting discount</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommitmentsTextualAbstract', window );"><strong>Commitments (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherUnderwritingExpense', window );">Other Underwriting Expense</a></td>
<td class="nump">$ 12,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CommitmentsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CommitmentsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_DiscountOnUnderwritersPublicOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount on underwriters public offer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_DiscountOnUnderwritersPublicOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 720<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35755714&amp;loc=d3e28434-158551<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6779548576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,500,000<span></span>
</td>
<td class="nump">27,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockSharesSubjectToPossibleConversion', window );">Common stock shares subject to possible conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,585,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sold</a></td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sold, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Offering price</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_EscrowSharePercentage', window );">Percentage of escrow share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockOutstandingDescription', window );">Common stock authorized a stock dividend outstanding description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Effective November 7, 2014, the Company's Board of Directors authorized a stock dividend of approximately 0.05 shares of common stock for each outstanding share of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_InitialBusinessCombinationDescription', window );">Initial business combination description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The earlier of one year after the date of the consummation of an initial Business Combination and the date on which the closing price of the common stock exceeds $12.50 per share for any 20 trading days within a 30-trading day period following the consummation of an initial Business Combination and, with respect to the remaining 50% of the shares, one year after the date of the consummation of an initial Business Combination, or earlier if, subsequent to the Company's initial Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company's stockholders having the right to exchange their shares of common stock for cash, securities or other property.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering', window );">Shares placed into an escrow account on the closing of the Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,026,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hrmn_CommonStockSharesSubjectToPossibleConversion', window );">Common stock shares subject to possible conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,585,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Company's initial stock redemption</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,498,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CommonStockOutstandingDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock outstanding description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CommonStockOutstandingDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_CommonStockSharesSubjectToPossibleConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares subject to possible conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_CommonStockSharesSubjectToPossibleConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_EscrowSharePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow share percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_EscrowSharePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_InitialBusinessCombinationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the initial business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_InitialBusinessCombinationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares placed into an escrow account on the closing of the Offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_SharesPlacedIntoAnEscrowAccountOnTheClosingOfTheOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hrmn_StockholdersEquityTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hrmn_StockholdersEquityTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hrmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>31
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MV]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    ( -"
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M=(HAT0Y+U@CS#<J;D*Q]4,*@)>_C6'=F',:=.)IH?@*>"'@F8/PE(9H(T4Q
ML8ET/)F)ZQN1I,@Y&P(^_HR>Z'^.GB-U<Z4VFHLR>RHRH:SW N;@KMU,B,.(
MP L$FA% ^9X%L$_@@!TZ_BQP=!&17R#R1A 9>K2@QWYZ[*7'AAXOZ(EU 2XB
M]0LD7H'$H6>6P(A(#:(;;SA%.,/0+Y-Z95)'9F/)N(BM7R#S"F0.'=FIXH&L
MY,K&*[%Q^5:R'#R0E6S9>B6V+C^V)#R0Q"^A'PA?34'70VI7%71^.H9H);'0
M2NTB5\?.K0F3+#&;%15O >\1=E6VMHJ+6<M>Y*]B%+D>D/503)A/A9+ 39PE
MMA98/'\MY5?3%D10LEMGNM#".K>>O7EOP0>\R'MRI;\(O]:="$Y,JD?8/)47
MQB15!X)/ZEHKU1SG14,O4D\S->=CNQ@7DO6/[C>WX.(_4$L#!!0    ( -"
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M"/U@#<;<^>R[@1W<AO-Q[WFL;G"/V(Z,>!!/SH3VB(LEO7ALI!B=E*GO/ A
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M:I;K1S$$D89BT:5^%MAI,BM-9M*$&DUFMB7,TBS6&V/J8 (%]9/NR-EH&R?
M)(KT>3)KLFWA8 >T-E:+;-L?H+%XFRG78WI1TY\Y-;D.7 Z4S>YZPKQ".26U
M_5*>/&IZ/L(4^8@N^!>BEW9@SI%P,8/5I#P3PK$@!#OQ'VO$V;@N.GSF\C81
M]W0^+>8%)^/]\%M/X.(_4$L#!!0    ( -" M$C<:.W;4 ,  -,-   8
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M@KZVH+4#.,[)E3("@W/B1$<D+)8>-K02 2%%N<OFKR(SL<%Z9;K8VURT&(%
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MF/MV/'.,#[T^78]0MW/<Z@]02P,$%     @ T("T2$Y";W*@ 0  K0,  !@
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MAU=-O:\1/00EV=V>DC;\G=E04/MX_!+.=ARGT?#8W3['_$.+?U!+ P04
M" #0@+1(>@83OIX!  "M P  &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;'U3VV[<(!#]%<0'!"]V>EEY+6435<E#I2@/[3-KCR\*, [@=?+W >SU6JW;
M%V"&<V;.#$,^HGFU+8 C[TIJ>Z"M<_V>,5NVH(2]P1ZTOZG1*.&\:1IF>P.B
MBB0E&4^2+TR)3M,BC[YG4^0X.-EI>#;$#DH)\W$$B>.![NC%\=(UK0L.5N1L
MX56= FT[U,1 ?:!WN_TQ"X@(^-7!:%=G$K2?$%^#\50=:!(D@(32A0C";V>X
M!RE#()_X;8YY31F(Z_,E^H]8K5=_$A;N4?[N*M=ZL0DE%=1BD.X%QT>82[@-
M 4N4-JZD'*Q#=:%0HL3[M'<Z[N-TDZ4S;9O 9P)?"-^2*'Q*%&4^"">*W.!(
MS-3:7H07W.VY;T09G+'N>.>%6N\]%]]W.3N'.#/D.$'X"G)%,!]\R<"W,ASY
M7W2^34\W!::1GJX%_H.?;?*SR,_^5^ &)/TC!5OU4X%IXMA84N*@XY"NO,MD
MWO'X'E=XD?>B@9_"-)VVY(3.OVKL?8WHP"M);FXI:?W?60P)M0O'K_YLIG&:
M#(?]Y7,L/[3X!%!+ P04    " #0@+1(J,IPT9X!  "M P  &    'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;'U3P6[<(!#]%<0'!"_K3=N5UU(V5=0>*D4Y
MM&?6'MLHP#B U^G?%_#:L5JK%V"&]V;>#$,QHGUU'8 G[UH9=Z*=]_V1,5=U
MH(6[PQY,N&G0:N&#:5OF>@NB3B2M&,^R>Z:%-+0LDN_9E@4.7DD#SY:X06MA
M?Y]!X7BB.SH[7F3;^>A@9<$67BTU&"?1$ O-B3[LCN<\(A+@IX31K<XD:K\@
MOD;C>WVB690 "BH?(XBP7>$1E(J!0N*W6\R/E)&X/L_1GU*U0?U%.'A$]4O6
MO@MB,TIJ:,2@_ N.W^!6PB$&K%"YM))J<![U3*%$B_=IER;MXW2SGVG;!'XC
M\(7P.4O"IT1)YE?A15E8'(F=6MN+^(*[(P^-J*(SU9WN@E 7O-?R2UZP:XQS
M@YPG"%]!=@N"A>!+!KZ5X<S_H?-M^GY3X#[1]VN!AVU^OLG/$S__7X$;D/N_
M4K!5/S78-HV-(Q4.)@WIRKM,Y@-/[_$!+XM>M/!#V%8:1R[HPZNFWC>('H*2
M[.Y 21?^SF(H:'P\?@IG.XW39'CLY\^Q_-#R#U!+ P04    " #0@+1(378Y
M.9X!  "M P  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;'U3P6[C(!#]
M%<0'%(>DVS9R+#5=5;N'E:H>VC.QQS8J,"[@N/W[ HY=:]?:"S##>S-OAB$?
MT+ZY%L"3#ZV,.]#6^V[/F"M;T,)=80<FW-1HM?#!M USG051)9)6C&?9#Z:%
M-+3(D^_)%CGV7DD#3Y:X7FMA/X^@<#C0#9T<S[)I?72P(F<SKY(:C)-HB(7Z
M0.\W^^,N(A+@1<+@%F<2M9\0WZ+QNSK0+$H !:6/$438SO  2L5 (?'[)>9W
MRDA<GJ?HCZG:H/XD'#R@>I65;X/8C)(*:M$K_XS#+[B4<!T#EJA<6DG9.X]Z
MHE"BQ<>X2Y/V8;SA$VV=P"\$/A-NLR1\3)1D_A1>%+G%@=BQM9V(+[C9\]"(
M,CI3W>DN"'7!>R[N;G)VCG$ND.,(X0O(9D:P$'S.P-<R'/D_=+Y.WZX*W";Z
M=BGP=IV_6^7O$G_WOP)7('=_I6"+?FJP31H;1TKL31K2A7>>S'N>WN,;7N2=
M:."/L(TTCIS0AU=-O:\1/00EV=4U)6WX.[.AH/;Q>!/.=ARGT?#839]C_J'%
M%U!+ P04    " #0@+1(O>C@0)X!  "Q P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q]4\%NW" 0_17$!P0ON]M6*Z^E;**H.42*<FC/K#VV48!Q
M *_3OR_@M>.T;B_ #//>O!F&?$#[ZEH 3]ZU,NY(6^^[ V.N;$$+=X,=F'!3
MH]7"!],VS'461)5 6C&>95^8%M+0(D^^9UODV'LE#3Q;XGJMA?UU H7#D6[H
MY'B13>NC@Q4YFW&5U&"<1$,LU$=ZNSF<=C$B!?R0,+C%F43M9\37:#Q61YI%
M":"@])%!A.T"=Z!4) J)WZZ<'RDC<'F>V!]2M4']63BX0_535KX-8C-**JA%
MK_P+#M_A6L(^$I:H7%I)V3N/>H)0HL7[N$N3]F&\V4^P=0"_ O@,^)8EX6.B
M)/->>%'D%@=BQ]9V(K[@YL!#(\KH3'6GNR#4!>^EV&19SBZ1Z!IS&F/X,F:.
M8(%]3L'74ISX7W"^#M^N*MPF^/:3PG_DWZT2[!+![K\EKL7\J9(M>JK!-FET
M'"FQ-VE0%]YY.F]Y>I./\"+O1 -/PC;2.')&'UXV];]&]!"D9#=[2MKP?V9#
M0>WC\6LXVW&D1L-C-WV0^9<6OP%02P,$%     @ T("T2&(3V8:A 0  KP,
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MH7_7O)_[9CM]N<C4MFY/P^:\[#>8_46M#^?]\F73OOP/4$L#!!0    ( -"
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M:NNG.S?78X.,"ZNZ:[O/_YSB/U!+ P04    " #0@+1(]&7NZ3@"  "Q!P
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MVOQWMN=:R>(:XCH%_VJ/66F.E_9)G'9A= !T = 'L/!F0- %!'U ZM\,"+N
MT*K@M4,Q$['ABB_GE;PX5?OV3KQI$O8<ZJG>-C?-S)IG>BIJ??=S"2R:>Y]-
MHDZS:C4PT+# 'VO66 -CQ890!+W$TR9[IT Z!1,?C)S&=(* 3!"8!.$@03BS
M1M%*8B,IVY'ZYL\:RWW=R$](^@FQG]3RTTK201W_25=AEIV[LI&;B'03(3?
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M'$? %&_54G='_5Y5R[)8)V]T=:NKY+*L5J.!F2YA&Y5:P/)3_2GY@UYWQUW
M1J>TV=<+==O]=:86=6_YR[:JZ(.\SF#J_Z-5A1!,7JJF-_;P<'Q\>#(>A-"'
M]:KWS?CH\$^#'USK*B^G@^N92_OJ5[_:>#/^WE_#'WNXT1TIZT;'_JEW/H'^
MZWR!]P/[O"VK'NC?EL6ARC(-8V#$E$</W6.YA"M/;IHR^Y@F-X3.R;NVJ1O
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M'WE<&K ):+[).Y)R\YS7[60!U/9.MI$20CYP7U=%#===@2J9]X=&L4(DXT;
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M3XQ*N)3'FF)YKKC/6SB57B CM/D.XZ/)V>%8*-?FE%Z@&>P[WYEC&H2E? *
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M?'%!GH@==TR=-B-*G%3D__=!;C;55TU6Z$/FY$;.VI#TV A=(!,MLYPNA4U
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MSG1?OKQ1G_)ENQRDJS-0)GL[>0,L8--')[&/WI%3,CC^*PXH[=1R8X<P74#
MYK-A.@X:3*1&8+ AM#G1&Y;8.B =$.CO@A#<9M>:E/Q'S;:SN%<MB*%LZKW@
MA2TV^ )W[/[P]3]-[X>'!!ZWA1@>NR?\3^N>\/5_F]X)7__2G1,&G$A?T@'%
M3?FTKIMO_S]02P$"% ,4    " #0@+1(LZ7R(X0!   -#P  $P
M    @ $     6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0    ( -" M$A(
M=07NQ0   "L"   +              "  ;4!  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( -" M$C/^U_+. $  'D-   :              "  :,"  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -" M$B@"LHD0@(
M !L'   0              "  1,$  !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ T("T2'7/L[<^ 0  :0,  !$              ( !@P8  &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ T("T2)E<G",0!@  G"<  !,
M         ( !\ <  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #0
M@+1(:Q3ZET<"  !\"@  #0              @ $Q#@  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( -" M$ANBH:9T@(  .\'   /              "  :,0
M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #0@+1(>51R&$("  ".!P
M&               @ &B$P  >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ T("T2!A]$HXV P  UPT  !@              ( !&A8  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( -" M$C!N3<M)P(
M '0'   8              "  889  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " #0@+1(,U5D$E\"  "-!P  &               @ 'C
M&P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ T("T2-QH
M[=M0 P  TPT  !@              ( !>!X  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( -" M$A.0F]RH $  *T#   8
M  "  ?XA  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #0
M@+1(>@83OIX!  "M P  &               @ '4(P  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ T("T2*C*<-&> 0  K0,  !@
M         ( !J"4  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( -" M$A-=CDYG@$  *T#   8              "  7PG  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #0@+1(O>C@0)X!  "Q P
M&0              @ %0*0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( -" M$AB$]F&H0$  *\#   9              "  24K  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ T("T2%'W\ B@
M 0  L0,  !D              ( !_2P  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " #0@+1(4<,6T!D"  !*!P  &0
M@ '4+@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( -"
MM$C5=*;350,  , /   9              "  20Q  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ T("T2#:P-M6% @  B D  !D
M         ( !L#0  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " #0@+1(;WW3)W\"  #("0  &0              @ %L-P  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( -" M$B[T&,(^0$  -,%
M   9              "  2(Z  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ T("T2)\BT-+$ 0  ?P0  !D              ( !4CP
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #0@+1(]&7N
MZ3@"  "Q!P  &0              @ %-/@  >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( -" M$A+ZTTV'P,  $D.   9
M  "  ;Q   !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
MT("T2-IWI?$4+P  >=,  !0              ( !$D0  'AL+W-H87)E9%-T
?<FEN9W,N>&UL4$L%!@     = !T O0<  %AS      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.4.0.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>26</ContextCount>
  <ElementCount>115</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/CondensedBalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/CondensedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Statements of Operations (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/CondensedStatementsOfOperationsUnaudited</Role>
      <ShortName>Condensed Statements of Operations (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - Condensed Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/CondensedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Disclosure - Organization and Plan of Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperations</Role>
      <ShortName>Organization and Plan of Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>007 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>008 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>009 - Disclosure - Private Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/PrivateUnits</Role>
      <ShortName>Private Units</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>010 - Disclosure - Notes Payable and Advance From Stockholders</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.harmonymergercorp.com/role/NotesPayableAndAdvanceFromStockholders</Role>
      <ShortName>Notes Payable and Advance From Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>011 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>012 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>013 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>014 - Disclosure - Organization and Plan of Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperationsDetails</Role>
      <ShortName>Organization and Plan of Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/OrganizationAndPlanOfBusinessOperations</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>015 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>016 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/InitialPublicOffering</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>017 - Disclosure - Private Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/PrivateUnitsDetails</Role>
      <ShortName>Private Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/PrivateUnits</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>018 - Disclosure - Notes Payable and Advance From Stockholders (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.harmonymergercorp.com/role/NotesPayableandAdvanceFromStockholdersDetails</Role>
      <ShortName>Notes Payable and Advance From Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/NotesPayableAndAdvanceFromStockholders</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>019 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/Commitments</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="hrmn-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>020 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.harmonymergercorp.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.harmonymergercorp.com/role/StockholdersEquity</ParentRole>
      <Position>20</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>hrmn-20160331.xml</File>
    <File>hrmn-20160331.xsd</File>
    <File>hrmn-20160331_cal.xml</File>
    <File>hrmn-20160331_def.xml</File>
    <File>hrmn-20160331_lab.xml</File>
    <File>hrmn-20160331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>37
<FILENAME>0001213900-16-013671-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-16-013671-xbrl.zip
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MD[P(DS' Y8$EERS%/F*?D7DZZ'7WESW%=[@/)6F2E-/Z9Z(BVRWF,[$+-^W
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M=*PP!(E^OPZSR$HX^GR]:A<TX29W#"?X9@S"&MZL>.[',(_"OP>Z)Q'(O6\
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M>5'K]!# \RQ%N59/B#EW3M-23Q'EU&R>"RC9YBQ1M$G]4KN9N_@]5"7 ?KW
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MR+S/T-_DS&[W'%5>_.#X4HI)\/X&7D9JQ"<>0,N9LDF=8=;2-5S]#M=P<2"
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MD2RG0HLVIF+/K!<FLGF:5)=.',?%"L9!@FL*@.0!J&LT8I8X;@2<687T:/Z
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MCQW3CY\V/FD] Q>8T=MV[Z+;;@%UF8?IXK;]]#CL_-%N??KSUU\^$DQ_S)"
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MM (I>TS5*\PFN>*?Y^P3]8-4<V8M<!&##2WT8Q(@2K7VNGB-QZ;?@P.;B4_
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MA7,:9/?S.&+_<_[?>_(0;.C;9//\-$C39^IP_19L]MHXI24S*-MABK4ABY2
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MS-&?OLI&?Q#GP@OO0 #N171K L-Z=0URWZZ,F'H.>CZ^7A%19UM4KH9X4##
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M1$G!,SV.:3RJE-T/5G ,*TPRCVHG&$JD4LGK>$R]RI;Y/4[MEYI2"YGQA+8
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M>IZ,SF^,G&Z2#$<Z>ZHA!DGZ5F!IB&31*X*/E3>CQ&CHG&T7%/S>! KYN)E
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M0NUB!#FM1X<7;D#E6GSSYD=F+0Z]7,:U&",TVS.#>00/RA .#^^Z"@O"!,)
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MYS]GB,BS77'?+CWP\,9>6HJO17F4;EZ][:/,D_^<RZH++'DN9OF^5LFD1JQ
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M)+0QPU@/-/!T9L<X@B,MYW4Q.+^ M\:8^0/LB4&<;>GBPMHQ3I,G3 GZ^OI
M>_J&O&T(AR'=X%?.)VIPYI5!GX!5= A79 N<'IR,[39<P&==.[9T]F+N4J3!
MW@D,H]^+K KTFB1W*$Q(B&.TA762N)LFNO@ZZ".W2R7KJG^ ;3-\9X7U&95M
M:% T(G5RNDW.)$4**5UYZ,-[5Z1RG!I,NL2#18EV8(J"#%VBZO]&E]61#WK7
M#9J50-L/#J-(=OWB@_5W'_%V;B\C)=H6/0)K@P&9N@JQC['MI,)[KN\(]& G
MI8R1(NS('H&]H0--X(#T84;0W]LY.1M#.UHX/B\9H/;AODF ^(8\T1V9(X.*
MI+(CRLK7WJ"BP.G#W$*GRG(K=YVD%'V(4)2QMX@KY/4#[4+U4 N#Y^FS8Y:O
M)9IPO=A]Z/>;D^D#/,>?2STQA V</:Y+=:D=)=VL.I+*P+,).EUV5$"/,NBG
MGAQ'L]&,-H'MXY.,NWA(2H,G&[0DA&,#DP#T8GW86@"SK&#1TE3W-U[.LFV#
M2A8\1Z$3/3"#Z\5FDH/TAB7C">)Q\1CC<#T8#)6#6P=X@L/.E40,VX<L.OQA
M\1;S^@TOF5O%.$AS0EOY0/M">A0QKPT\^^$!9AEU!WCBAZG9D4YVG>")$ITJ
MCB%N'YP_^0^056_-[EJ5)1IC4LT19%VT.:$80_3A$9/#O-D'G[K1G4+PL+F:
M*%:ELM'6IKG7^@"?ZK$[?6AD?FSM_UWIPQ6!.OG>%ZM57'94$*\[BO-DL\P'
M5Z^&(\@#::,1)NB 0]WYEJQA&*9%$(]F>V]'4'V6O*"ADH//^VC #,>DI86O
M*W^NP_K\C])Y0/ ?5;>0:!P'9#3[6F28H"S;A+,?VN>_V:P+^OU)C*.W-C;Z
MHI&A8!.TH#$Q.:D?)(H@R(L4-3,-R YZ>X6AHP"<];O@A,<%[,=(O<=S@F<X
M#$A>>__0R6A,.[!\.07FP;-&"W2\T85"$"-)VI\3RM376&[<UZL >L3).UVP
ML=%&YL?0XEONV_O;<VJ5#!.UD.$P,6B63-\UI*"47*_+.#L\-1P_-'N<TH-J
MCJH[A=87WXW*5'K,*^M$?9L5*[666QA4647]PKM8%S7>#]6\37*T]E\N\]P\
ML8L<=JG3S+S>6FGY7U->'I7AW/7WJ/39L!HGJJ[YG<I18%H/Z "QZ&C.V+&!
MW%V Z:'#^-\>$SSTL4#RCN$ESL(XR>CQ3..D8%0/Q.&AT<!-@W0.#7)!Z,."
M<;\+3.5*D+Z,-<X3*H=.U*+['.+.*R@0)^Z]SF+3M-GXT:X#>BCM=[?@K&T"
MR(^=G]2\<+)H64-@F8FRT6RG4:_5OSJ#2Z\"Z)%E8]'21^9!F+[ E45;#;3D
MH7/-V&B!-K"CS-_!FKWK?=#,-?$/%$=UOHFZ<]24NZD8.B6,B2ZX0^R#:_)U
M@-/2<:5QX79#:-\5R\W0D$P56O+@"6$LI@IM8#YX%>^F.-1?*A22X!E<+)C7
M@ 3\(HWZ+2KQTTJZ2X)-9=!)5\R7 5N4/F1XK9(838(7_=$N$H'.L6(SS&58
M?'B7YB&C2]=5EN-ED$NC0;8+0J=$L:%R'T%G;\P<D,!;]-SHC#0A],<0-78?
M^N/6M"KHU"8V2F"#L5:3G_JL)G3ARM!_"HKSZLE&-[3DP9.;6'DQ:2.K]>!+
MS^VJFKZ\ER@/<'QRZ3T6E][[<(&B(BXCY6,*+*F>^AFF:4#F:'T9=YO0#0O_
MSQ/Z4T8;S\B=*/+EN?\R:'-PQR[%W728(RMS#+/F3'#..N2&1/@)1T40#U^P
M;(O)+0]M0.Z&6+X2"3O ,SWX#>>+.Q17Z\P"KR;)%5VT\]?+9!E@W@O8EC5!
M&YR%?&K2KT;7;\6X6& TNWI!8<'&S&@VPR%*OR/V@H[LWDDL!6U"MF!0< 4E
MQ]AOVMF.&T<X2%_O ]9=I65-L38(9:!MQX=<'Z2=X.HR$DHI-HAN@R7]L=$O
MRG5!+0QM=)92)V!;"U2_IX*;\4@YW[^5@;8?ZQ$BL",W0?2;,P?SW#=,T T]
M6\EF?)=? VVN/N0BX;K?7/DOF&LK_P)3TWS%3'>%]*61%K5!6[Y=<\RY]+3O
M&%C7.('2U+%[Y55]Z;!Q$2<9]X%*:7DP"W=+3G@$RR >/8>9 7_9&AADP%)W
MW#7A^9 T=52VF9ZAT0N*)@G+W?CF]%X!EIGWE<)@J;&=JH$A7A^<$,N-=PDP
MNBR8]E=9]\JIZQ8]EW^1FA!TY,$R;G>B'?J07?DGKI(,LUT'D(X<..$RD+FQ
M$UTQ@^W*M]'ZG57^'J$ZHF^W=YSB$*W=-$4;!J4@6'9M][L'/:P^."^*<D"7
M&1-H)U:>/X9SP7X%8(FS#S81"##[X &Y[JEA2#=-;/%B_@%9SJ+ Z <4075C
MTS@[BQ[R:%DC6!;M3K2H32?XX)?9>!NKF192_6:I7! L;78W4XT:JP_.EY?H
M,=]$!7UGV0?9'3"=3B]1%J:XA"11"2UYL/S9G6B&/N3.O#(/J"!O860W9%7D
M&<NH0=LT3M$2%TN)8DCEP!)H=Z(0:JAOMJ]>:P*F1R[TC9Z@HQO*&)FS(*-A
MEJ$\NT6RG:I<$"QU=C>ZH,:Z5H9>6T(;@6?*E/H[1<%R:W=".!?=FN+61DUK
M&X33\P?%^(A)U67U%OD.A8B>NJAR9WH;!>.ZIN<^F3OMX*_UJ->QV9SC5@/G
M[JG+[/ JJ6AZ[I,)U +[6GF.*\B;,Q J<U]]8;@)6D9IR%B;"PVC%E5-S[TQ
ME=JB7ZM%:^OIT:U-]SE:-<9'==-(=V&(=@<]L=5#!$D5RV7UTW.?;*_.>F2M
M@,?UD@QG@AT7:;@(,E1>0-#=^V1K.Z^:E;0KFI[[8%QM@7VM$.Z-JD>4%1 H
M9M6#I("GZ-+#!YZ?0D9U7Q:4QP:)A?X_!8_*>Z'?:G%'MSIT:<M1Q$?)_U09
M6=*F6NC84CG=?!5IB[??2O1P/V'/\A;IZR:#HU)%Q$+0L:9MR>2KB!QOOQ7@
M%'=ZBCL]Q9V>XDY/<:>]Y&S7 U%)(%\ /!:T!9MB1#X$_KSE6ZILG!?)<I40
MC?.?5 XZ5/.@Z[2J(^!B>=TDH-Z&I5R>N>7!DQ0J6>*3*P;3[VF]X=NA3OVS
M6Q8LIE/-BM*3I8&@WPQ>HADF*/J*"/TA9Y<;7U_9O^7MPP55]GF2,HNH?!8W
MJ 4LA!-B4C?M%U>1?%"[O'UHRGE>* ,6S6E+GF#;)\77[\FCWM)6\^AU02*U
M34XD A:/J<>3=$O/!^/#*U,]S!8$%>H)<FWDNN-<10:[RA<D=1C0S!)D4@=8
M,&AGC')\4(P[Y!@3RC3?=2G=^22ONX@TPZ0.V !/8\HXM!NC]6 !>[C_-:&0
M"!LCFSNQ(5WCT_25=J$J,D-+'C:LLZ5JF"/UP5HICE"4'G)%0K#AFXXT0 '/
MARQ$=?=DX^"5;:SHFDH_20O:<AP\XKA4^8LB93U>K[?5+VI/0.,J80,\':E,
M*_"N;!VP7O;K+MC$*-VBW$AS!)*P49^.%42&$?BE16>NCPHG1]B@3D=\O@%Q
ME6 (=O *4JQ5V^,6:>EV*H -U'1$O0%45YF%UOGH_G6\2C+*%U)SIUH8-@KS
M$,JQ@>DJ-]!Q* :;#*\O;R[HIKF@+1\N6?<I5H&]\K#QE@Z7!3ZRSC( '39P
MB9M+T3Q@B6_*XE:NLFI*A4""D-Z<%4=I=2'R'>6+)+HA3RC+$6JX3GU]W2^\
M+J8,/W+X-5"!1WH$"F9:Q_C[?0'IUBL<VC'!,;4J!>+ [[DV=.P.#NR/(&5.
M0+86J'ZS;N8.#NQEH$<(G\PM$/WFK!MO8>B;_\/,WZHNZ'E,CQL_8>C('15)
M?&Z%6/H]VG\+F*>".N9CJQQTX(Z0"SYU>VWO-V7<O<8W#5\NN2!X_ [<%GNK
M#X[M73;N8533OTI'%CR01\D(QV%&%]@QND?M&60G"U3;9,L.>*#8,N&#3*95
MP+ZLILL3AV)3C(ZH!GYHIP14IIN23>1OA6#?7K-C5X"BYWOCA@O?.$A':;G-
MK%Z$DKR18R -^[Y:.ZIUX?G@R%1-2=7$I7HB22D#^VR:@_$M!.6'BU%CRZ+-
MM4 $]M6SEE3+,/G@1,3)#7E%.RED.P7FAEGG,*[^,I"P;U81[.-H[73" JD/
M3Z-Q,LW>H2!+R'62<OZFH2J:-<$^EN9&5TR@ K^1QC_;35"Z',UJ@Y/H]+95
M"#9XI<7Y;!^%*Q<BV"5]V]?^#D5H6>)8+VSJ]-N:-<#&IK0;L"80/?$SJ@.*
M2[.#*_>B9ITJ6QZOK*$SD;P1>1T5P"RIA J_BOQ]-*1 W7=$/<69Q-0H^GU7
M</@4(I!&"C6;HMG,"%^_5<)M(I >Y0&Q2 /2>P<<EUE CC8)B'D.$/ 4((8K
ML>QV5U,2R@/':F(VP 1W;:#>TFG>TDI$H)QE# B0,"< Y$'R@J:O8,&F%/I+
MP]Q]0QJ^@YJ.K:IJH)QN=!A56H6UT#G2"W]N!"#M VT9WT/B0VZ*!KZ+A&0X
MJE^8JF*H430R'_?J>J <=)RH@1X\'^Y]8=^;!?7RL5(2.XRNKHV!C8FW28[6
MJ3D"$@VCIX"$Z)IV:SEJ%DE,83HS,S:_;?CV;5GY=6QZKK].M4\UK ;VN;4[
M%#,?DW&0YJ_-%&Q?7[?^HOVBFD%]H,9/"Y($D[@M]'Y;3/3 *@RF^I6 !S;:
MLLQ7&C/@_FB*TH*Z7QC:=&I&E9IN7TRF%PN,9E<O*"R8I\IH-J/GF%2=05\L
M!6TXY9/$)U0!PP-FZU>!R=R(6;X4=%2C,;-B&#WWOA9,9C*[N:XH>+SB05;H
M+;C'9E/7W--JFMOM:H..>=3AC6.*MP?K@95^VTMI2 B%.$XQ"?&*_A"\+N59
M('7$06VT]N2*_"#T 'NG&NQ"@G4=\TN6>6]+I$"MM-TJPAY.'TSYXI3*>B9:
M+7E8LVRW6B&#[,J>S[G*.ZR=E@6NX;Q\Y<'<&.LLKK!N 7MU.BG3 "+"D@!>
MXBR,$Y;63[+EL:KG9+H%>V/$D*63[?9DNSW9;D^VVY/M]F2[]=EV>\>>TU+-
MW.LRT'99UQ-S$U??#;4,BW)$-DI!FU^W.E_"SZ:U_1YHWX,7O"R62HJVRH$;
M1[<9X-.TUV(O_$V_8Z+'5[,<=*XW/;YV6^R#V:G+BRKH1&X'OJARZ#?JZJ*J
M<7S7O(P22X#9#DT(X-PX*1 =8]P5,ZVP9S%&Y('0UCVGF%7?"(T7L:<4A,W/
MIJ""0YX>("\6SOH^*[M.TC>LF,RO7E:(9#+#HEP0-DV;$>,&@%PMO;"4<U(2
M-6XNZH1$%,H5R7'^JN&?KU<1;!(W*Y6P .A##$?Y');9;" 2@4WG9D6Z%$IG
M@1< XW\WY*12\'J_<Y%DN6P;KE\);/:V5N->$YRKU'[@][S-J)LJ70#0=6_U
MY1KWN=L%3Z^*'?6K8F+2!/>WIY?$3B^)G5X2.[TD=GI)K,9X>DFL?YQU]5 -
M].WN,3Q4<X29C_;WT)HV<*4@]!VPF@N.*54+E0>>].-U2TO 58*?84$'1(K_
MV!S&N(GF9(*@Z8ZTN!,84Y6HO./<XKT3O0I @VN<Z8 ,G0]7VCR-KS)\&0[^
M2@@TD,;QP-\@\L$ZSD,X*O(L#TB$R=R0[88D;)B,8\YW<?E@.&^\WV2PP$ND
M8._%6S"NPM2A11R&;Q\?,W/#O\Y+9KU^RF;O!<;J^<42["UZ+O\B?Q%<0Q[V
M<KR%)NBC WZIIDM=J.; %LJP4P'LK;E[;>#!<_5,#O@CAR;/E$+>A+>A=1M"
M9T_9M+&[766T)YZKELJ>)Q(7AGTZS((>!92:IB]'15-CY] X(LB3#>@)PCXA
M9DN?'JPW \E1<5D_GL7QEM'@4TL8]G$P6T[UH:UYA?,H%5QBE OV. Y"EJ ^
M3X:DFF:&8>T7/5F@BSC)RAQJ].?URVG"NPW+^J:#GIG!VJ-=JP24C4PY;5?H
M[HO'WU&83Y)QDF7X,487":%*F.G-X,HZIN<]LX79(5R3W6NSV.&>BCSOJ;G,
M!-]:)7K]4/3>0%#>A @DIN?]MY#MX5E3W&NSV!Y O3L0F=CTO*=&,"6H->/N
MC5]<!_$SULK'($/TE_\#4$L! A0#%     @ T("T2!$3&96Q3P  124" !$
M             ( !     &AR;6XM,C Q-C S,S$N>&UL4$L! A0#%     @
MT("T2-U.,( E"0  AE   !$              ( !X$\  &AR;6XM,C Q-C S
M,S$N>'-D4$L! A0#%     @ T("T2+0O'.^[!0  GTD  !4
M ( !-%D  &AR;6XM,C Q-C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( -" M$CZ
MT((]\0\  /H" 0 5              "  2)?  !H<FUN+3(P,38P,S,Q7V1E
M9BYX;6Q02P$"% ,4    " #0@+1(O#Y"IPDL  #H>P( %0
M@ %&;P  :')M;BTR,#$V,#,S,5]L86(N>&UL4$L! A0#%     @ T("T2&-I
M8+;0&@  +-8! !4              ( !@IL  &AR;6XM,C Q-C S,S%?<')E
:+GAM;%!+!08     !@ & (H!  "%M@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
